<SUBMISSION>
<ACCESSION-NUMBER>0001903596-22-000293
<TYPE>10-Q
<PUBLIC-DOCUMENT-COUNT>56
<PERIOD>20220331
<FILING-DATE>20220516
<DATE-OF-FILING-DATE-CHANGE>20220516
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ALR TECHNOLOGIES INC.
<CIK>0001087022
<ASSIGNED-SIC>3669
<IRS-NUMBER>880225807
<STATE-OF-INCORPORATION>NV
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>10-Q
<ACT>34
<FILE-NUMBER>000-30414
<FILM-NUMBER>22927602
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7400 BEAUFONT SPRINGS DRIVE
<STREET2>SUITE 300
<CITY>RICHMOND
<STATE>VA
<ZIP>23225
<PHONE>(804) 554-3500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7400 BEAUFONT SPRINGS DRIVE
<STREET2>SUITE 300
<CITY>RICHMOND
<STATE>VA
<ZIP>23225
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ALR TECHNOLOGIES INC
<DATE-CHANGED>19990524
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sfsalr10q051222.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ALRT="http://alrt.com/20220331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_ALRT_alrt.com_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001087022 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCentralIndexKey">0001087022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0018" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0032" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0033" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0038" name="dei:EntityEmergingGrowthCompany">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" contextRef="AsOf2021-12-31" id="xdx2ixbrl0053" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-03-31" id="xdx2ixbrl0103" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0104" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0143" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0182" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:StockbasedCompensationgeneralSellingAndAdministration" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0236" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:FixedInterest" contextRef="AsOf2021-12-31" id="xdx2ixbrl0386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0588" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0590" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0596" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0598" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options11Member" id="xdx2ixbrl0788" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options11Member" id="xdx2ixbrl0790" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options11Member" id="xdx2ixbrl0792" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options12Member" id="xdx2ixbrl0800" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options12Member" id="xdx2ixbrl0802" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options12Member" id="xdx2ixbrl0804" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options13Member" id="xdx2ixbrl0812" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options13Member" id="xdx2ixbrl0814" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options13Member" id="xdx2ixbrl0816" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl1023" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl1026" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_OtherMember" id="xdx2ixbrl1064" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31_custom_OtherMember" id="xdx2ixbrl1066" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31_country_SG" id="xdx2ixbrl1070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_country_US" id="xdx2ixbrl1072" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31_country_US" id="xdx2ixbrl1074" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl1078" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_custom_OtherMember" id="xdx2ixbrl1082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_country_SG" id="xdx2ixbrl1086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="alrt-20220331.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options10Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options10Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options17Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options17Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options18Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options18Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options19Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options19Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options22Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options22Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_Options23Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options23Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 3.5pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20220101__20220331_zxxddKIxpD1b"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--DocumentQuarterlyReport_c20220101__20220331" title="Document Quarterly Report"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">[X]</ix:nonNumeric></span></b></span></td>
    <td style="width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUARTERLY REPORT UNDER TO SECTION
    13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED <span id="xdx_90D_edei--DocumentPeriodEndDate_c20220101__20220331" title="Document Period End Date"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">MARCH 31, 2022</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>OR</i></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--DocumentTransitionReport_c20220101__20220331_zxzACOZuPrMg"><span style="-sec-ix-hidden: xdx2ixbrl0018">[&#160;&#160;&#160;]</span></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number <span id="xdx_907_edei--EntityFileNumber_c20220101__20220331_zUfxea36Dbjk"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityFileNumber">000-30414</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityRegistrantName_c20220101__20220331_zEC9kRSbN3q4"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityRegistrantName">ALR TECHNOLOGIES INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Exact
name of registrant as specified in its charter)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20220101__20220331_zAv7GpOjbDGl" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">nevada</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State
or other jurisdiction of incorporation or organization)</i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20220101__20220331_zu2qmhP1Wmbl"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityTaxIdentificationNumber">88-0225807</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S.
Employer Identification No.)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20220101__20220331" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine1">7400 Beaufont Springs Drive</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressAddressLine2_c20220101__20220331" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20220101__20220331_zm5u9wymXRBl"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressCityOrTown">Richmond</ix:nonNumeric></span>,
<span id="xdx_909_edei--EntityAddressStateOrProvince_c20220101__20220331_zTKUk2iDtxa9"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressStateOrProvince">VA</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20220101__20220331_zl9uutYHVgob"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressPostalZipCode">23225</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address
of principal executive offices, including zip code.)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--CityAreaCode_c20220101__20220331_zAkfNzAIb6k9"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:CityAreaCode">(804)</ix:nonNumeric></span>
<span id="xdx_90C_edei--LocalPhoneNumber_c20220101__20220331_zRKAgsBVB7vh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:LocalPhoneNumber">554-3500</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Telephone
number, including area code)</i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the last 90 days. <b><span id="xdx_904_edei--EntityCurrentReportingStatus_c20220101__20220331_zicuWzZGS3yg"><span style="-sec-ix-hidden: xdx2ixbrl0032">YES</span></span> [ x ] NO [ ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit and post such files). <b><span id="xdx_908_edei--EntityInteractiveDataCurrent_c20220101__20220331_zPQOnU5Jjy9h"><span style="-sec-ix-hidden: xdx2ixbrl0033">YES</span></span> [X] NO [ ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; &#8220;non-accelerated filer,&#8221;
and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Large Accelerated Filer</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accelerated Filer</b></span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityFilerCategory_c20220101__20220331" title="Entity Filer Category"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Smaller Reporting Company</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntitySmallBusiness_c20220101__20220331_zZ4fHfLsb5P2"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">[X]</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Do not check if smaller reporting company)</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20220101__20220331" title="Entity Emerging Growth Company" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0038">[&#160;&#160;&#160;]</span></span></i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <b>YES [ ] <span id="xdx_90D_edei--EntityShellCompany_c20220101__20220331_zeJWKemerKB1"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">NO</ix:nonNumeric></span> [ X ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPLICABLE
ONLY TO CORPORATE ISSUERS:</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
the number of shares outstanding of each of the issuer&#8217;s classes of common equity, as of the latest practicable date: <b><span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_c20220516_zpi3uQDeXHIa" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-05-16" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,716,844</ix:nonFraction></span>
as of May 16, 2022. </b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART I.
    FINANCIAL INFORMATION</i></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Financial
    Statements.</span></td>
    <td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Balance Sheets (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Operations (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Cash Flows (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Condensed Consolidated Financial Statements
    (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial
    Condition and Results of Operations.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market
    Risk.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART II. OTHER INFORMATION</i></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defaults Upon Senior Securities.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Signatures</i></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART
I. FINANCIAL INFORMATION</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 1.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                                            CONSOLIDATED FINANCIAL STATEMENTS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_001.jpg" alt="" style="height: 79px; width: 236px" /></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Financial Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
2022 and 2021 </b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCCCCC">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 84%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 16%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Balance Sheets</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Statements of Operations</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Statements of Cash Flows</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">6</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Notes
    to Condensed Consolidated Financial Statements</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">7
    &#8211; 22</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_zyaIOH2RUBri" summary="xdx: Statement - Condensed Consolidated Balance Sheets (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20220331_zC3iqBf2kbXg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20211231_z7u6AfuwHbug" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsAbstract_iB_zozD1qUrZVTb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 5.4pt">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrentAbstract_iB_zWmYvqfnTWTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Cash_i01I_maCzv3z_zYrJzC5oTIEc" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-indent: -7.6pt; padding-left: 7.6pt">Cash</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,937</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,922</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_i01I_maCzv3z_z2E3uN1oKnS2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">Share subscription receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0053">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidExpenseCurrent_i01I_maCzv3z_zSUjavMcunK1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Prepaid expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,416</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,295</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Assets_i01TI_mtCzv3z_zBA8LUj8JAb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,378</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Liabilities and Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrentAbstract_iB_zeBj4kGBxAh4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i01I_maCzhqY_zJRSJd2lrm9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,323,363</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,130,546</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--PromissoryNotesPayableToRelatedParties_i01I_maCzhqY_znb28sSxBt8j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Promissory notes payable to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableToRelatedParties" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableToRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PromissoryNotesPayableUnrelatedLender_i01I_maCzhqY_zQy3Mfqviik7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Promissory notes payable to unrelated parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnrelatedLender" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,412,763</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnrelatedLender" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,213,368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestPayableCurrent_i01I_maCzhqY_z7iUJmH1NQ5g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,248,183</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LinesOfCreditFromRelatedParties_i01I_maCzhqY_zn0sqUBwb49b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Lines of credit from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:LinesOfCreditFromRelatedParties" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,613,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:LinesOfCreditFromRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,008,833</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_mtCzhqY_maCzzck_maLASEzsdZ_zBDXKPi5FHTa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,639,349</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,505,360</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_iB_ztaw1ONWecnb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Preferred stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">Authorized: <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20220331_pdd" title="Preferred shares, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span> shares of preferred stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred shares, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span>) with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220331_pdd" title="Preferred shares, par value"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred shares, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Shares issued and outstanding: Nil <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_c20220331_pdd" title="Preferred shares, issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_c20220331_pdd" title="Preferred shares, outstanding" style="display: none"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock (December&#160;31,
    2021&#160;&#8211; Nil <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_c20211231_pdd" title="Preferred shares, issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_c20211231_pdd" title="Preferred shares, outstanding" style="display: none"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span>) were issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PreferredStockValue_i01I_pp0p0_maSEzTTC_c20220331_zR3ytNJSif2e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0103">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PreferredStockValue_c20211231_pp0p0" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0104">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Common stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Authorized: <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_c20220331_pdd" title="Common shares, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000,000</ix:nonFraction></span> shares of common stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd" title="Common shares, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000,000</ix:nonFraction></span>) with a par value of $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331_pdd" title="Common shares, par value"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Shares issued and outstanding: <span id="xdx_906_eus-gaap--CommonStockSharesIssued_c20220331_pdd" title="Common shares, Issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_c20220331_pdd" title="Common shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,716,844</ix:nonFraction></ix:nonFraction></span></span> shares of common stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20211231_pdd" title="Common shares, Issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd" title="Common shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,716,344</ix:nonFraction></ix:nonFraction></span></span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CommonStockValue_i01I_pp0p0_maSEzTTC_c20220331_zHqo0Xa1LoEf" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">542,716</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CommonStockValue_c20211231_pp0p0" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">542,716</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapital_i01I_maSEzTTC_zSQ71oWfgn3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,517,579</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,171,627</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_pp0p0_maSEzTTC_z7nQQllqIW5a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">12,340</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">11,409</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCz7m6_maSEzTTC_zBpVwwEML9Ri" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">103,419,926</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">102,015,077</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_iTI_pp0p0_mtSEzTTC_maLASEzsdZ_zXrQN8JnZRPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total stockholders&#8217; deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">25,371,971</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,312,143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEzsdZ_z8bNC5Dd1N6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities and stockholders&#8217; deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">267,378</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of presentation, nature of operations and going concern</b> (note 1)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsequent
event</b> (note 11)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Operations</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zvZlgqAdhqTc" summary="xdx: Statement - Condensed Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220101__20220331_zcs7E28KZDRi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20210101__20210331_zKkZKuNn02Ci" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="7" style="font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_maCzQHd_znEKb6McoTTg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: bold; padding-left: 5.4pt">Revenue</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,043</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0140">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_msCzQHd_zxAnPGr2gY8c" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 5.4pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">594</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0143">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GrossProfit_iT_mtCzQHd_maCzacg_zNsrUzcepbv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">449</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0146">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingExpensesAbstract_iB_zIvaErSlDYsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ResearchAndDevelopmentExpense_i01_msCzj3D_zjSVzBfrufei" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,042</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfessionalFees_i01_msCzj3D_zYpVQEBIYPPk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,617</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,228</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_msCzj3D_zfqhtF8HvJPf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,825</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,286</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_i01NT_di_mtCzj3D_maCzacg_zbTvVeMPK3Ql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Operating Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">854,662</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">537,556</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i01T_mtCzacg_maCzujC_zpDFz8CsAscb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Loss before other item</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">854,213</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">537,556</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zjCQG61giJld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Other Item</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestExpense_i01N_di_msCzHYw_zcNvvt4ojso4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,636</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">479,367</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzHYw_maCzujC_zu4mITG2mhl1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total Other Item</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">550,636</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">479,367</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_i01T_mtCzujC_zp5WRfp1Soqh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,404,849</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_iB_z32ZR3aRy2y5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_i01_zrU8sYQs3N49" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Exchange difference on translating foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">931</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0182">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ComprehensiveIncomeNetOfTax_zvW45kNJ4O9a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,405,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_zNnAeslHobei" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Weighted average number of shares of common stock outstanding, basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,716,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">521,414,066</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--LossPerShareBasicAndDiluted_z7xqTpBpjIne" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Loss per share, basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Cash Flows</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_112_zQFv9p0xlXN3" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20220101__20220331_zi84vcSJLsf8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20210331_zdQvLr13ozwc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="7" style="font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z4lFUbU45Ve9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_i01_maCzoUu_zOWMOqE10X58" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,404,849</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockbasedCompensationproductDevelopmentCosts_i01N_di_msCzoUu_zC9IfWNbe9b7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationproductDevelopmentCosts" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">62,168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationproductDevelopmentCosts" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockbasedCompensationgeneralSellingAndAdministration_i01_maCzoUu_zbjl1hOnpzIi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-selling, general and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationgeneralSellingAndAdministration" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,662</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0203">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockbasedCompensationProfessionalFees_i01_maCzoUu_z1UCfAJ9GMh5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationProfessionalFees" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,959</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationProfessionalFees" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,225</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InterestExpenseOnLinesOfCredit_i01_maCzoUu_zZHRRmLYh7Sb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest expense on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCredit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,922</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCredit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">314,737</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashImputedInterestExpenses_i01_maCzoUu_zcQL1Kvomwsi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Non-cash imputed interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NoncashImputedInterestExpenses" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NoncashImputedInterestExpenses" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,963</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zMRNKz1UOo4g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Changes in assets and liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzoUu_zrhuu0J649Y4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 2.1pt; padding-left: 7.6pt">Decrease (increase) in prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,121</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,330</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maCzoUu_z1g8p6UByMA9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Increase in accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,345</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInInterestPayableNet_i01_maCzoUu_zLWzZ5iZq8fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Increase in interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137,536</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,218</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzoUu_maCz9fO_zr9OnafPSrfh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">353,768</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">318,960</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zZcqdcIKe76j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromLinesOfCredit_i01_maCzGQv_zRLfJOueMX3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">299,695</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,331</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maCzGQv_zIBh73kS3RLa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0236">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--RepaymentOfLinesOfCreditInterest_i01N_di_msCzGQv_zE31NBodeEe5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Repayment of lines of credit interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfLinesOfCreditInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,376</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfLinesOfCreditInterest" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,398</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzGQv_z4towiIPKiwl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from sales of shares of common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0241">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">536,832</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzGQv_maCz9fO_zrNhwo7OOy4h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,714</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">510,765</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01_maCz9fO_zKZ1j134XGO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">931</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_i01T_mtCz9fO_zrWvfSWoIwB5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Change in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,805</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Cash_i01S_zZ8nwREjCULg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Cash, beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,922</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashEquivalentsAtCarryingValue_i01E_zLdGZV7TRIza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Cash, end of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,937</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">257,995</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zTayP8eBYsmc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82B_zCDqO5jIcOVa">Basis
of presentation, nature of operations and going concern</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
Technologies Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On May&#160;16,
2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#8220;ALRT SG&#8221;), under the <i>Companies
Act</i> of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes Solution Centre, Inc.,
under the <i>Business Corporations Act </i>of Alberta. The Company has developed its Diabetes Solution, which is a comprehensive approach
to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring
and diabetes test supplies. The Company is seeking commercial opportunities to deploy the Diabetes Solution in the United States (&#8220;U.S.&#8221;),
Canada and Singapore.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#8220;U.S. GAAP&#8221;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the three-month
periods ended March&#160;31, 2022 and 2021 of $<span id="xdx_909_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220331_z9rdDcY8lih2" title="Net loss"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,404,849</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210331_zCtcBlxJmWX9" title="Net loss"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></span>, respectively. As of March&#160;31, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_c20220331_pp0p0" title="Working capital deficit"><ix:nonFraction name="ALRT:WorkingCapitalDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,371,971</ix:nonFraction></span> (December&#160;31, 2021&#160;- $<span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit"><ix:nonFraction name="ALRT:WorkingCapitalDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,312,143</ix:nonFraction></span>), accumulated
deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220331_z4NEhN78wNmi" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">103,419,926</ix:nonFraction></span> (December&#160;31, 2021&#160;- $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_ztc0fby9smlf" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">102,015,077</ix:nonFraction></span>), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#8217;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $25,639,349 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#8217;s product line, and
ultimately, the Company&#8217;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of March&#160;31,
2022, the total principal balance outstanding was $<span id="xdx_90E_ecustom--PrincipalBorrowed_c20220331_pp0p0" title="Principal Borrowed"><span id="xdx_90F_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_zi5hej5HjyAe" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,988,100</ix:nonFraction></ix:nonFraction></span></span>. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#8217;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#8217;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 7 -->
    <div id="xdx_23C_zGUP6iUbkVbd" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td id="xdx_235_zoXk83Colfik" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_z40FkDcHgIwd" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_z0w9TJ886Zjl" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zraRYy83Oj4f" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z6SayREqr55a" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zsZ1XGebxh9c" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z59vAwSywWbi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zf4Ez2rL0o99" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z6XMQRpV1h1i" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zuTY4wDgvin4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z08s0PZzbAu7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basis
of presentation, nature of operations and going concern (continued)</b></span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&#8217;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rates. The Company
will seek to obtain creditors&#8217; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#8217;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#8217;s capital
requirements will depend on many factors, including the success of the Company&#8217;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zVgTkNMBGndl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zwxRiiaUTT44">Significant
accounting policies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALRT SG, which
was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements as of March&#160;31, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have
been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate
to make the information not misleading.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments necessary to present fairly the financial position as of March&#160;31, 2022 and December&#160;31,
2021, and the results of operations and cash flows as of March&#160;31, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations for the three-month period ended March&#160;31, 2022 are not necessarily indicative of the results to be expected
for the full year.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 8 -->
    <div id="xdx_237_zFMzgSFDgXBa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zJC1jVFu1xy6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td id="xdx_236_zRJuvWPSMXJ1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zc78Vyjc93Qh" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zTs2Rc89UGeh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zLgyDbH1aMVb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zDCVpirYHJP7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zVyt9Lr8BbD7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<ix:exclude><p id="xdx_23B_z7lPvfeyMKKk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zoTLoyqaLZk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zEQ6MIQdQtn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_826_z2grHBCKSNoi">Accounts
payable and accrued liabilities</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the accounts payable and accrued liabilities is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z5BEFGJr9pFi" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B4_z28ZlB8TmLGj">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220331" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzeC1_zRDjvbYfKH5g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">993,063</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">806,059</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzeC1_zRig40cBAsE5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">328,948</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">322,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzeC1_zrrPzSJmGf8b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,352</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzeC1_z6HbOLyJjiCi" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,363</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,130,546</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock"><p id="xdx_807_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zNKIeQt3W5Tg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zkWw3w9zE4V6">Interest,
advances and promissory notes payable</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_zrwYo1dp2O7i" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold">
<span id="xdx_8B5_zXEdeNkXGMY8">Summary of activities of promissory notes payable</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z4f3AlIM6lx5" title="Carrying value at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2020-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,031,966</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zM27yHEB3gqj" title="Transferred from promissory notes payable pursuant to private transaction" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021 and March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zJFrk3pWfv9b" title="Carrying value at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2021-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_z22PVCPtlCca" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zZdswlJHkgk4" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span id="xdx_8B6_zOu81QUSNM14"><span id="xdx_8B9_z5VqDXCbLAj8" style="display: none">Schedule of activity of promissory notes payable to related parties</span></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220331_zEpBD8JOdVtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z7yUc6EqGMJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Related Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:
    </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzwx0_zqUTXq10H9Ma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:NotePayablewithInterestat1PercentInterestperMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">720,619</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:NotePayablewithInterestat1PercentInterestperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">720,619</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzwx0_zJ6hDiJV9zjk" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 1.25% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:InterestAt1.25PerMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">51,347</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:InterestAt1.25PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">51,347</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzwx0_zUnNTqWaL2ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at the U.S. bank prime rate plus 1%</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzwx0_zDb7OtsjEEE5" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Interest at 0.5% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iv.InterestAt0.5PerMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">695,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iv.InterestAt0.5PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">695,000</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzwx0_z8JuCR6UvbAc" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,475,000</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,475,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzwx0_zDmVlwLqu6Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Related Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesRelatedParty" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,041,966</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesRelatedParty" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,041,966</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_za17SXqU78A2" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<ix:exclude><p id="xdx_232_zmCIV8gjJLEc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_23B_zQeRrXr9wMSg" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_zsY347Z81AD2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zsCP5jQHjH4a" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zwhr6Xlla0P6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z5zkxU62TZLl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zmy9345SCSmg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zSzcMTkxLB72" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zgQ9P9OXpSBj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_237_zNRCOCTt4PI2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zchy8ppxjpcj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Interest,
advances and promissory notes payable (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zt4kzmjAuKhh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zqEsnuhd2D35" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B2_zgsqeXLqdxB5" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zPVz5L7tZpne" title="Balance at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2020-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,254,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" title="Reclassified to interest payable" style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,985</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" title="Extinguished through issuance of shares of common stock (note 6)" style="text-align: right">(<ix:nonFraction name="ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock" contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" title="Transferred from promissory notes payable pursuant to private transaction" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zWWPpIyXAFG" title="Balance at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,213,368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory note received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PromissoryNoteReceived_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zF3C8qyN6DId" title="Promissory note received" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNoteReceived" contextRef="From2022-01-012022-03-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,395</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zLhWNc9XbLo8" title="Balance at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-03-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,412,763</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zYorNWnpVhEe" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zeiGCHUTgwtd" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B5_zkQN3p7cBnN3" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220331_zNynpsuSazw9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zoMPkDQGjw68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzzz1_zyh2G4Vwtkja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,317,456</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,317,456</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_ecustom--Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzzz1_zYikQA7NoUc2" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_ecustom--Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzzz1_zNIYEiuDdGKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzzz1_zb9LS1pXmKu8" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Noninterestbearing" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,912</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Noninterestbearing" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,912</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_ecustom--FixedInterest_i01I_pp0p0_maTPNPTzzz1_zACJq6XXMU2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&#160;&#160;&#160;&#160;&#160;&#160;
    Fixed interest</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:FixedInterest" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,395</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzzz1_zILcMTBjvb08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzzz1_zeSh7VKeTUag" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:TotalPromissoryNotesPayableToUnrelatedParties" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,412,763</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:TotalPromissoryNotesPayableToUnrelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,213,368</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AC_zXa60Fv8Cds4" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received an advance from a shareholder for Singapore dollars (&#8220;SGD&#8221;) $270,000 (US$199,395), with a fixed interest
amount of SGD$8,000, which will mature and be repayable on July&#160;31, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<ix:exclude><p id="xdx_237_zJLMYYTzzqdg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_23A_z88jhnQHvyye" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zKNmkeAXVT9j" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td id="xdx_238_zyQMtNUQ6hei" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_236_z8A2PXLZZeA1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zykdCzS6Cfp6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zPcsVq8ZgG91" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zQfnviSsbs1b" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zxmOMLr0YYVl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zEdhOP6tGy4k" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zUOfjU3JIxse" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zf0FWy6IAcx2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zgqU5YgFAlCi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Interest,
advances and promissory notes payable (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zyB6rkQXDkua" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the interest payable activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:InterestAndOtherIncomeTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--InterestAndOtherIncomeTableTextBlock_z8qw3QLtv2Ti" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B7_z1mwe2QR2N9c">Schedule of interest payable activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zCkIGnDbRA" title="Beginning Balance" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,575,326</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" title="Reclassified from promissory notes payable" style="text-align: right"><ix:nonFraction name="ALRT:ReclassifiedFromPromissoryNotesPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" title="Interest incurred on promissory notes payable" style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">527,336</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" title="Interest payable retired through issuance of shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:InterestPayableRetiredThroughIssuanceOfShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220331_zJI75QwAXNT5" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220331_pp0p0" title="Interest incurred on promissory notes payable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,536</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220331_zEeUohQ0Jvzf" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,248,183</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zKWFLCJ2ERNb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable is due to related and non-related parties as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zngSYBij7SG4" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BC_zdAoRKh1I1Zi" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220331_zzGN8XqsD4J3" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zmDZQm0Yeo75" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestPayableRelativesOfDirectors" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,279,462</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestPayableRelativesOfDirectors" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,200,170</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayabletoNonrelatedParties" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,968,721</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayabletoNonrelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,910,477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayableCurrentAndNoncurrents" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,248,183</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayableCurrentAndNoncurrents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zhAcVepCBgvg" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March&#160;31, 2022, the Company incurred interest expense of $<span id="xdx_901_eus-gaap--InterestExpense_c20220101__20220331_pp0p0" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,636</ix:nonFraction></span> (2021&#160;- $<span id="xdx_907_eus-gaap--InterestExpense_pp0p0_c20210101__20210331_zHbg6VQoQKa7" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">479,367</ix:nonFraction></span>) as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$384,922
                                            (2021&#160;- $314,737) incurred on lines of credit payable as shown in note&#160;5; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$137,536
                                            (2021&#160;- $132,218) incurred on promissory notes (notes&#160;4(a) and 4(b));</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$26,138
                                            (2021&#160;- $31,963) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--OtherExpenses_pp0p0_c20220101__20220331_zkROgaZ8LqFl" title="Interest on other"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,040</ix:nonFraction></span>
                                            (2021&#160;- $<span id="xdx_905_eus-gaap--OtherExpenses_pp0p0_c20210101__20210331_zI5hx791WXc6" title="Interest on other"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">449</ix:nonFraction></span>) interest on other items.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23E_zADzYCyrMQ4d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_236_zctYqIKSErt2" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zRnjKLU13aQ6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td id="xdx_233_zMho5wWum6X1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23A_zANQ0hJw5d5l" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_zpBbGj7bVN7f" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zQK41fn9zdOi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zKp2Kz1ZwDLj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zprl3Qwa8zV1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zlTf1EldybN9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zDxX2Z9OipB3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zWnb5fPoi956" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:LineOfCreditTextBlock"><p id="xdx_806_ecustom--LineOfCreditTextBlock_z8WW1df1mPuc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zsLSRV5VDhv6">Lines of credit</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of lines of credit activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zpkGAS38diMc" summary="xdx: Disclosure - Lines of credit (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B6_zWfW50S2ATl8">Schedule of lines of credit activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_z24upRkNbaUi" title="Balance at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,914,092</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" title="Advances received on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,149,279</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" title="Interest incurred on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,402,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" title="Repayment of interest on lines of credit" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfInterestOnLinesOfCredit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">456,725</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220331_z3slIMhliBH1" title="Balance at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,008,833</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220331_pp0p0" title="Advances received on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">299,695</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220331_pp0p0" title="Interest incurred on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">384,922</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220331_pp0p0" title="Repayment of interest on lines of credit" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfInterestOnLinesOfCredit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">80,376</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220331_zPHIUwXPxjF8" title="Balance at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,613,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zXdDI8tmADid" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common of the Company at a price of $0.05 per share until December&#160;31, 2026
(note&#160;7).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2022, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduledOfLineOfCreditTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--ScheduledOfLineOfCreditTableTextBlock_zgG2R27AbvB5" summary="xdx: Disclosure - Lines of credit (Details1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B5_zk1NL8eJYqFb" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_909_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,300,000</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,283,100</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,481,047</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_906_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,764,147</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,705,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,927</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,848,927</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90E_ecustom--BorrowingLimit_c20220331_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,300,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_z2nrwRqt5h2l" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,988,100</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--AccruedInterest_c20220331_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,624,974</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--TotalOutstanding_c20220331_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,613,074</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,300,000</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,220,700</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,208,582</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,429,282</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,467,705</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,846</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,579,551</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,300,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,688,405</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,320,428</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,008,833</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zYHrQSNSsK8b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_234_z1QSqIXztN9e" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td id="xdx_231_zQ8nWAhjzWj7" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_zAZ4pPbJDRWi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zZQhy6OSMME5" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zYO02hsGbxa5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z27c0dky8R56" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zYRll2gxcGs2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zKc2PfUkPG96" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zoQ3H3PofDL6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zYpaBYsKqPid" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zEe4BQCfLo79" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_zfGnN0o2Tef7">Capital
stock</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            capital stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000,000
shares of common stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            stock </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000
shares of preferred stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended March&#160;31, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription rights to its shareholders to purchase shares of common stock of the Company at a price of $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022. On March 21, 2022, the Company recognized share subscriptions receivable of $25 pursuant to its registration statement and issued a total of 500 shares of common stock for gross proceeds of $25. </span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"></p>


<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_230_zmQFPYEfrLpl" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_232_zeiNspJhwSo4" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zqZfm2MVWTci" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zomTbNcaCDul" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zzPGvyRPlO9i" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zBRxUQ0h4Vn7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zQFo7hrpOxj5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zwjz3uNN1D3c" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zNdmpWkvBQu2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zs3HF8COueZb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capital
stock (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zHizNhLUmhGf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNkGxCK0Xroj" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zMrKfJBwsIX8" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration was exchanged.</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021) by an additional 100-day period related to the closing of the rights offering. The Company had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The Company further extended the offering period to October 29, 2021. The Company filed a post-effective amendment to further extend the rights offering from October 29, 2021 to March 15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company collected subscriptions of $1,124,832 pursuant to its registration statement and issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000 of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized as obligation to issue shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000 shares of common stock at a price of $0.015 per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into two shares for debt agreements with two creditors to issue an aggregate 4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: </span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Accounts payable&#9;-&#9;$ 194,186</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Promissory notes &#8211; Principal &#9;-&#9;$ 20,000</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Line of credit &#8211; Accrued interest&#9;-&#9;$ 3,000</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement of
$1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer letters
have not been executed.</span></p>

<ix:exclude><p id="xdx_238_zyXum6LQrili" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_236_z24aGeYIEvk3" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_231_zOHpZsypCG6g" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_z5e59daJLm6k" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zYyT8u64P6Wa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zJnqFA0K71l2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zVz0ktEhkVI5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zUDUUL66j2J5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zTfcGvrT2Vih" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zmGWCmrfLTfj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:AdditionalPaidInCapitalTextBlock"><p id="xdx_80D_ecustom--AdditionalPaidInCapitalTextBlock_z5G0pTW8pNn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_824_zasfWQYNeLs">Additional paid-in capital </span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4AsrMRxgbsl" summary="xdx: Disclosure - Additional paid-in capital (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zHqaRUZv2zE8" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331_zewLNedBE0Mf" title="Outstanding, beginning of period" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331_zw4kCVbN6Bx4" title="Average Exercise Price, beginning" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zWNNMMwvmpLk" title="Outstanding, beginning of period" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,362,701,500</ix:nonFraction></span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zgEEMAaN1VV4" title="Average Exercise Price, beginning" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220331_pdd" title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331_pdd" title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">165,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220331_zHmrvw6LI0s4" title="Exercised" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220331_zesSSuXLCIEb" title="Exercised per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></span></td>
    <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z2PtN5CBTQX2" title="Exercised" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_z2NZ6l5srZq2" title="Exercised per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220331_zaEWQZ3qhqte" title="Cancelled" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000,000</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--CancelledPerShares_iN_di_c20220101__20220331_zfWtAN6ZUcK5" title="Cancelled per share" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:CancelledPerShares" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.036</ix:nonFraction>)</span></td>
    <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_zBdTfkGX0N81" title="Cancelled" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,900,000</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zPadCdABhMd1" title="Cancelled per share" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:CancelledPerShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.034</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331_zotG3w7078N7" title="Outstanding, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,437,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331_zRLctlaqtyI5" title="Average Exercise price, ending" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.005</ix:nonFraction></span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zHTFB09Gag54" title="Outstanding, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zoeY6EO3MTuf" title="Average Exercise price, ending" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20220331_zaesLuaQsSgg" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,701,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220331_zjaJZEbvpYu" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zd6wd95993Pc" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,221,701,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zuZFtakjibz2" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zMrUk1TIaVta" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the period ended March&#160;31, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022 and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended March 31, 2022, $59,639 related
to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the period ended March&#160;31, 2022, the Company recorded a total of $319,789 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23C_zJSjHaKVCbn8" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_232_zp9btzXt96h6" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td id="xdx_234_zLcjGtLuQvzd" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zOtj42emxOhi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zLC4FQaxhQ02" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zitfTH56Ue6g" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zXMzOeuP32vh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zpljl41tm5Q7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zGUJ96X4UzW5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zqfxIE3Cr3gf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zuiPVAU9lenh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zI2rZvMKSixg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zITxComLqJu3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zFRgSK5eLzv5" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z3PiIDw9RlYg" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at March&#160;31, 2022, 2,000,000 (December&#160;31, 2021, 1,000,000) options have vested to date. The fair value of the options
granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952 relates
to stock options that have performance vesting conditions. During the period ended March&#160;31, 2022, $52,238 (December 31, 2021 -
$248,189) related to stock options with time-based vesting conditions and $56,648 (December 31, 2021 - $nil) related to stock options
with performance-based vesting conditions was recognized. The remaining fair value of $1,349,169 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended March 31, 2022, $17,319 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $150,092 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 14, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended March 31, 2022, $27,279 (December&#160;31, 2021 - $88,540) related to the stock
options with time-based vesting conditions was recognized. The remaining fair value of $1,449,993 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 12, 2021, the Company&#8217;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_233_z66MUmlKTiNi" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td id="xdx_23F_zH559teWpGq" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zdcIIxvBikwc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zOxxz6ceZBhf" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zEZX4tdYIg3h" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zCD3n3vkxx05" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zqAosMpuhzQb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zXpYO5Ou9co3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zjwXeSwq5Dhk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zTaq3RZOkNe3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zey0M4nO6CVe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_ztGzqdkvLDZg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zq0ReLCCkSd1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zbKWVoQk9Deh" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zh2e2PMcwVpi" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z3y3OaluQzi8" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021: (continued)</b></span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended March 31, 2022,
$4,908 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,359,484 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. <span style="background-color: white">As
at March&#160;31, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended March 31, 2022, $101,758 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December 31, 2021 - $nil) related to stock options with performance-based
vesting conditions was recognized. The remaining fair value of $780,535 has not been recorded.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.</span></p>

<ix:exclude><p id="xdx_236_zFD3lG0o4nV4" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_239_zecKmVKd3V7k" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td id="xdx_236_z2gVjtnOdlif" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_zITIlOsWxGXi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zISnfVgHwWFi" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zFopbrgSn9H2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_znzS9LN4dT22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z78a6JPvR06g" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zYDuUXhBTOsi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zJDAqRxP8nQg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zBBdwEt2AcS1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zwJlxmBbMgc1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zEcY4JJP0mp4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zVpNH2PpeR3i" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zFVBLgq9EKY2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z2HJlOubBPPl" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zVAEI4gfNf87" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021: (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zRkM0b9p7eb6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Outstanding</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
options outstanding at March&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="ALRT:ScheduleofOptionsOutstandingTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_zXyF1qSyHaA4" summary="xdx: Disclosure - Additional paid-in capital (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 34%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zkVIYPp57eL5">Schedule of Options Outstanding</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,600,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,600,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zQsaFIIvJWr4" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zl4xtWNPQi2" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zr4Wcw7RdAdl" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zmHvyfXiJebl" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zgLs8PRH1n58" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zuB2YrhLIFDk" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,650,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zybLnZ4vXcAh" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,650,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zgEjmXKdrEz6" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zalLDSP4XOl1" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,925,001,500</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.002</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.057</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zbp4OhtGBVOf" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,925,001,500</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zOwsU8uNShw5" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.002</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zZ4OmKr38U3c" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.058</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zkYoTUsy5208" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_z0PPixvI4lUc" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zN3qGefbsynh" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.029</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zoZ45sHd4bsh" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zj03nMyoGAo6" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zYu3AIfwwwZ" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zIaRCzZbb5s8" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_z2JRbqTxybvf" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zklzM95CraAa" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zZ1qnIhiBEIj" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">77,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zEPV00fsnNj4" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zaWIcrryeUS4" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,400,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zkPX8zVPvGVh" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_z52H4LGqLVX6" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zARMDYYHzy6i" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,400,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zHTRgqGlz7m" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zzfFfIYf8hkk" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zzdFiIe5gsCf" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zV7sxGltCkT6" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zogzpfnNvnCa" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0800">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zDuoxYcooD0l" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zo4E4PiALeei" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zWSiVmLtXb8a" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_z7ZiIdxyXyo" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zpcfaDrpz5m3" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zqN9iJDcu1wf" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zDRfzBphbFw8" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zq0qBs1Twby1" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zbTWTqpS5MH9" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zl6qtF2V2MM" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zGmfHtkNgHt7" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_z1Kf3JRQhxRj" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zhYgls60Am65" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zQ0Aerh0O109" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zxenfCtZrkVe" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zA3N5LA2uIHj" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zX7pOLNTkCh2" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zfc0wyb8O68a" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zRjNxgKHP5Jd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zh3Wt2L1NuCg" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zwpMJuVp5nj4" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zDU8BvH17f8b" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,300,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zKAa7B6Z8XD1" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,300,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zCDwMRtekFd7" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zjL78NqsiRo2" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_z5YDeIQZpPv9" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zuHJ4HlsCkn5" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zGsHop79GxN8" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2026</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zsT0xxlYigng" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zBDYCjLDrjL7" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zr6r5QjsGYo" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zyS5zUv1LCfa" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zUe8uxzfYWAh" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zhchiY59Uxz8" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Options" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-03-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Exercise Price" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-03-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Intrinsic Value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-03-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zbbShHY3NPji" title="Options" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zGg6Hin4Z35h" title="Exercise Price" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_z6p1JyOrzRUb" title="Intrinsic Value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331_pdd" title="Options" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,437,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331_pdd" title="Exercise Price" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.005</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331_pdd" title="Intrinsic Value" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.053</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_zm33HCasP58b" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231_zMqQhVKS0fUc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231_zAEAP0IWAbm1" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.054</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_z0xzPIGTBlFl" title="Weighted Average Remaining Contractual Life"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.13</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zAHKFdt9AiIh" title="Weighted Average Remaining Contractual Life"><ix:nonNumeric contextRef="From2021-01-012021-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.37</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_8A3_zI74RFUIKmjk" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23A_zPknbJi2EYza" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_23E_zQ20scHFEsWb" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td id="xdx_232_zp2m23PmIsi6" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zXuzQeQyoVn7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zTufIKhMilPa" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z1bCpMCLnsAh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z2AFdC2KfzH4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zLS9uDOZDmV" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zDjD7MPHcEQ6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zphuwTpCCEl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zq3wDveLVKk4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z20oElaYFMbb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_znnlrtgfgxvb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z0njNtOC3nvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zM8TQfnXLxll" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the stock options granted and vested was allocated as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyT8ZkXatug8" summary="xdx: Disclosure - Additional paid-in capital (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zy1rzAdhTFJa">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220101__20220331_z4Gj6U4kzXJ8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20210101__20210331_zekMmOUqJ8L5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2022</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2021</b></span></p></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzUxR_zJridlSPNIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Product development expense</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,168</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,145</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTzUxR_zxmDo3iumBW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,959</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,225</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzUxR_zkBCgczs96vj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,662</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--Total_iT_pp0p0_mtTzUxR_zz1CaEDkDKb9" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">319,789</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,370</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zO9OQwO4eqOa" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4IzhzKCld6" summary="xdx: Disclosure - Additional paid-in capital (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B8_zQW9iFHK9oxf" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210331_zIllHMW2kIlh" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.87</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210331_zBTwLtyacena" title="Expected life"><ix:nonNumeric contextRef="From2021-01-012021-03-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.8</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20210331_zwnm8CDud4bl" title="Expected dividends"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="-2" unitRef="USD">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210331_z53wjH06Pabe" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">278</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20210331_zr55srGLE1Xb" title="Forfeiture rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="USDPShares">0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zRfTyVliV4Y4" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
were no options granted during the three months ended March&#160;31, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z8vUfO4d1DFf" title="Weighted average fair value options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></span><span style="background-color: white">.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_237_zkWSuBRozCT7" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_233_zdtl5W9SVWj3" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td id="xdx_237_z5CObREW6AYd" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_zPZEz3tGtU02" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zPe7So77WAU3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zsLn4AWEi8x" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zPGVlANVjaZ9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zdQFGt3qpBH7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zfS1FTUyQrBa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zgBUbGAYvyXc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zXVruptj3RRa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_zdJ8G7ijWuqb">Related
party transactions and balances</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zQUXSUyS9JA3" summary="xdx: Disclosure - Related party transactions and balances (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_z7VjfLqxIxM9" style="display: none">Schedule of related party transactions</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220101_20220331" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20210101_20210331" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,292</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,982</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,922</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">314,737</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1026">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(v)). These offer letters expired on December&#160;31, 2021 without the
parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.</span></p>

<ix:exclude><p id="xdx_23F_zNudolrmgOcl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_234_zBCEGJVwp1da" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td id="xdx_23B_zTZGkpcAl766" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zS7006QK5xs8" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zbAnGTaFopE9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zGkYwzavTwO1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zKDFveNY8Qke" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zZ1JRtF0yqU5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_za8AaK6EdeQ7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zMbzJtIx7Rd9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zpSySDlWhA44" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z5tuN6GBzpC6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82C_zcqhqNyrsTlg">Commitments
and contingencies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18.9pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,262,582, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $285,457 related to one
of these promissory notes.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            contract</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#8217; notice and the payment of two years&#8217; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
                                            revenue bonus</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#8217;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of business</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
more than 50% of the Company&#8217;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2%
                                            of sales price up to $24,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3%
                                            of sales price between $25,000,000 and $49,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4%
                                            of sales price between $50,000,000 and $199,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
                                            of sales price in excess of $200,000,000.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            commitment</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a lease agreement for the Singapore office with a remaining obligation of $12,185.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_232_zffBjrOOpuXh" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23C_zfLTUY6FiJWb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zGCem2IJ9A67" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z83FAvFJ3sM6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_ztSXLlNhEPD9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended March&#160;31, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z1GJwqn4tifb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z7urEYeZBPa7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zCOs1JPmNpt5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zA6kjmROGMdi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82C_z2t8Xc5SkrQf">Operating
segments</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one operating segment, development of diabetes hardware and software. The Company&#8217;s geographical segments are summarized
as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zIF2be3Qw0uj" summary="xdx: Disclosure - Operating segments (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BD_zvt8Eosy7jOj" style="display: none">Schedule of Operating Segments</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Current and Total Assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,908</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Current and Total Assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,547</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Current and Total Assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,490</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Current and Total Assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,527</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--US_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,980</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_c20220331_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">267,378</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Revenue" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zoPOWkgbWfOe" title="Revenue" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,043</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zG9dcS0Nqmbc" title="Revenue" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1070">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1072">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zZHp1S9rdUil" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1074">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,043</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20210331_zyVWquK0WsIc" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Net Loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,063</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zYn8O0Pl7JTd" title="Net Loss" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Net Loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">84,392</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zkmDBUtj6r8l" title="Net Loss" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,319,394</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zWOf7HWrExd2" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220331_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,404,849</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331_z9dBKEw4wXKl" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,016,923</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zfdIe8bTjpGh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zVZZquQljiie" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_z1zM1shZff79">Subsequent
event </span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2022, the Company provided termination notice to a contractor and as a result the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 will be cancelled, unvested, effective June&#160;30, 2022.</span></p>

</ix:nonNumeric><p id="xdx_81A_zLoM4As1RF81" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          2.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
                                            DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information must be read in conjunction with the unaudited Condensed Consolidated Financial Statements and Notes thereto included
in Item 1 of this Quarterly Report and the audited Consolidated Financial Statements and Notes thereto and Management&#8217;s Discussion
and Analysis or Plan of Operations contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Form 10-Q includes &#8220;forward-looking statements&#8221;, as such term is used within the meaning of the <i>Private Securities Litigation
Reform Act of 1995</i>. These &#8220;forward-looking statements&#8221; are not based on historical fact and involve assessments of certain
risks, developments and uncertainties in our business looking to the future. Such forward-looking statements can be identified by the
use of terminology such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;,
&#8220;estimate&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;believe&#8221;, or the negatives or other variations of
these terms or comparable terminology. Forward-looking statements may include projections, forecasts or estimates of future performance
and developments. Forward-looking statements contained in this Form 10-Q are based upon assumptions and assessments that we believe to
be reasonable as of the date of this report. Whether those assumptions and assessments will be realized will be determined by future
factors, developments and events, which are difficult to predict and may be beyond our control. Actual results, factors, developments
and events may differ materially from those we assumed and assessed. Risks, uncertainties, contingencies and developments, including
those identified in the <i>Risk Factors </i>section of filings we make with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
pursuant to Section 13(a), 13(c), 14 or 15(d) <span style="letter-spacing: -0.3pt">of </span>the <i>Securities Exchange Act of 1934</i>,
as amended (the &#8220;Exchange Act&#8221;), incorporated by reference herein, could cause our future operating results to differ materially
from those set forth in any forward-looking statement. There can be no assurance that any such forward-looking statement, projection,
forecast or estimate contained can be realized, or that actual returns, results or business prospects will not differ materially from
those set forth in any forward-looking statement. Given these uncertainties, readers are cautioned not to place undue reliance on such
forward-looking statements. <span style="letter-spacing: -0.4pt">We </span>disclaim any obligation to update any such factors or to publicly
announce the results of any revisions to any of the forward-looking statements contained herein to reflect future results, events or
developments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the description of historical facts contained herein, the Form 10-Q contains certain forward-looking statements concerning future
applications of the Company&#8217;s technologies and the Company&#8217;s proposed services and future prospects, that involve risk and
uncertainties, including the possibility that the Company will: (i) be unable to commercialize services based on its technology, (ii)
ever achieve profitable operations, or (iii) not receive additional financing as required to support future operations, as detailed herein
and from time to time in the Company&#8217;s future filings with the SEC and elsewhere. Such statements are based on management&#8217;s
current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from
those described in the forward-looking statements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are stated in United States dollars and are prepared in accordance with U.S. GAAP.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this quarterly report, unless otherwise specified, all references to &#8220;common shares&#8221; refer to the common shares in our capital
stock.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this quarterly report, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, the &#8220;Company&#8221; and &#8220;ALRT&#8221;
mean ALR Technologies Inc., unless otherwise indicated.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ALRT
is a data management company that developed a comprehensive approach to diabetes care that includes: (i) a Food and Drug Administration
(&#8220;FDA&#8221;) cleared and <i>Health Insurance Portability and Accountability Act of 1996</i> (&#8220;HIPAA&#8221;) compliant diabetes
management system (as previously defined, the &#8220;Diabetes Solution&#8221;) that collects data directly from blood glucose meters
(&#8220;BGM&#8221;) (and which was subsequently modified to integrate with continuous glucose monitoring (&#8220;CGM&#8221;) devices),
(ii) a patent pending Predictive A1C algorithm to track treatment success between lab reports, and (iii) an FDA-cleared Insulin Dosing
Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution for human health, and the GluCurve,
a modified version of the Diabetes Solution, for animal health (&#8220;GluCurve&#8221;).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALRT
was incorporated under the laws of the state of Nevada on March&#160;24, 1987 as Mo Betta Corp. In April 1998, the Company changed its
business purpose to marketing a pharmaceutical compliance device. In December 1998, the common shares of the Company began trading on
the Bulletin Board operated by the National Association of Securities Dealers Inc. under the symbol &#8220;MBET&#8221;. On December&#160;28,
1998, the Company changed its name from Mo Betta Corp. to ALR Technologies Inc. Subsequently the symbol was changed to &#8220;ALRT.&#8221;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two subsidiaries:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    </span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    Percentage</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation
    Date</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
    Technologies SG Pte. Ltd. </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    16, 2020</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada
    Diabetes Solution Centre, Inc. </span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9, 2021</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">During
2011, the Company received FDA clearance and achieved HIPAA compliance for an early version of its Diabetes Solution. The Company subsequently
completed a clinical trial and pilot programs, which led to the development of its &#8220;Insulin Dosage Adjustment&#8221; technology,
for which it received FDA clearance in 2017, and its &#8220;Predictive A1C&#8221; technology, for which it has submitted a worldwide
patent application under the Patent Cooperation Treaty to the World Intellectual Property Organization. Subsequently the Company has
continued making advancements to its Diabetes Solution technology by increasing functionality and capability to improve diabetes care
for patients. The Company is actively seeking to commence revenue-generating activities for the Diabetes Solution.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2020, the Company: (i) entered into an agreement with Bionime Corporation (&#8220;Bionime&#8221;) whereby the Company will bundle its
Diabetes Solution application (or &#8220;app&#8221;) with Bionime BGM and diabetes test supplies and sell the bundle to diabetes patients
of private medical clinics in Singapore, (ii) initiated a clinical pilot with Singapore General Hospital to <span style="background-color: white">prove
the efficacy of the ALRT Diabetes Solution in insulin-treated diabetes patients, (</span>iii) entered into a memorandum of understanding
to form a collaboration with Diabetes Singapore, a non-profit Singapore-based organization serving the Singapore Minister for Health
and a member of the International Diabetes Federation, with the view of raising the diabetes management standard in Singapore, and (iv)
advanced its Diabetes Solution to integrate with CGM devices. See page 30 for discussion on CGM.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021: (i) the Company announced it had advanced its Diabetes Solution for animal health purposes under the brand name &#8220;GluCurve&#8221;
and (ii) the Company announced its intent to redomicile to Singapore.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the ALRT Diabetes Solution is offered both individually and bundled with BGMs, the Company is focused on offering the ALRT Diabetes Solution
with a cost effective CGM. ALRT believes that the current trend in diabetes care is shifting from the use of traditional BGM to diabetes
care management using CGM and that CGM will become the future standard of diabetes care. ALRT believes it is uniquely positioned to bundle
its Diabetes Solution application with CGM to improve health outcomes globally at a price point that is reasonable for wide scale adoption.
The Company is focusing its resources on seeking opportunities in the ASEAN (Association of Southeast Asia Nations) area to secure supply
of CGM through one or more strategic transactions.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
it continues to try to identify a suitable strategic CGM transaction, as of the time of filing this Report, ALRT desires to complete
its redomestication transaction to Singapore, even though it has not yet identified a suitable CGM source for human health or finalized
its supply arrangement for animal health. ALRT currently considers both its proposed redomestication, and also its ongoing search for
a CGM supply source, as critical to its successful commercial launch for both human and animal health. No guaranties can be given as
to the timing or successful completion of either the redomestication or a strategic CGM transaction.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">On
January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription rights to its shareholders to purchase
shares of common stock of the Company at a price of $0.05 per share. The rights were set to expire on February&#160;18, 2022, subsequently
extended to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until August 12,
2022. The Company recognized share subscription receivable of $25 pursuant to its registration statement and issued a total of 500 shares
of common stock for gross proceeds of $25.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2022, the Company extended the commitment letters previously issued to two creditors who are relatives of the Chairman and
Chief Executive Officer of the Company offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment
of $1,541,000 in promissory notes and interest payable from December&#160;31, 2021 to December&#160;31, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022 and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options and cancelling the remaining 1,500,000 options with performance conditions. During the period ended March 31, 2022, $59,639 related
to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
March 2022, the Company received an advance from a shareholder for SGD$270,000 (US$199,395), with a fixed interest amount of SGD$8,000,
which will mature and be repayable on July&#160;31, 2022. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments &#8211; Subsequent to March&#160;31, 2022</b></span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 27, 2022, the Company provided termination notice to a contractor, and as a result the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 will be cancelled, unvested, effective June&#160;30, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Financing</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Rights
Offering </span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">On
December 4, 2020, the Company filed a Form S-1 Registration Statement to distribute subscription rights to purchase up to an aggregate
127,522,227 shares of our common stock at a price of $0.05 per share. As at December&#160;31, 2021, the Company issued 26,496,635 unrestricted
shares of common stock related to proceeds received of $1,324,832. The Company had until October&#160;29, 2021 to sell the remaining
101,025,592 shares of common stock for total proceeds of $5,051,280, if exercised. On December&#160;14, 2021, the Company filed a post-effective
amendment to distribute subscription rights to purchase up to an aggregate 101,025,592 shares of our common stock at a price of $0.05
per share. Each stockholder as of the record date of the December&#160;4, 2020 Form S-1 Registration Statement who received rights and
had not previously exercised those subscription rights as of the expiration date of January&#160;22, 2021, received one subscription
right for each previous subscription right held as at such time. The rights expired March&#160;15, 2022. On such case-by-case basis,
the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised
subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022. In March
2022, the Company recognized share subscription receivable of $25 pursuant to its registration statement and issued an additional 500
shares of common stock for gross proceeds of $25.</span></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Products</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, the Company may seek to adapt its Diabetes Solution to be used in the management of other chronic diseases. The Company may
be required to obtain additional clearance from the FDA prior to commencing selling activities in the United States for other chronic
health conditions.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diabetes
is a leading cause of death, serious illness and disability across North America. By the year 2030, it is expected that 1 in 10 adults,
globally, will have diabetes (diagnosed and undiagnosed instances). We believe diabetes is a global pandemic.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
from the American Diabetes Association (&#8220;ADA&#8221;) shows 30&#160;million Americans have diabetes and 84&#160;million have prediabetes.
That is 1 in 3 Americans coping with the disease or serious threat of it. The total cost of diagnosed diabetes is staggering at $327&#160;billion
annually ($237&#160;billion in direct medical costs and $90&#160;billion in reduced productivity), putting serious drag on an already
strained healthcare system. Taking a broader view, the global cost of diabetes was estimated at a whopping $825&#160;billion annually
in 2016.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diabetes
is a lifelong chronic disease with no cure. However, people with diabetes can take steps to control their disease and reduce the risk
of developing the associated serious complications, thereby controlling healthcare costs. The Canadian Diabetes Association Clinical
Practice Guidelines Expert Committee reports that, &#8220;Successful diabetes care depends on the daily commitment of persons with diabetes
mellitus to self-manage through the balance of lifestyle and medication. Diabetes care should be organized around a multi- and interdisciplinary
diabetes healthcare team that can establish and sustain a communication network between the person with diabetes and the necessary healthcare
and community systems&#8221;. Diabetes incidence rates, economic costs and human costs are increasing even though we know how to control
the disease. The Diabetes Control and Complication Trial conducted from 1983 to 1993 outlined management as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Testing
                                            blood glucose levels four or more times per day;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Injecting
                                            insulin at least three times a day or using an insulin pump;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusting
                                            insulin dose according to food intake and exercise;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                            a diet and exercise plan; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
                                            visits to healthcare team.</span></td></tr></table>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Failure
to Control Diabetes</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe there are five causes why diabetes is not controlled:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patient
                                            non-adherence;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unreliable
                                            data;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
                                            overload;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                            inertia; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insulin
                                            under-prescription.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Patient
Non-adherence</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted in Patrick Connole, <i>&#8220;UnitedHealthcare, Other Large Insurers Seek Better Adherence to Diabetes Care&#8221;, Health Plan
Week, </i>February 11, 2013, Volume 23, Issue 5, 80% of United States patients with diabetes do not follow their prescribed care plan.
Central to conventional diabetes care is patient self-management.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Unreliable
Data</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted in Gonder-Frederick, L.A., et al, <i>&#8220;Self Measurement of Blood Glucose: Accuracy of Self-Reporting Data and Adherence to
Recommended Regimen&#8221; Diabetes Care, </i>Volume 11, no. 7, July 1988, 77% of patient data contain errors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Data
Overload</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
providers (&#8220;HCPs&#8221;) face a lack of timely and reliable blood glucose data, resulting in delays to advance therapy and sub-optimal
insulin dosing. The amount of patient data for clinicians to analyze is too vast and significant during 15&#45;minute clinical appointments,
and the information they have is unreliable.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Clinical
Inertia </span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted in Khunti, K., et al, <i>&#8220;Clinical Inertia in People with Type 2 Diabetes: A Retrospective Cohort Study of More than 80,000
People.&#8221; Diabetes Care, </i>Volume 36, no. 11, July 2013, across over 80,000 patients, when A1C goals were not met, therapy intensification
was late across every measure. It took on average 19 months to escalate patients with an average A1C of 8.7% from single medication to
dual therapy and 82 months to escalate patients with an average A1C of 8.8% from dual medication to triple therapy. Furthermore, they
found that it took approximately 20 years to advance patients with an average A1C of over 9% to insulin. At the end of the study, less
than 50% of the patients had their treatment intensified.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
in <i>Treatment intensification for patients with type 2 diabetes and poor glycaemic control </i>by Fu and Sheenan, it was noted that
out of 11,525 patients investigated with an A1C greater than 8% patients received intensification as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37%
                                            within 6 months; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11%
                                            within 6-12 months; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52%
                                            never.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to respond to higher than targeted A1C with treatment intensification puts patients with escalated A1C at risk for complications and
diabetes-associated co-morbidities.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Insulin
Under-prescription</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insulin
dosing is complex requiring review of large amounts of data, which takes significant amounts of time. We believe HCPs routinely under-prescribe
insulin to ensure they avoid insulin dosage adjustments, which could result in hypoglycemia for their patients.</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cleveland
Clinic Study </span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
team at Cleveland Clinic examined historical electronic medical record data of more than 7,300 patients with type 2 diabetes and concluded
that there is a pervasiveness of clinical inertia for the management of type 2 diabetes in real-world clinical practice settings.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selected patients had an A1C value of &#8805; 7% on a stable regimen of two oral anti-diabetic agents for at least 6 months (from 2005
to 2016). The median time to treatment intensification after A1C was above target was longer than one year. For patients with an A1C
of &#8805; 9%, therapy was not intensified in 44% of patients.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to lead study author Dr. Kevin Pantalone of Cleveland Clinic&#8217;s Endocrinology &amp; Metabolism Institute, &#8220;Short of a patient
reporting non-adherence to their existing regimen of diabetes therapies, it is hard to imagine a reason why treatment intensification
was not observed more frequently, when indicated, particularly in patients with an A1C &#8805; 9%. <b><i>In general, if intensification
does not occur, the A1C can be expected to stay the same or get worse, it is not magically going to get better&#8221;</i></b><i>.</i>
(emphasis added)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Products</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ALRT
Diabetes Solution</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
Technologies Inc. has created the Diabetes Solution to address the diabetes marketplace globally. The Company&#8217;s Diabetes Solution
consists of hardware, software and diabetes test supplies. We designed the Diabetes Solution to be focused on the HCP and is agnostic
and proactive. Our software operates on iOS, Android, Windows and MacOS systems. Enrollment into the ALRT Diabetes Solution will include
a branded glucometer, diabetes test strips, lancets and a carrying case. Our technology collects all the blood glucose data from the
glucometers, uploads it to a secure account and ships diabetes test strips as required. The patient data is aggregated to a predictive
A1C value for a comprehensive view of the treatment plan and patient adherence to the plan, with the data available (and messaged) to
authorized people.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ALRT Diabetes Solution addresses the five causes for not controlling diabetes with:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Active
                                            patient monitoring;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct
                                            meter uploads;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machine
                                            intelligent data processing;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Predictive
                                            A1C; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insulin
                                            dosage adjustment.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Active
Patient Monitoring</span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
data indicates that 50% or more of people on medications do not take them as prescribed, and that this non-compliance contributes to
10% of hospitalizations and billions of dollars spent annually in excessive and preventable healthcare costs. Reminding a person to take
an action is the first step in our system; monitoring their actions and their data is the second, and intervention when needed is the
important follow-up.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ALRT System monitors patient uploads and the underlying data providing more timely access to patient blood glucose data. Our system initiates
interventions by notifying the HCP of out-of-range results, or failure to upload data in accordance with the requirements of the care
plan. The ALRT System does not rely upon the patient for uploading data. The ALRT Diabetes Solution provides the notifications and audit
trail needed for achieving best practice results. Its performance tracking allows care teams to identify areas in treatment plans that
require change of improvement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Direct
Meter Uploads</span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
is uploaded via Bluetooth directly from the glucometer into the ALRT application. This ensures that the data is accurate and reliable
based on the results of testing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Machine
Intelligent Data Processing</span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
machine intelligence processes large amounts of data, notifies relevant stakeholders and flags patients for review making collaboration
real time. Across segments and populations, this also provides significant data points on use of diabetes test strips and insulin, which
may be significant for businesses in those industries.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Predicative
A1C</span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in the Diabetes Solution is Predictive A1C. Predictive A1C is a patent-pending unique feature for monitoring the effectiveness of care
plans. This technology utilizes data diagnostics to compare targeted A1C with indicated results. Weekly patient blood glucose data is
evaluated, and HCPs are notified as needed for care plan review when blood glucose values exceed parameters set by the HCPs. Our platform
provides HCPs with patient prioritization reports and alerts based on the Predictive A1C measures and other related diagnostics. Predictive
A1C was designed to assist HCPs in addressing clinical inertia in diabetes care.</span></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Insulin
Dose Adjustment</span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in the Diabetes Solution is Insulin Dose Adjustment (&#8220;IDA&#8221;). IDA is an FDA-cleared feature that makes optimal insulin adjustment
suggestions to HCPs based on dosing guidelines from organizations like the ADA. This ensures that HCPs are making timely insulin dosage
assessments based on the blood testing results uploaded. ALRT&#8217;s next phase of technology advancement will produce an algorithm
for advancing non-insulin diabetes therapies according to clinical practice guidelines.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">ALRT
Prediabetes System </span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prevention-based feature of the Diabetes Solution, the ALRT Prediabetes System has been designed in direct response to discussions with
government healthcare authorities for a scalable solution to the growing problem of prediabetes. The Prediabetes Solution provides patients
with educational videos and supplemental content formatted for mobile devices and a private online community to discuss disease management
(e.g., support, weight loss, diet, etc.). Most importantly, the System tracks patients and reminds them to test their A1C according to
payer protocols.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evolution
of the Diabetes Solution </i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2021, the Company enrolled a small number of patients with Diabetes Singapore into the Diabetes Solution utilizing BGM, which provided
for improved efficacy of the Diabetes Solution.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is preparing for a clinical trial for its Diabetes Solution for human health utilizing CGM and to concurrently submit an FDA
application for clearance to sell the Diabetes Solution in the United States submitted thereafter. ALR is targeting to offer the ALRT
Diabetes Solution for sale bundled with CGM in 2023, with pricing to compete with the standalone BGM offerings.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Continuous
Glucose Monitoring </i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
CGM is a medical device that is worn on the body of a diabetic subject for up to 14 days and continually takes glucose (blood sugar)
readings every 1-5 minutes. A CGM consists of three pieces:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A sensor that measures
    glucose levels in the interstitial fluid that is attached to the skin of the subject via an adhesive pad;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Bluetooth transmitter
    that wirelessly sends the glucose readings to a mobile device or reader and can be integrated into the sensor or come as a separate
    piece that clips into the sensor; and</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An applicator that applies
    the sensor onto the subject.</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
CGM can be factory calibrated thus eliminating the need for diabetics to prick their finger to test blood on a strip inserted into a
BGM throughout the day. A CGM works by utilizing glucose oxidase-based enzymes that are coated onto an electrode that is inserted into
the subcutaneous tissue when the sensor is applied to the skin. The transmitter then securely sends the data wirelessly to a receiver,
such as a mobile device, where the data is organized and displayed for the user.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
subjects have a target blood glucose range. Time in range is the amount a subject spends in the target blood glucose range. The time
in range method works with the data provided by the CGM&#8217;s data by looking at the amount of time your blood sugar has been in target
range and the times you have had high blood sugar or low blood sugar. This data is helpful in finding out which types of foods and what
activity level causes your blood sugar to rise and fall and assessing adherence to a care plan.</span></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ALR
GluCurve for Pets</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
has developed the GluCurve Pet CGM to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM
with the software of an adapted version of its Diabetes Solution platform for use by veterinarians in animal health.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GluCurve Pet CGM platform allows the blood glucose readings from the medical device placed on the pet to be uploaded to the Cloud where
the data is processed and converted into daily glucose curve graphs and data sets that can be reviewed and compared by the veterinarian
at any time. The system provides the doctor with insulin dose calculators and recommendations based on current clinical practice guidelines.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current method to monitor glucose levels in diabetic felines and canines is to prepare an in-clinic glucose curve that consists of the
following steps:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pet is dropped off
    at a veterinary clinic;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pet is given an insulin
    shot;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The clinic staff will draw
    blood every 2 hours for 10-12 hours, performing the following steps each time:</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">test the blood in a BGM;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">record readings;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">plot the data into a graph;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assess the effectiveness
    of the insulin dose and glycemic control; and</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pet is picked up by
    their owner.</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GluCurve Pet CGM solves the multiple issues that arise from doing an in-clinic glucose curve:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inaccurate
                                            data;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manual
                                            process of data collection, review and analysis; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burden
                                            on the clinic staff and the pet owner.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inaccurate
Data</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
CGM is placed on the pet by the veterinarian in minutes and the pet is sent home where the glucose readings will be automatically taken
and uploaded for up to 14 days. This eliminates the stress on the animal from being housed in the clinic and from getting its blood drawn,
which can elevate glucose levels. A CGM also provides readings every 5 minutes, which gives better insight to the veterinarian of the
highs and lows of the pet&#8217;s glucose levels throughout the day. This is often missed when only checking every 2 hours during an
in-clinic glucose curve.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Manual
Process of Data Collection, Review and Analysis</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
CGM automatically uploads 288 glucose readings per day to the ALRT Cloud, where the data is analyzed, organized, then displayed on the
platform for the veterinarian to view. The GluCurve platform provides the pet owner and practitioner with the historical blood glucose
data to allow for management of the pet&#8217;s health and tracking.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Burden
on Clinic Staff and Pet Owner </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
CGM is placed on the pet in minutes, after which they are sent home, greatly reducing the time spent by the staff during an in-clinic
glucose curve of caring for the pet and manually drawing blood and recording readings every 2 hours. The platform also greatly reduces
the time needed by the doctor to review and make insulin dose adjustments by offering dosing calculators, guidelines and decision flowcharts
based on current clinical practice guidelines.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Current
Status </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has completed non-inferiority studies with a United States-based veterinary clinic for the GluCurve app and the CGM supplies
being bundled with the GluCurve app. The results indicated the CGM utilized were non-inferior to other competing CGM systems. The Company
is seeking to secure a strategic transaction with a pharmaceutical company with a global sales network in order to commercialize the
GluCurve CGM. The Company has made the GluCurve app available on Google Play and the Apple Store for users of the validation and non-inferiority
studies.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Three
months ended March&#160;31, 2022 compared to Three months ended March&#160;31, 2021</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-indent: -12.15pt; padding-left: 12.15pt">Revenue</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">100</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">112,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Selling, general and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">555,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">208,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">347,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">167</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Operating loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">854,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">537,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">317,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">59</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Loss before other item</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">854,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">537,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">317,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">59</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">Other Item</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Interest expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">551,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">479,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">72,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Total other item</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">551,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">479,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">72,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Net Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,405,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,016,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">389,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">38</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss for the three-month period ended March&#160;31, 2022 was 38% ($389,000) higher than the net loss at March&#160;31, 2021. Loss
before other item and stock-based compensation was $48,000 (10%) higher during the three months ended March&#160;31, 2022, as compared
to the three months ended March&#160;31, 2021. We highlight that <b><i>loss before other item and stock-based compensation </i></b>is
a &#8220;non-GAAP financial measure&#8221;. This measure is calculated by removing those items from the net loss presented on our consolidated
statements of operations. This measure does not have a standardized meaning under U.S. GAAP. Management uses this measure internally
to evaluate its results of operations, as it removes the impact of stock-based compensation, non-operational losses and interest accretion.</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 5.4pt">Loss Before Other Items</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">854,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">537,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">317,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">59</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Stock-based compensation included in selling, general and administrative expense, professional fees and product development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">320,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">51,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">269,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">527</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Loss Before Other Items and Stock-based Compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">534,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">486,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">48,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss before interest and stock-based compensation for the Company&#8217;s three months ended March&#160;31, 2022 increased by $48,000
due primarily to increased selling, general and administrative fees of as a result of costs incurred in relation to ALRT SG and in relation
to the Rights Offering.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Selling,
General and Administrative</span></span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
general and administrative costs incurred consist of salaries and consulting fees of management personnel, stock-based compensation for
options vested to management personnel, travel and trade show costs, rent of the Company&#8217;s corporate office, website development
costs and general costs incurred through day-to-day operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period, the Company had increased selling, general and administrative operating expenses, as compared to the same period in 2021.
The selling, general and administrative expenses, excluding stock-based compensation, increased by $98,000 during 2022, as compared to
2021, primarily driven by an increase in salaries, payroll expenses and consulting fees paid to personnel, mailing and printing of materials
related to the Rights Offering in the current period offset by fees paid to a market research firm related to commercialization plans
for the Company&#8217;s Diabetes Solution in the comparative period of the prior year. The components of selling, general and administrative
expenses and the changes therein can be seen as follows:</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Selling, general and administrative:</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Salaries and consulting fees</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">204,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">141,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">63,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Travel and trade shows</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Website and information technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Transfer agent, filing fees and quotation costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Market research consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Payroll expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">License and permits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Shareholder communications</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Foreign exchange</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Other general and administration costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">249,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">249,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">555,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">208,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">347,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Product
development costs</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of the product development costs incurred related to a) services provided by contractors of the Company and b) expenses incurred
for product development. The Company incurred stock-based compensation expense of $62,000 during Q1 2022 related to the vesting of options
to its product development team compared to $36,000 during Q1 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Professional
fees</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
fees incurred consists of consulting and advisory fees of certain professionals retained, audit fees, tax consultant fees, recruiter
fees, legal fees and stock-based compensation for options granted to professionals. Excluding the difference in net loss attributed to
the vesting of stock options granted in the prior year, professional fees decreased by $39,000 from the comparative period of the prior
year. The decrease in professional fees was mainly due to recruiter fees paid in the comparative period of the prior year offset by an
increase in legal fees in the current period. During the period, the increase in legal fees related to:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessing
                                            business structure alternatives, including evaluating and forming the animal health division;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluating
                                            retaining additional personnel to support commercialization strategies in Singapore and the
                                            United States;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its
                                            proposed migration to Singapore; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completing
                                            the rights offering financing, preparing subsequent amendments to extend the rights offering
                                            and issuing the post-effective amendment to the rights offering.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
type of professional cost, the variance can be seen as follows:</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Professional fees:</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Corporate auditor</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">22,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">10,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">12,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Accounting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Tax consultant fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Legal fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Recruiter fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(48,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Market consultants and outreach</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">172,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">217,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(45,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
expense</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expense was from the following sources for the three months ended March&#160;31, 2022 and 2021:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Interest expense:</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Interest expense incurred on promissory notes</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">138,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">132,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">6,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Interest expense incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Imputed interest on zero interest loans and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">32,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">551,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">479,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">72,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
on Promissory Notes </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received an advance from a shareholder for SGD$270,000 (US$200,000), with a fixed interest amount of SGD$8,000 during the three
months ended March&#160;31, 2022. There were no other significant changes in the amount of promissory notes outstanding as at March&#160;31,
2022 and 2021. The interest incurred on promissory notes was consistent during the three months ended March&#160;31, 2022 and 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
on Lines of Credit </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two line of credit facilities with balances as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Lines of credit:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br />March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br />March&#160;31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Line of credit provided by Mr. Sidney Chan</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,283,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">9,731,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">552,000</td><td style="width: 1%; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Line of credit provided by Mrs. Christine Kan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,705,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">705,000&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">12,988,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">11,731,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,257,000</td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal balance of the lines of credit due to Mr. Sidney Chan and Ms. Christine Kan increased due to advances from Mr. Chan and Ms.
Kan under the lines of credit to finance the operations of the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred interest on the lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Interest expense on lines of credit:</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; text-indent: -10.35pt; padding-left: 10.35pt">Interest expense incurred on the line of credit from Sidney Chan during the period</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">308,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">255,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">53,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10.35pt; padding-left: 10.35pt">Interest expense incurred on the line of credit from Christine Kan during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">77,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">60,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -10.35pt; padding-left: 10.35pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">385,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">315,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Imputed
Interest </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the 2022 and 2021 periods, the Company had certain zero interest promissory notes and accounts payable in excess of one year. Pursuant
to the Company&#8217;s accounting policy, these zero interest amounts are considered to be financing items in nature and are assigned
a deemed interest rate (1% per month). The interest incurred on these is expensed as imputed interest and instead of increasing the liabilities
of the Company, it is allocated to equity under the financial statement line item <i>additional paid-in capital</i>. The change from
the prior period is related to the discussion included under <i>Interest on Promissory Notes</i> above.</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Working Capital</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As At</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31,</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As At</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2021</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount ($)</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase /</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Decrease)</span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 5.4pt">Current Assets</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">267,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">193,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">74,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">38</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Current Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25,639,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">24,505,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,134,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Working Capital Deficiency</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,372,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,312,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,060,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a severe working capital deficiency. It does not have the ability to service its current liabilities for the next twelve
months and is reliant on its line of credit facilities to meet its ongoing operations. Until the Company has revenue-producing activities
that exceed its operating requirements, it will be unable to service its current liabilities and the working capital deficit will continue
to increase. As of the date of this report, the Company has not commenced revenue-generating activities. The Company is expected to continue
generating revenues in Singapore during the 2022 fiscal year; however, the amount and timing are uncertain. The revenues generated in
2021 and 2022 are not expected to be sufficient to finance the ongoing operations of the business and repay the current liabilities.
The Company is also evaluating opportunities for its GluCurve product, the timing and amount of revenues from which are uncertain. There
is substantial doubt about the Company&#8217;s ability to repay its current liabilities in the near term or any time in the future, which
could ultimately lead to business failure.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Assets</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s current assets as at March&#160;31, 2022 and December&#160;31, 2021 consist of cash, share subscription receivable and
prepaid expenses.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Liabilities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has current liabilities of $25,639,000 as at March&#160;31, 2022, as compared to $24,505,000 as at December&#160;31, 2021. Current
liabilities are as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31,</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December&#160;31, 2021</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(%)</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,323,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">1,130,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">193,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">17</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to arm&#8217;s length parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,413,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,213,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,248,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,111,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Lines of credit from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,613,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,009,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">604,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,639,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,505,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,134,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Payable and Accrued Liabilities</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consists of trade payables and accrued liabilities of the Company. Accounts payable totaling approximately
$993,000, accrued liabilities totaling approximately $329,000 and unearned revenue totaling approximately $1,000. Approximately $600,000
of accounts payable is more than one year old with the majority of these being more than ten years old.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fluctuations in accounts payable occurred in the regular course of business.</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Promissory
Notes to Related Parties and Promissory Notes Payable to Arm&#8217;s Length Parties </span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has promissory notes with 20 individuals or corporations that relate to historical amounts borrowed. With the exception of the
SGD$270,000 advance received during the period ended March 31, 2022, there has been no new activity for several years. All of the promissory
notes, other than the SGD$270,000 loan, are past due and continue to accrue interest at their respective legal rates of interest (mostly
1% per month). During the three months ended March&#160;31, 2022, the Company received an advance from a shareholder for SGD$270,000
(US$200,000), with a fixed interest amount of SGD$8,000.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
Payable&#9;</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable relates to the unpaid interest expense incurred on the promissory notes to related parties and promissory notes to arm&#8217;s
length parties. The change from December&#160;31, 2021 to March&#160;31, 2022 relates to $138,000 of accrued interest incurred on promissory
notes at their stated rates of interest.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the promissory notes, except for the promissory note received during the current period, and related interest payable is overdue.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flows</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Cash Flows</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Cash flows used in Operating Activities</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(354,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(319,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Cash flows provided by Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">419,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">511,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Increase in Cash During Period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">64,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">192,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Balances and Working Capital</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2022, the Company&#8217;s cash balance was $180,000 compared to $116,000 as of December&#160;31, 2021. The Company
does not have sufficient cash on hand to fund its requirements for the 2022 fiscal year and will need to secure additional financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Used in Operating Activities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used by the Company in operating activities during the three-month period ended March&#160;31, 2022 was $354,000 in comparison with $319,000
used during the same period last year. The Company&#8217;s expenditures from operations were used as follows (approximate amounts):</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Cash Used in Operating Activities Reconciliation</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,405,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,017,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Stock-based compensation incurred for product development costs; selling, general and administrative; and professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Non-cash imputed interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net purchases with balances owing in accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">192,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Retainers and prepaid services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued interest on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Reclassification from promissory notes payable to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accrued interest from promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">138,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(354,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(319,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>


<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expenditures incurred were to fund the operating activities of the business.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Proceeds from Financing Activities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
sourced by the Company from financing activities during the three-month period ended March&#160;31, 2022 was $419,000 in comparison with
$511,000 sourced during the same period last year. The funds were sourced as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 10pt">Cash from Financing Activities Reconciliation</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Three Months Ended <br />March&#160;31,
    2022</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Three Months Ended <br />March&#160;31,
    2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Proceeds from Rights Offering</span></td><td style="width: 8%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">&#8212;&#160;&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">525,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Proceeds from exercise of options</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#8212;&#160;&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">12,000</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Proceeds from promissory notes</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">199,000</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#8212;&#160;&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-size: 10pt">Net proceeds from lines of credit
    </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">220,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(26,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-size: 10pt">Cash provided by financing activities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">419,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">511,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Short-
and Long-Term Liquidity</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2022, the Company does not have the current financial resources and committed financing to enable it to meet its administrative
overhead, product development budgeted costs and debt obligations over the next twelve months.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&#8217;s debt financing is due on demand or overdue. The Company will seek to obtain creditors&#8217; consents to delay
repayment of these loans until it is able to replace these financings with funds generated by operations, replacement debt, or from equity
financings through private placements or the exercise of options and warrants. While the Company&#8217;s creditors have agreed to extend
repayment deadlines in the past, there is no assurance that they will continue to do so in the future. The Company has faced litigation
from creditors in the past and is currently being sued by one creditor. There is no assurance that additional creditors will not make
claims against the Company in the future. Failure to obtain either replacement financing or creditor consent to delay the repayment of
existing financing could result in the Company having to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tabular
Disclosure of Contractual Obligations:</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="19" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Payments Due by Period</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Less</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Than 1</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1-3</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3-5</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>More</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Than 5</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,323,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,323,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to arm&#8217;s length parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,413,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,413,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,248,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,248,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Line of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,613,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,613,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,639,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,639,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to use the funds available from the lines of credit to cover administrative overhead and product development requirements
until such time as it can establish cash flows from operations. In the next year, the Company anticipates the amount borrowed under the
lines of credit to increase, as it expects to</span></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commercially
launch its GluCurve before December&#160;31, 2022 and proceed with activities to launch the Diabetes Solution with CGM for Human Health
during 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Critical
Accounting Policies and Going Concern</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited condensed consolidated
financial statements for the three months ended March&#160;31, 2022 and 2021, which have been prepared in accordance with U.S. GAAP.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. We base our estimates on
historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including
assumptions as to future events. These estimates form the basis for making judgments about the carrying value of assets and liabilities
that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual
results may materially differ from our estimates.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s condensed consolidated financial statements have been prepared on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. See note 1
of the condensed consolidated financial statements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to our being a development stage company and not having generated significant revenues, in the notes to our condensed consolidated financial
statements, we have included disclosure regarding concerns about our ability to continue as a going concern.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Off
Balance Sheet Arrangements</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no off-balance sheet financing arrangements that have or are reasonably likely to have a current or future effect on the
Company&#8217;s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources, that is material to investors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUANTITATIVE
                                            AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company is a smaller reporting company as defined in Rule 12b-2 of the <i>Securities Exchange Act of 1934</i>.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          4.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONTROLS
                                            AND PROCEDURES.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including the Principal Executive Officer and Principal Financial Officer,
we have evaluated the effectiveness of our disclosure controls and procedures as required by <i>Exchange Act</i> Rule 13a-15(b) as of
the end of the period covered by this report. Based on this assessment, we found our disclosure controls and procedures to be not effective
due to insufficient written policies and procedures for reporting requirements and accounting and financial reporting with respect to
the requirements and application of U.S. GAAP and SEC disclosure requirements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
assessment is consistent with the evaluation by Company management of our internal controls over financial reporting, as set forth in
Item 9A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company is working to remedy these deficiencies as its business activities evolve, there were no changes in our internal controls
over financial reporting during the quarter ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.</span></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART
II. OTHER INFORMATION</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
                                            PROCEEDINGS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no other changes from the period beginning January&#160;1, 2022 to the date of this 10-Q.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          1A.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
                                            FACTORS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. We are a smaller reporting company as defined in Rule 12b-2 of the <i>Securities Exchange Act of 1934.</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DEFAULTS
                                            UPON SENIOR SECURITIES.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As at March&#160;31, 2022, the
Company had promissory notes payable and related interest payable, totaling $9,704,000 in default.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          5.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
                                            INFORMATION.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0"></p><table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"><td style="width: 1in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
                          6.</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b>EXHIBITS.</b></span></td></tr></table>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0"></p><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0"></p><p style="margin: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.25in"></p><p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-top: Black 3pt double"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit</b></span></td>
    <td style="border-top: Black 3pt double"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Incorporated
    by reference</b></span></td>
    <td style="border-top: Black 3pt double; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Filed</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 8%"><span style="font: 10pt Times New Roman, Times, Serif"><b>No.</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 62%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Document
    Description</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Form</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Date</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>herewith</b></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000108702299000004/0001087022-99-000004.txt">Initial Articles of Incorporation.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-SB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">12/10/99</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.2</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000108702299000004/0001087022-99-000004.txt">Bylaws.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-SB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">12/10/99</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.2</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.3</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000108702299000004/0001087022-99-000004.txt">Articles of Amendment to the Articles of Incorporation, dated October 22, 1998.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-SB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">12/10/99</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.3</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.4</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000108702299000004/0001087022-99-000004.txt">Articles of Amendment to the Articles of Incorporation, dated December 7, 1998.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-SB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">12/10/99</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.4</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.5</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201405000033/exh31.htm">Articles of Amendment to the Articles of Incorporation, dated January 6, 2005.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8-K</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1/20/05</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.6</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201411000486/exh32.htm">Amendment to Bylaws, dated October 13, 2011</a>    </span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8-K</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10/17/11</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.7</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201412000228/exh3-6.htm">Amendment
    to Bylaws, dated April 10, 2012</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8-K</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/16/12</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">14.1</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex14_1.htm">Code
    of Ethics.</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-KSB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/14/03</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">14.1</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">31.1</span></td>
    <td><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="sfsalr10q051222ex31_1.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></p></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">X</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">32.1</span></td>
    <td><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><a href="sfsalr10q051222ex32_1.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></p></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">X</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000190359622000108/sfsalr10k032222ex99_10.htm">Line of Credit Agreement with Sidney Chan.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/22</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;X</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000172186821000901/f2salr8k121421ex99_1.htm">Line of Credit Agreement with Christine Kan.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/10/21</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.12</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000190359622000108/sfsalr10k032222ex99_12.htm">Services Agreement between the Company and Sidney Chan.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/22</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.12</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;X</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.04</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000190359622000108/sfsalr10k032222ex99_13.htm">Employment Agreement between the Company and Christine Kan.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/22</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.13</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;X</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.19</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_19.htm">Audit
    Committee Charter.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/14</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.19</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.20</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_20.htm">Disclosure
    Committee Charter.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/14/03</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.20</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">99.30</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000100201413000341/exh99-8.htm">Nomination
    Committee Charter</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-KSB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3/31/14</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">99.30</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">99.40</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_40.htm">Compensation
    Committee Charter</a></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10-KSB</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3/31/14</span></td>
    </tr></table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SIGNATURES</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the <i>Securities and Exchange Act of 1934</i>, the Registrant has duly caused this amended
report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 16th day of May 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BY:</span></td>
    <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">SIDNEY CHAN</span></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney Chan</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Executive Officer, Principal Accounting Officer,
    Principal Financial Officer, Secretary/Treasurer and Director</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>sfsalr10q051222ex31_1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Sidney Chan, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Form 10-Q for the quarter ended March 31, 2022 of ALR Technologies, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
    defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
    Rules 13a-15(f) and 15d-15(f)) for the Company and have</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
    of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent
    fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
    likely to materially affect, the Company's internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent
    functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>May 16, 2022</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;<U>/s/
Sidney Chan</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney
Chan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Chief Financial Officer</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>sfsalr10q051222ex32_1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C SECTION 1350)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of ALR Technologies Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended March 31,
2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), I, Sidney Chan, Chief Executive Officer of the
Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter&nbsp;63, Section&nbsp;1350 of the United States
Code, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company at the dates and for the periods indicated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section&nbsp;906, or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version of this written statement required by Section&nbsp;906,
has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Certification has not been, and shall not be deemed, &#8220;filed&#8221; with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>March 16, 2022</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>/s/ Sidney Chan</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney
Chan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Chief Financial Officer</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !/ .P# 2(  A$! Q$!_\0
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M3<PQ@QR;0=IW =#QWKQ3_A9WC+_H--_WXC_^)KW'Q7H\OB+PO>Z7;S)%)=(
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M'H*]"^,.O_VCXDCTJ)\PZ<OSX/!D;D_D,"N?\":%_P )#XNLK1UW01MYT_\
MN+SC\3@?C7737+"[&=5KG@0V7PHLKQ8O].MF^U7''.U\9'X#;^1KS6.1XI$E
MB8JZ,&5AV(Y!KZLNK6*\M);69 T4R&-U/<$8-?+^MZ5+HFMWFF3 [K:4H"?X
ME['\1BE2G>Z8(^C_  KK:>(O#=EJ:D;I8QY@'\+CAA^8K7KQ[X*Z_P"5=W>@
M3/\ +,//@!_O#AA^6#^%>PUA./+*PC"\;?\ (E:Q_P!>C_RKYH'05]+^-O\
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M,\7_ +5U+_H(W?\ W_;_ !JO+-+/(9)I'E<]6=B2?Q->X_\ "F/"_P#SUO\
M_O\ C_"JVH_!G0ETZX:PEO/M8C8P^9,"I;' (QTJ%5@!Y#HVJ3:)K%IJ<'W[
M:4/C^\.X_$9%?4%G=PW]E!>6[;HIXQ(A]01D5\ILK(Q1U*LIPP/8]Z]M^#>O
M_;O#\NCROF;3VR@/>-N1^1R/RI5HW5P9U/C;_D2M8_Z]'_E7S0.@KZ7\;?\
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;&#Q2KM9?G8\BNDHHJ&[NX@HHHI %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>alrt-20220331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96sps7xRiXgOn8uFZn9MSauFWbOdx5Z7eelBtmV2bRlKrywv4eS8UyKLDuhWQSMM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ALRT="http://alrt.com/20220331" elementFormDefault="qualified" targetNamespace="http://alrt.com/20220331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://alrt.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" id="BasisOfPresentationNatureOfOperationsAndGoingConcern">
	  <link:definition>00000006 - Disclosure - Basis of presentation, nature of operations and going concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000007 - Disclosure - Significant accounting policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000008 - Disclosure - Accounts payable and accrued liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" id="InterestAdvancesAndPromissoryNotesPayable">
	  <link:definition>00000009 - Disclosure - Interest, advances and promissory notes payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCredit" id="LinesOfCredit">
	  <link:definition>00000010 - Disclosure - Lines of credit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/CapitalStock" id="CapitalStock">
	  <link:definition>00000011 - Disclosure - Capital stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapital" id="AdditionalPaid-inCapital">
	  <link:definition>00000012 - Disclosure - Additional paid-in capital</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
	  <link:definition>00000013 - Disclosure - Related party transactions and balances</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - Commitments and contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegments" id="OperatingSegments">
	  <link:definition>00000015 - Disclosure - Operating segments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/SubsequentEvent" id="SubsequentEvent">
	  <link:definition>00000016 - Disclosure - Subsequent event</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" id="InterestAdvancesAndPromissoryNotesPayableTables">
	  <link:definition>00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditTables" id="LinesOfCreditTables">
	  <link:definition>00000019 - Disclosure - Lines of credit (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" id="AdditionalPaid-inCapitalTables">
	  <link:definition>00000020 - Disclosure - Additional paid-in capital (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" id="RelatedPartyTransactionsAndBalancesTables">
	  <link:definition>00000021 - Disclosure - Related party transactions and balances (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegmentsTables" id="OperatingSegmentsTables">
	  <link:definition>00000022 - Disclosure - Operating segments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" id="BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000024 - Disclosure - Accounts payable and accrued liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" id="InterestAdvancesAndPromissoryNotesPayableDetails">
	  <link:definition>00000025 - Disclosure - Interest, advances and promissory notes payable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" id="InterestAdvancesAndPromissoryNotesPayableDetails1">
	  <link:definition>00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" id="InterestAdvancesAndPromissoryNotesPayableDetails2">
	  <link:definition>00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" id="InterestAdvancesAndPromissoryNotesPayableDetails3">
	  <link:definition>00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" id="InterestAdvancesAndPromissoryNotesPayableDetails4">
	  <link:definition>00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" id="InterestAdvancesAndPromissoryNotesPayableDetails5">
	  <link:definition>00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" id="InterestAdvancesAndPromissoryNotesPayableDetailsNarrative">
	  <link:definition>00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditDetails" id="LinesOfCreditDetails">
	  <link:definition>00000032 - Disclosure - Lines of credit (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditDetails1" id="LinesOfCreditDetails1">
	  <link:definition>00000033 - Disclosure - Lines of credit (Details1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" id="AdditionalPaid-inCapitalDetails">
	  <link:definition>00000034 - Disclosure - Additional paid-in capital (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" id="AdditionalPaid-inCapitalDetails1">
	  <link:definition>00000035 - Disclosure - Additional paid-in capital (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" id="AdditionalPaid-inCapitalDetails2">
	  <link:definition>00000036 - Disclosure - Additional paid-in capital (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" id="AdditionalPaid-inCapitalDetails3">
	  <link:definition>00000037 - Disclosure - Additional paid-in capital (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" id="AdditionalPaid-inCapitalDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Additional paid-in capital (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" id="RelatedPartyTransactionsAndBalancesDetails">
	  <link:definition>00000039 - Disclosure - Related party transactions and balances (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegmentsDetails" id="OperatingSegmentsDetails">
	  <link:definition>00000040 - Disclosure - Operating segments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="ALRT_RelatedPartyMember" name="RelatedPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnRelatedPartyMember" name="UnRelatedPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ChairmanAndCEOMember" name="ChairmanAndCEOMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WifeOfChairmanMember" name="WifeOfChairmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options1Member" name="Options1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options2Member" name="Options2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options3Member" name="Options3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options4Member" name="Options4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options5Member" name="Options5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options6Member" name="Options6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options7Member" name="Options7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options8Member" name="Options8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options9Member" name="Options9Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options10Member" name="Options10Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options11Member" name="Options11Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options12Member" name="Options12Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options13Member" name="Options13Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options14Member" name="Options14Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options15Member" name="Options15Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options16Member" name="Options16Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options17Member" name="Options17Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options18Member" name="Options18Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options19Member" name="Options19Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options20Member" name="Options20Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options21Member" name="Options21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options22Member" name="Options22Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options23Member" name="Options23Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableToRelatedParties" name="PromissoryNotesPayableToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableUnrelatedLender" name="PromissoryNotesPayableUnrelatedLender" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LinesOfCreditFromRelatedParties" name="LinesOfCreditFromRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" name="WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LossPerShareBasicAndDiluted" name="LossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationproductDevelopmentCosts" name="StockbasedCompensationproductDevelopmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationgeneralSellingAndAdministration" name="StockbasedCompensationgeneralSellingAndAdministration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationProfessionalFees" name="StockbasedCompensationProfessionalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnLinesOfCredit" name="InterestExpenseOnLinesOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NoncashImputedInterestExpenses" name="NoncashImputedInterestExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentOfLinesOfCreditInterest" name="RepaymentOfLinesOfCreditInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" name="DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" name="InterestAdvancesAndPromissoryNotesPayableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureLinesOfCreditAbstract" name="DisclosureLinesOfCreditAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LineOfCreditTextBlock" name="LineOfCreditTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureAdditionalPaidinCapitalAbstract" name="DisclosureAdditionalPaidinCapitalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_AdditionalPaidInCapitalTextBlock" name="AdditionalPaidInCapitalTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" name="SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" name="ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" name="ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" name="ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" name="ScheduledOfInterestPayableDueToRelatedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduledOfLineOfCreditTableTextBlock" name="ScheduledOfLineOfCreditTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofOptionsOutstandingTableTextBlock" name="ScheduleofOptionsOutstandingTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PrincipalBorrowed" name="PrincipalBorrowed" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." name="TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" name="PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NotePayablewithInterestat1PercentInterestperMonth" name="NotePayablewithInterestat1PercentInterestperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestAt1.25PerMonth" name="InterestAt1.25PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" name="NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Iv.InterestAt0.5PerMonth" name="Iv.InterestAt0.5PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" name="PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesRelatedParty" name="PromissoryNotesRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" name="ExtinguishedThroughIssuanceOfSharesOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNoteReceived" name="PromissoryNoteReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" name="UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" name="I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" name="Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" name="Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Noninterestbearing" name="Noninterestbearing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_FixedInterest" name="FixedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" name="PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" name="TotalPromissoryNotesPayableToUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ReclassifiedFromPromissoryNotesPayable" name="ReclassifiedFromPromissoryNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" name="InterestExpenseIncurredonPromissoryNotesandOtherPayables" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableRetiredThroughIssuanceOfShares" name="InterestPayableRetiredThroughIssuanceOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableRelativesOfDirectors" name="InterestPayableRelativesOfDirectors" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayabletoNonrelatedParties" name="InterestPayabletoNonrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableCurrentAndNoncurrents" name="InterestPayableCurrentAndNoncurrents" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentOfInterestOnLinesOfCredit" name="RepaymentOfInterestOnLinesOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestRate" name="InterestRate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_BorrowingLimit" name="BorrowingLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentTerms1" name="RepaymentTerms1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_AccruedInterest" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TotalOutstanding" name="TotalOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Security1" name="Security1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Purpose1" name="Purpose1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" name="ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_CancelledPerShares" name="CancelledPerShares" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_OpenOptionContractsWrittenNumbersOfShare" name="OpenOptionContractsWrittenNumbersOfShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ExercisePrices" name="ExercisePrices" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_IntrinsicValue" name="IntrinsicValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Total" name="Total" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" name="RelatedPartyTransactionIncludedWithinInterestExpense" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" name="InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" name="InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" name="RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" name="ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" name="SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" name="RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>alrt-20220331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220331.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220331.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220331.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220331.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvent" xlink:href="alrt-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220331.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220331.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220331.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="loc_ALRTPromissoryNotesPayableToRelatedParties" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTPromissoryNotesPayableToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="loc_ALRTPromissoryNotesPayableUnrelatedLender" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTPromissoryNotesPayableUnrelatedLender" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="loc_ALRTLinesOfCreditFromRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTLinesOfCreditFromRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="loc_ALRTStockbasedCompensationproductDevelopmentCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationproductDevelopmentCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="loc_ALRTStockbasedCompensationProfessionalFees" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="loc_ALRTInterestExpenseOnLinesOfCredit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTInterestExpenseOnLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="loc_ALRTNoncashImputedInterestExpenses" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTNoncashImputedInterestExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="loc_ALRTRepaymentOfLinesOfCreditInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ALRTRepaymentOfLinesOfCreditInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="loc_ALRTPromissoryNotesRelatedParty" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="loc_ALRTInterestAt1.25PerMonth" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTInterestAt1.25PerMonth" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="loc_ALRTIv.InterestAt0.5PerMonth" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTIv.InterestAt0.5PerMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="loc_ALRTIii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTIii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:label="loc_ALRTVi.InterestAt0.625PerMonthWith125000DueJanuary152011" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTVi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Noninterestbearing" xlink:label="loc_ALRTNoninterestbearing" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTNoninterestbearing" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_FixedInterest" xlink:label="loc_ALRTFixedInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTFixedInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Total" xlink:label="loc_ALRTTotal" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="loc_us-gaapProfessionalAndContractServicesExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapProfessionalAndContractServicesExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>alrt-20220331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220331.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220331.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220331.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220331.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvent" xlink:href="alrt-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220331.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220331.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220331.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyMember" xlink:label="loc_ALRTRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_UnRelatedPartyMember" xlink:label="loc_ALRTUnRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTUnRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNoteReceived" xlink:label="loc_ALRTPromissoryNoteReceived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTPromissoryNoteReceived_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ChairmanAndCEOMember" xlink:label="loc_ALRTChairmanAndCEOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTChairmanAndCEOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WifeOfChairmanMember" xlink:label="loc_ALRTWifeOfChairmanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTWifeOfChairmanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestRate" xlink:label="loc_ALRTInterestRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTInterestRate_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_BorrowingLimit" xlink:label="loc_ALRTBorrowingLimit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTBorrowingLimit_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentTerms1" xlink:label="loc_ALRTRepaymentTerms1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTRepaymentTerms1_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPrincipalBorrowed_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_AccruedInterest" xlink:label="loc_ALRTAccruedInterest_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTAccruedInterest_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalOutstanding" xlink:label="loc_ALRTTotalOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTTotalOutstanding_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Security1" xlink:label="loc_ALRTSecurity1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTSecurity1_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Purpose1" xlink:label="loc_ALRTPurpose1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPurpose1_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options1Member" xlink:label="loc_ALRTOptions1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options2Member" xlink:label="loc_ALRTOptions2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options3Member" xlink:label="loc_ALRTOptions3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options4Member" xlink:label="loc_ALRTOptions4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions4Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options5Member" xlink:label="loc_ALRTOptions5Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions5Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options6Member" xlink:label="loc_ALRTOptions6Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions6Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options7Member" xlink:label="loc_ALRTOptions7Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions7Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options8Member" xlink:label="loc_ALRTOptions8Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions8Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options9Member" xlink:label="loc_ALRTOptions9Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions9Member_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options10Member" xlink:label="loc_ALRTOptions10Member_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions10Member_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options11Member" xlink:label="loc_ALRTOptions11Member_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions11Member_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options12Member" xlink:label="loc_ALRTOptions12Member_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions12Member_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options13Member" xlink:label="loc_ALRTOptions13Member_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions13Member_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options14Member" xlink:label="loc_ALRTOptions14Member_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions14Member_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options15Member" xlink:label="loc_ALRTOptions15Member_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions15Member_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options16Member" xlink:label="loc_ALRTOptions16Member_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions16Member_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options17Member" xlink:label="loc_ALRTOptions17Member_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions17Member_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options18Member" xlink:label="loc_ALRTOptions18Member_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions18Member_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options19Member" xlink:label="loc_ALRTOptions19Member_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions19Member_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options20Member" xlink:label="loc_ALRTOptions20Member_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions20Member_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options21Member" xlink:label="loc_ALRTOptions21Member_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions21Member_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options22Member" xlink:label="loc_ALRTOptions22Member_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions22Member_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options23Member" xlink:label="loc_ALRTOptions23Member_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions23Member_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="loc_ALRTOpenOptionContractsWrittenNumbersOfShare_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTOpenOptionContractsWrittenNumbersOfShare_490" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExercisePrices" xlink:label="loc_ALRTExercisePrices_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTExercisePrices_490" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_IntrinsicValue" xlink:label="loc_ALRTIntrinsicValue_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTIntrinsicValue_490" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_490" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OtherMember" xlink:label="loc_ALRTOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ALRTOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="loc_countrySG_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countrySG_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>alrt-20220331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyMember" xlink:label="ALRT_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyMember" xlink:to="ALRT_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_UnRelatedPartyMember" xlink:label="ALRT_UnRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnRelatedPartyMember" xlink:to="ALRT_UnRelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnRelatedPartyMember_lbl" xml:lang="en-US">Un Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ChairmanAndCEOMember" xlink:label="ALRT_ChairmanAndCEOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ChairmanAndCEOMember" xlink:to="ALRT_ChairmanAndCEOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ChairmanAndCEOMember_lbl" xml:lang="en-US">Chairman And C E O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WifeOfChairmanMember" xlink:label="ALRT_WifeOfChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WifeOfChairmanMember" xlink:to="ALRT_WifeOfChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WifeOfChairmanMember_lbl" xml:lang="en-US">Wife Of Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options1Member" xlink:label="ALRT_Options1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options1Member" xlink:to="ALRT_Options1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options1Member_lbl" xml:lang="en-US">Options 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options2Member" xlink:label="ALRT_Options2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options2Member" xlink:to="ALRT_Options2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options2Member_lbl" xml:lang="en-US">Options 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options3Member" xlink:label="ALRT_Options3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options3Member" xlink:to="ALRT_Options3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options3Member_lbl" xml:lang="en-US">Options 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options4Member" xlink:label="ALRT_Options4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options4Member" xlink:to="ALRT_Options4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options4Member_lbl" xml:lang="en-US">Options 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options5Member" xlink:label="ALRT_Options5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options5Member" xlink:to="ALRT_Options5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options5Member_lbl" xml:lang="en-US">Options 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options6Member" xlink:label="ALRT_Options6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options6Member" xlink:to="ALRT_Options6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options6Member_lbl" xml:lang="en-US">Options 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options7Member" xlink:label="ALRT_Options7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options7Member" xlink:to="ALRT_Options7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options7Member_lbl" xml:lang="en-US">Options 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options8Member" xlink:label="ALRT_Options8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options8Member" xlink:to="ALRT_Options8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options8Member_lbl" xml:lang="en-US">Options 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options9Member" xlink:label="ALRT_Options9Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options9Member" xlink:to="ALRT_Options9Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options9Member_lbl" xml:lang="en-US">Options 9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options10Member" xlink:label="ALRT_Options10Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options10Member" xlink:to="ALRT_Options10Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options10Member_lbl" xml:lang="en-US">Options 10 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options11Member" xlink:label="ALRT_Options11Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options11Member" xlink:to="ALRT_Options11Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options11Member_lbl" xml:lang="en-US">Options 11 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options12Member" xlink:label="ALRT_Options12Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options12Member" xlink:to="ALRT_Options12Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options12Member_lbl" xml:lang="en-US">Options 12 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options13Member" xlink:label="ALRT_Options13Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options13Member" xlink:to="ALRT_Options13Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options13Member_lbl" xml:lang="en-US">Options 13 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options14Member" xlink:label="ALRT_Options14Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options14Member" xlink:to="ALRT_Options14Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options14Member_lbl" xml:lang="en-US">Options 14 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options15Member" xlink:label="ALRT_Options15Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options15Member" xlink:to="ALRT_Options15Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options15Member_lbl" xml:lang="en-US">Options 15 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options16Member" xlink:label="ALRT_Options16Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options16Member" xlink:to="ALRT_Options16Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options16Member_lbl" xml:lang="en-US">Options 16 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options17Member" xlink:label="ALRT_Options17Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options17Member" xlink:to="ALRT_Options17Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options17Member_lbl" xml:lang="en-US">Options 17 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options18Member" xlink:label="ALRT_Options18Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options18Member" xlink:to="ALRT_Options18Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options18Member_lbl" xml:lang="en-US">Options 18 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options19Member" xlink:label="ALRT_Options19Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options19Member" xlink:to="ALRT_Options19Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options19Member_lbl" xml:lang="en-US">Options 19 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options20Member" xlink:label="ALRT_Options20Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options20Member" xlink:to="ALRT_Options20Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options20Member_lbl" xml:lang="en-US">Options 20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options21Member" xlink:label="ALRT_Options21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options21Member" xlink:to="ALRT_Options21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options21Member_lbl" xml:lang="en-US">Options 21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options22Member" xlink:label="ALRT_Options22Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options22Member" xlink:to="ALRT_Options22Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options22Member_lbl" xml:lang="en-US">Options 22 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options23Member" xlink:label="ALRT_Options23Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options23Member" xlink:to="ALRT_Options23Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options23Member_lbl" xml:lang="en-US">Options 23 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OtherMember" xlink:label="ALRT_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_OtherMember" xlink:to="ALRT_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="country_SG" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SG" xlink:to="country_SG_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_SG_lbl" xml:lang="en-US">SINGAPORE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xml:lang="en-US">Share subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="ALRT_PromissoryNotesPayableToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableToRelatedParties" xlink:to="ALRT_PromissoryNotesPayableToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableToRelatedParties_lbl" xml:lang="en-US">Promissory notes payable to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="ALRT_PromissoryNotesPayableUnrelatedLender" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnrelatedLender" xlink:to="ALRT_PromissoryNotesPayableUnrelatedLender_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableUnrelatedLender_lbl" xml:lang="en-US">Promissory notes payable to unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="ALRT_LinesOfCreditFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LinesOfCreditFromRelatedParties" xlink:to="ALRT_LinesOfCreditFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LinesOfCreditFromRelatedParties_lbl" xml:lang="en-US">Lines of credit from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred shares, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common shares, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before other item</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Item</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Item</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_lbl" xml:lang="en-US">Exchange difference on translating foreign operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:label="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:to="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares of common stock outstanding, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LossPerShareBasicAndDiluted" xlink:label="ALRT_LossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LossPerShareBasicAndDiluted" xlink:to="ALRT_LossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:to="ALRT_StockbasedCompensationproductDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts_lbl" xml:lang="en-US">Stock-based compensation-product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="ALRT_StockbasedCompensationgeneralSellingAndAdministration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:to="ALRT_StockbasedCompensationgeneralSellingAndAdministration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationgeneralSellingAndAdministration_lbl" xml:lang="en-US">Stock-based compensation-selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="ALRT_StockbasedCompensationProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationProfessionalFees" xlink:to="ALRT_StockbasedCompensationProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationProfessionalFees_lbl" xml:lang="en-US">Stock-based compensation-professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="ALRT_InterestExpenseOnLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnLinesOfCredit" xlink:to="ALRT_InterestExpenseOnLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnLinesOfCredit_lbl" xml:lang="en-US">Interest expense on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="ALRT_NoncashImputedInterestExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NoncashImputedInterestExpenses" xlink:to="ALRT_NoncashImputedInterestExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NoncashImputedInterestExpenses_lbl" xml:lang="en-US">Non-cash imputed interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Decrease (increase) in prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase in accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Increase in interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfLinesOfCreditInterest" xlink:to="ALRT_RepaymentOfLinesOfCreditInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest_lbl" xml:lang="en-US">Repayment of lines of credit interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sales of shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of foreign exchange on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Basis of presentation, nature of operations and going concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract_lbl" xml:lang="en-US">Interest Advances And Promissory Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:label="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:to="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock_lbl" xml:lang="en-US">Interest, advances and promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="ALRT_DisclosureLinesOfCreditAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureLinesOfCreditAbstract" xlink:to="ALRT_DisclosureLinesOfCreditAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureLinesOfCreditAbstract_lbl" xml:lang="en-US">Lines Of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LineOfCreditTextBlock" xlink:label="ALRT_LineOfCreditTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LineOfCreditTextBlock" xlink:to="ALRT_LineOfCreditTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LineOfCreditTextBlock_lbl" xml:lang="en-US">Lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="ALRT_DisclosureAdditionalPaidinCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:to="ALRT_DisclosureAdditionalPaidinCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureAdditionalPaidinCapitalAbstract_lbl" xml:lang="en-US">Additional Paid-in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_AdditionalPaidInCapitalTextBlock" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AdditionalPaidInCapitalTextBlock" xlink:to="ALRT_AdditionalPaidInCapitalTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related party transactions and balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent event</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:label="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:to="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_lbl" xml:lang="en-US">Summary of activities of promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:label="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:to="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_lbl" xml:lang="en-US">Schedule of activity of promissory notes payable to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:label="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:to="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Promissory Notes Payable to Unrelated Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:label="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:to="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_lbl" xml:lang="en-US">Schedule of activity of promissory notes payable to unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="us-gaap_InterestAndOtherIncomeTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:to="us-gaap_InterestAndOtherIncomeTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncomeTableTextBlock_lbl" xml:lang="en-US">Schedule of interest payable activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:label="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:to="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock_lbl" xml:lang="en-US">Schedule of Interest payable due to related and non-related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US">Schedule of lines of credit activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:label="ALRT_ScheduledOfLineOfCreditTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:to="ALRT_ScheduledOfLineOfCreditTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduledOfLineOfCreditTableTextBlock_lbl" xml:lang="en-US">Schedule of lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of share-based compensation, stock options, activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:label="ALRT_ScheduleofOptionsOutstandingTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:to="ALRT_ScheduleofOptionsOutstandingTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofOptionsOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Options Granted-Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of related party transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Operating Segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WorkingCapitalDeficit" xlink:label="ALRT_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WorkingCapitalDeficit" xlink:to="ALRT_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PrincipalBorrowed" xlink:label="ALRT_PrincipalBorrowed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PrincipalBorrowed" xlink:to="ALRT_PrincipalBorrowed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PrincipalBorrowed_lbl" xml:lang="en-US">Principal Borrowed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Carrying value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:to="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._lbl" xml:lang="en-US">Transferred from promissory notes payable pursuant to private transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_2_lbl" xml:lang="en-US">Carrying value at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:label="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_lbl" xml:lang="en-US">Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:to="ALRT_NotePayablewithInterestat1PercentInterestperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth_lbl" xml:lang="en-US">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="ALRT_InterestAt1.25PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestAt1.25PerMonth" xlink:to="ALRT_InterestAt1.25PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_InterestAt1.25PerMonth_lbl" xml:lang="en-US">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:to="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_lbl" xml:lang="en-US">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="ALRT_Iv.InterestAt0.5PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Iv.InterestAt0.5PerMonth" xlink:to="ALRT_Iv.InterestAt0.5PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Iv.InterestAt0.5PerMonth_lbl" xml:lang="en-US">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:to="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_lbl" xml:lang="en-US">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="ALRT_PromissoryNotesRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_PromissoryNotesRelatedParty_lbl" xml:lang="en-US">Total Promissory Notes Payable to Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Balance, December&#160;31, 2020</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xml:lang="en-US">Reclassified to interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:to="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock_lbl" xml:lang="en-US">Extinguished through issuance of shares of common stock (note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNoteReceived" xlink:label="ALRT_PromissoryNoteReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNoteReceived" xlink:to="ALRT_PromissoryNoteReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNoteReceived_lbl" xml:lang="en-US">Promissory note received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NotesPayable_3_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_lbl" xml:lang="en-US">Unsecured promissory notes payable to unrelated lenders, past maturity:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:to="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_lbl" xml:lang="en-US">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:to="ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_lbl" xml:lang="en-US">ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:label="ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:to="ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_lbl" xml:lang="en-US">iii.&#160;&#160;&#160; Interest at 0.625% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Noninterestbearing" xlink:label="ALRT_Noninterestbearing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Noninterestbearing" xlink:to="ALRT_Noninterestbearing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Noninterestbearing_lbl" xml:lang="en-US">iv.&#160;&#160;&#160;&#160; Non-interest-bearing</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_FixedInterest" xlink:label="ALRT_FixedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_FixedInterest" xlink:to="ALRT_FixedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_FixedInterest_lbl" xml:lang="en-US">v.&#160;&#160;&#160;&#160;&#160;&#160; Fixed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:to="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_lbl" xml:lang="en-US">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:to="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_lbl" xml:lang="en-US">Total Promissory Notes Payable to Unrelated Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:label="ALRT_ReclassifiedFromPromissoryNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:to="ALRT_ReclassifiedFromPromissoryNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ReclassifiedFromPromissoryNotesPayable_lbl" xml:lang="en-US">Reclassified from promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:to="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_lbl" xml:lang="en-US">Interest incurred on promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:label="ALRT_InterestPayableRetiredThroughIssuanceOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:to="ALRT_InterestPayableRetiredThroughIssuanceOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableRetiredThroughIssuanceOfShares_lbl" xml:lang="en-US">Interest payable retired through issuance of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableRelativesOfDirectors" xlink:label="ALRT_InterestPayableRelativesOfDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRelativesOfDirectors" xlink:to="ALRT_InterestPayableRelativesOfDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableRelativesOfDirectors_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayabletoNonrelatedParties" xlink:label="ALRT_InterestPayabletoNonrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayabletoNonrelatedParties" xlink:to="ALRT_InterestPayabletoNonrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayabletoNonrelatedParties_lbl" xml:lang="en-US">Unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableCurrentAndNoncurrents" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableCurrentAndNoncurrents" xlink:to="ALRT_InterestPayableCurrentAndNoncurrents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Interest on other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Advances received on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_lbl" xml:lang="en-US">Interest incurred on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:label="ALRT_RepaymentOfInterestOnLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:to="ALRT_RepaymentOfInterestOnLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentOfInterestOnLinesOfCredit_lbl" xml:lang="en-US">Repayment of interest on lines of credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LongTermLineOfCredit_2_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestRate" xlink:label="ALRT_InterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestRate" xlink:to="ALRT_InterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestRate_lbl" xml:lang="en-US">Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_BorrowingLimit" xlink:label="ALRT_BorrowingLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_BorrowingLimit" xlink:to="ALRT_BorrowingLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_BorrowingLimit_lbl" xml:lang="en-US">Borrowing Limit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentTerms1" xlink:label="ALRT_RepaymentTerms1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentTerms1" xlink:to="ALRT_RepaymentTerms1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentTerms1_lbl" xml:lang="en-US">Repayment Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_AccruedInterest" xlink:label="ALRT_AccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AccruedInterest" xlink:to="ALRT_AccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_AccruedInterest_lbl" xml:lang="en-US">Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalOutstanding" xlink:label="ALRT_TotalOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalOutstanding" xlink:to="ALRT_TotalOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TotalOutstanding_lbl" xml:lang="en-US">Total Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Security1" xlink:label="ALRT_Security1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Security1" xlink:to="ALRT_Security1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Security1_lbl" xml:lang="en-US">Security</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Purpose1" xlink:label="ALRT_Purpose1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Purpose1" xlink:to="ALRT_Purpose1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Purpose1_lbl" xml:lang="en-US">Purpose</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average Exercise Price, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised per share</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_lbl" xml:lang="en-US">Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_CancelledPerShares" xlink:label="ALRT_CancelledPerShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_CancelledPerShares" xlink:to="ALRT_CancelledPerShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_CancelledPerShares_lbl" xml:lang="en-US">Cancelled per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Average Exercise price, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="ALRT_OpenOptionContractsWrittenNumbersOfShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:to="ALRT_OpenOptionContractsWrittenNumbersOfShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_OpenOptionContractsWrittenNumbersOfShare_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExercisePrices" xlink:label="ALRT_ExercisePrices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ExercisePrices" xlink:to="ALRT_ExercisePrices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ExercisePrices_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_IntrinsicValue" xlink:label="ALRT_IntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_IntrinsicValue" xlink:to="ALRT_IntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_IntrinsicValue_lbl" xml:lang="en-US">Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US">Product development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="us-gaap_ProfessionalAndContractServicesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="us-gaap_ProfessionalAndContractServicesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalAndContractServicesExpense_lbl" xml:lang="en-US">Professional expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Total" xlink:label="ALRT_Total" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Total" xlink:to="ALRT_Total_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_Total_lbl" xml:lang="en-US">Fair value of the stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xml:lang="en-US">Expected dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xml:lang="en-US">Forfeiture rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:label="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:to="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense_lbl" xml:lang="en-US">Related party transactions included within interest expense:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:to="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xml:lang="en-US">Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:label="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:to="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_lbl" xml:lang="en-US">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:label="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:to="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_lbl" xml:lang="en-US">Related party transactions included within selling, general and administrative expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:label="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:to="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_lbl" xml:lang="en-US">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:to="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xml:lang="en-US">Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:label="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:to="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_lbl" xml:lang="en-US">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Current and Total Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:to="ALRT_NotePayablewithInterestat1PercentInterestperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:to="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:to="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_PromissoryNotesRelatedParty_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:to="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_doc" xml:lang="en-US">The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRelativesOfDirectors" xlink:to="ALRT_InterestPayableRelativesOfDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestPayableRelativesOfDirectors_doc" xml:lang="en-US">Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayabletoNonrelatedParties" xlink:to="ALRT_InterestPayabletoNonrelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestPayabletoNonrelatedParties_doc" xml:lang="en-US">Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_doc" xml:lang="en-US">The number of shares under options that were cancelled during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:to="ALRT_StockbasedCompensationproductDevelopmentCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts_2_lbl" xml:lang="en-US">StockbasedCompensationproductDevelopmentCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfLinesOfCreditInterest" xlink:to="ALRT_RepaymentOfLinesOfCreditInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest_2_lbl" xml:lang="en-US">RepaymentOfLinesOfCreditInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AdditionalPaidInCapitalTextBlock" xlink:to="ALRT_AdditionalPaidInCapitalTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock_2_lbl" xml:lang="en-US">AdditionalPaidInCapitalTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_3_lbl" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestAt1.25PerMonth" xlink:to="ALRT_InterestAt1.25PerMonth_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestAt1.25PerMonth_2_lbl" xml:lang="en-US">InterestAt1.25PerMonth</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesRelatedParty_3_lbl" xml:lang="en-US">PromissoryNotesRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:to="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_2_lbl" xml:lang="en-US">I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:to="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_2_lbl" xml:lang="en-US">TotalPromissoryNotesPayableToUnrelatedParties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_3_lbl" xml:lang="en-US">Interest Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableCurrentAndNoncurrents" xlink:to="ALRT_InterestPayableCurrentAndNoncurrents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents_2_lbl" xml:lang="en-US">InterestPayableCurrentAndNoncurrents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_3_lbl" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_CancelledPerShares" xlink:to="ALRT_CancelledPerShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_CancelledPerShares_2_lbl" xml:lang="en-US">CancelledPerShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Other Selling, General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Total" xlink:to="ALRT_Total_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Total_2_lbl" xml:lang="en-US">Total</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>alrt-20220331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220331.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220331.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220331.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220331.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvent" xlink:href="alrt-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220331.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220331.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220331.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220331.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220331.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220331.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220331.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220331.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="loc_ALRTPromissoryNotesPayableToRelatedParties" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTPromissoryNotesPayableToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="loc_ALRTPromissoryNotesPayableUnrelatedLender" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTPromissoryNotesPayableUnrelatedLender" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="loc_ALRTLinesOfCreditFromRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTLinesOfCreditFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:label="loc_ALRTWeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_ALRTWeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LossPerShareBasicAndDiluted" xlink:label="loc_ALRTLossPerShareBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_ALRTLossPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="loc_ALRTStockbasedCompensationproductDevelopmentCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationproductDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="loc_ALRTStockbasedCompensationProfessionalFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="loc_ALRTInterestExpenseOnLinesOfCredit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTInterestExpenseOnLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="loc_ALRTNoncashImputedInterestExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTNoncashImputedInterestExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="loc_ALRTRepaymentOfLinesOfCreditInterest" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ALRTRepaymentOfLinesOfCreditInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:label="loc_ALRTInterestAdvancesAndPromissoryNotesPayableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_LineOfCreditTextBlock" xlink:label="loc_ALRTLineOfCreditTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTLineOfCreditTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_AdditionalPaidInCapitalTextBlock" xlink:label="loc_ALRTAdditionalPaidInCapitalTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTAdditionalPaidInCapitalTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:label="loc_ALRTSummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTSummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:label="loc_ALRTScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:label="loc_ALRTScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:label="loc_ALRTScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="loc_us-gaapInterestAndOtherIncomeTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestAndOtherIncomeTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:label="loc_ALRTScheduledOfInterestPayableDueToRelatedTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:label="loc_ALRTScheduledOfLineOfCreditTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTScheduledOfLineOfCreditTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:label="loc_ALRTScheduleofOptionsOutstandingTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTScheduleofOptionsOutstandingTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WorkingCapitalDeficit" xlink:label="loc_ALRTWorkingCapitalDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ALRTWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ALRTPrincipalBorrowed" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyMember" xlink:label="loc_ALRTRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:label="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="loc_ALRTInterestAt1.25PerMonth" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTInterestAt1.25PerMonth" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="loc_ALRTIv.InterestAt0.5PerMonth" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTIv.InterestAt0.5PerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="loc_ALRTPromissoryNotesRelatedParty" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTPromissoryNotesRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_UnRelatedPartyMember" xlink:label="loc_ALRTUnRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTUnRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNoteReceived" xlink:label="loc_ALRTPromissoryNoteReceived" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTPromissoryNoteReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_3" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="loc_ALRTIii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTIii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:label="loc_ALRTVi.InterestAt0.625PerMonthWith125000DueJanuary152011" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTVi.InterestAt0.625PerMonthWith125000DueJanuary152011" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Noninterestbearing" xlink:label="loc_ALRTNoninterestbearing" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTNoninterestbearing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_FixedInterest" xlink:label="loc_ALRTFixedInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTFixedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:label="loc_ALRTReclassifiedFromPromissoryNotesPayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTReclassifiedFromPromissoryNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:label="loc_ALRTInterestExpenseIncurredonPromissoryNotesandOtherPayables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:label="loc_ALRTInterestPayableRetiredThroughIssuanceOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableRetiredThroughIssuanceOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableRelativesOfDirectors" xlink:label="loc_ALRTInterestPayableRelativesOfDirectors" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableRelativesOfDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayabletoNonrelatedParties" xlink:label="loc_ALRTInterestPayabletoNonrelatedParties" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayabletoNonrelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestPayableCurrentAndNoncurrents" xlink:label="loc_ALRTInterestPayableCurrentAndNoncurrents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableCurrentAndNoncurrents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="loc_us-gaapLineOfCreditFacilityPeriodicPaymentPrincipal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="loc_us-gaapLineOfCreditFacilityPeriodicPaymentInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityPeriodicPaymentInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:label="loc_ALRTRepaymentOfInterestOnLinesOfCredit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTRepaymentOfInterestOnLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLongTermLineOfCredit_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ChairmanAndCEOMember" xlink:label="loc_ALRTChairmanAndCEOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTChairmanAndCEOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_WifeOfChairmanMember" xlink:label="loc_ALRTWifeOfChairmanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTWifeOfChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestRate" xlink:label="loc_ALRTInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_BorrowingLimit" xlink:label="loc_ALRTBorrowingLimit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTBorrowingLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RepaymentTerms1" xlink:label="loc_ALRTRepaymentTerms1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTRepaymentTerms1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPrincipalBorrowed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_AccruedInterest" xlink:label="loc_ALRTAccruedInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_TotalOutstanding" xlink:label="loc_ALRTTotalOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTTotalOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Security1" xlink:label="loc_ALRTSecurity1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTSecurity1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Purpose1" xlink:label="loc_ALRTPurpose1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPurpose1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:label="loc_ALRTShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_CancelledPerShares" xlink:label="loc_ALRTCancelledPerShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTCancelledPerShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options1Member" xlink:label="loc_ALRTOptions1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options2Member" xlink:label="loc_ALRTOptions2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options3Member" xlink:label="loc_ALRTOptions3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options4Member" xlink:label="loc_ALRTOptions4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options5Member" xlink:label="loc_ALRTOptions5Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options6Member" xlink:label="loc_ALRTOptions6Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options7Member" xlink:label="loc_ALRTOptions7Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options8Member" xlink:label="loc_ALRTOptions8Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options9Member" xlink:label="loc_ALRTOptions9Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options10Member" xlink:label="loc_ALRTOptions10Member" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions10Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options11Member" xlink:label="loc_ALRTOptions11Member" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions11Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options12Member" xlink:label="loc_ALRTOptions12Member" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions12Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options13Member" xlink:label="loc_ALRTOptions13Member" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions13Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options14Member" xlink:label="loc_ALRTOptions14Member" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions14Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options15Member" xlink:label="loc_ALRTOptions15Member" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions15Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options16Member" xlink:label="loc_ALRTOptions16Member" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions16Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options17Member" xlink:label="loc_ALRTOptions17Member" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions17Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options18Member" xlink:label="loc_ALRTOptions18Member" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions18Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options19Member" xlink:label="loc_ALRTOptions19Member" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions19Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options20Member" xlink:label="loc_ALRTOptions20Member" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions20Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options21Member" xlink:label="loc_ALRTOptions21Member" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options22Member" xlink:label="loc_ALRTOptions22Member" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions22Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Options23Member" xlink:label="loc_ALRTOptions23Member" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions23Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="loc_ALRTOpenOptionContractsWrittenNumbersOfShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTOpenOptionContractsWrittenNumbersOfShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ExercisePrices" xlink:label="loc_ALRTExercisePrices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTExercisePrices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_IntrinsicValue" xlink:label="loc_ALRTIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="loc_us-gaapProfessionalAndContractServicesExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapProfessionalAndContractServicesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_Total" xlink:label="loc_ALRTTotal" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTTotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:label="loc_ALRTRelatedPartyTransactionIncludedWithinInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRelatedPartyTransactionIncludedWithinInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="loc_ALRTInterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTInterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:label="loc_ALRTInterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTInterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:label="loc_ALRTRelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:label="loc_ALRTConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="loc_ALRTSalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTSalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:label="loc_ALRTRentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220331.xsd#ALRT_OtherMember" xlink:label="loc_ALRTOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ALRTOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="loc_countrySG" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countrySG" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816591704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALR TECHNOLOGIES INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0225807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7400 Beaufont Springs Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">554-3500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,716,844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816365192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 179,937<span></span>
</td>
<td class="nump">$ 115,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Share subscription receivable</a></td>
<td class="nump">25<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">87,416<span></span>
</td>
<td class="nump">77,295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">267,378<span></span>
</td>
<td class="nump">193,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,323,363<span></span>
</td>
<td class="nump">1,130,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableToRelatedParties', window );">Promissory notes payable to related parties</a></td>
<td class="nump">3,041,966<span></span>
</td>
<td class="nump">3,041,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableUnrelatedLender', window );">Promissory notes payable to unrelated parties</a></td>
<td class="nump">2,412,763<span></span>
</td>
<td class="nump">2,213,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">4,248,183<span></span>
</td>
<td class="nump">4,110,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_LinesOfCreditFromRelatedParties', window );">Lines of credit from related parties</a></td>
<td class="nump">14,613,074<span></span>
</td>
<td class="nump">14,008,833<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">25,639,349<span></span>
</td>
<td class="nump">24,505,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">542,716<span></span>
</td>
<td class="nump">542,716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">77,517,579<span></span>
</td>
<td class="nump">77,171,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</a></td>
<td class="num">(12,340)<span></span>
</td>
<td class="num">(11,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(103,419,926)<span></span>
</td>
<td class="num">(102,015,077)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(25,371,971)<span></span>
</td>
<td class="num">(24,312,143)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">$ 267,378<span></span>
</td>
<td class="nump">$ 193,217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LinesOfCreditFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LinesOfCreditFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableUnrelatedLender">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableUnrelatedLender</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816579144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, Issued</a></td>
<td class="nump">542,716,844<span></span>
</td>
<td class="nump">542,716,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, outstanding</a></td>
<td class="nump">542,716,844<span></span>
</td>
<td class="nump">542,716,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821895048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 1,043<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(594)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">449<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">128,220<span></span>
</td>
<td class="nump">112,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">171,617<span></span>
</td>
<td class="nump">217,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">554,825<span></span>
</td>
<td class="nump">208,286<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="nump">854,662<span></span>
</td>
<td class="nump">537,556<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before other item</a></td>
<td class="num">(854,213)<span></span>
</td>
<td class="num">(537,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Item</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(550,636)<span></span>
</td>
<td class="num">(479,367)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Item</a></td>
<td class="num">(550,636)<span></span>
</td>
<td class="num">(479,367)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(1,404,849)<span></span>
</td>
<td class="num">(1,016,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Exchange difference on translating foreign operations</a></td>
<td class="num">(931)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss for the period</a></td>
<td class="num">$ (1,405,780)<span></span>
</td>
<td class="num">$ (1,016,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted', window );">Weighted average number of shares of common stock outstanding, basic and diluted</a></td>
<td class="nump">542,716,400<span></span>
</td>
<td class="nump">521,414,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_LossPerShareBasicAndDiluted', window );">Loss per share, basic and diluted</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074814484312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (1,404,849)<span></span>
</td>
<td class="num">$ (1,016,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_StockbasedCompensationproductDevelopmentCosts', window );">Stock-based compensation-product development costs</a></td>
<td class="nump">62,168<span></span>
</td>
<td class="nump">36,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_StockbasedCompensationgeneralSellingAndAdministration', window );">Stock-based compensation-selling, general and administrative</a></td>
<td class="nump">248,662<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_StockbasedCompensationProfessionalFees', window );">Stock-based compensation-professional fees</a></td>
<td class="nump">8,959<span></span>
</td>
<td class="nump">15,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestExpenseOnLinesOfCredit', window );">Interest expense on lines of credit</a></td>
<td class="nump">384,922<span></span>
</td>
<td class="nump">314,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_NoncashImputedInterestExpenses', window );">Non-cash imputed interest expense</a></td>
<td class="nump">26,138<span></span>
</td>
<td class="nump">31,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Decrease (increase) in prepaid expenses</a></td>
<td class="num">(10,121)<span></span>
</td>
<td class="nump">16,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in accounts payable and accrued liabilities</a></td>
<td class="nump">192,817<span></span>
</td>
<td class="nump">151,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Increase in interest payable</a></td>
<td class="nump">137,536<span></span>
</td>
<td class="nump">132,218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(353,768)<span></span>
</td>
<td class="num">(318,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="nump">299,695<span></span>
</td>
<td class="nump">192,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from promissory notes</a></td>
<td class="nump">199,395<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RepaymentOfLinesOfCreditInterest', window );">Repayment of lines of credit interest</a></td>
<td class="num">(80,376)<span></span>
</td>
<td class="num">(218,398)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sales of shares of common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">536,832<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">418,714<span></span>
</td>
<td class="nump">510,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange on cash</a></td>
<td class="num">(931)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash</a></td>
<td class="nump">64,015<span></span>
</td>
<td class="nump">191,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, beginning of period</a></td>
<td class="nump">115,922<span></span>
</td>
<td class="nump">66,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash, end of period</a></td>
<td class="nump">$ 179,937<span></span>
</td>
<td class="nump">$ 257,995<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NoncashImputedInterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NoncashImputedInterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentOfLinesOfCreditInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentOfLinesOfCreditInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationgeneralSellingAndAdministration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationgeneralSellingAndAdministration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationproductDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationproductDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074822023416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation, nature of operations and going concern<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of presentation, nature of operations and going concern</a></td>
<td class="text"><p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zTayP8eBYsmc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82B_zCDqO5jIcOVa">Basis
of presentation, nature of operations and going concern</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
Technologies Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On May&#160;16,
2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#8220;ALRT SG&#8221;), under the <i>Companies
Act</i> of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes Solution Centre, Inc.,
under the <i>Business Corporations Act </i>of Alberta. The Company has developed its Diabetes Solution, which is a comprehensive approach
to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring
and diabetes test supplies. The Company is seeking commercial opportunities to deploy the Diabetes Solution in the United States (&#8220;U.S.&#8221;),
Canada and Singapore.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#8220;U.S. GAAP&#8221;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the three-month
periods ended March&#160;31, 2022 and 2021 of $<span id="xdx_909_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220331_z9rdDcY8lih2" title="Net loss">1,404,849</span> and $<span id="xdx_90F_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210331_zCtcBlxJmWX9" title="Net loss">1,016,923</span>, respectively. As of March&#160;31, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_c20220331_pp0p0" title="Working capital deficit">25,371,971</span> (December&#160;31, 2021&#160;- $<span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit">24,312,143</span>), accumulated
deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220331_z4NEhN78wNmi" title="Accumulated deficit">103,419,926</span> (December&#160;31, 2021&#160;- $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_ztc0fby9smlf" title="Accumulated deficit">102,015,077</span>), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#8217;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $25,639,349 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#8217;s product line, and
ultimately, the Company&#8217;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of March&#160;31,
2022, the total principal balance outstanding was $<span id="xdx_90E_ecustom--PrincipalBorrowed_c20220331_pp0p0" title="Principal Borrowed"><span id="xdx_90F_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_zi5hej5HjyAe" title="Principal Borrowed">12,988,100</span></span>. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#8217;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#8217;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.</span></p>




















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&#8217;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rates. The Company
will seek to obtain creditors&#8217; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#8217;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#8217;s capital
requirements will depend on many factors, including the success of the Company&#8217;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074822002440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant accounting policies</a></td>
<td class="text"><p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zVgTkNMBGndl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zwxRiiaUTT44">Significant
accounting policies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALRT SG, which
was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements as of March&#160;31, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have
been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate
to make the information not misleading.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments necessary to present fairly the financial position as of March&#160;31, 2022 and December&#160;31,
2021, and the results of operations and cash flows as of March&#160;31, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations for the three-month period ended March&#160;31, 2022 are not necessarily indicative of the results to be expected
for the full year.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>





<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074822028968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zEQ6MIQdQtn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_826_z2grHBCKSNoi">Accounts
payable and accrued liabilities</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the accounts payable and accrued liabilities is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z5BEFGJr9pFi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B4_z28ZlB8TmLGj">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220331" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzeC1_zRDjvbYfKH5g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">993,063</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">806,059</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzeC1_zRig40cBAsE5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">328,948</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,087</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzeC1_zrrPzSJmGf8b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,352</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzeC1_z6HbOLyJjiCi" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,323,363</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,130,546</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821736936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock', window );">Interest, advances and promissory notes payable</a></td>
<td class="text"><p id="xdx_807_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zNKIeQt3W5Tg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zkWw3w9zE4V6">Interest,
advances and promissory notes payable</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_zrwYo1dp2O7i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold">
<span id="xdx_8B5_zXEdeNkXGMY8">Summary of activities of promissory notes payable</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z4f3AlIM6lx5" style="width: 18%; text-align: right" title="Carrying value at beginning">3,031,966</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zM27yHEB3gqj" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">10,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021 and March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zJFrk3pWfv9b" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending">3,041,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z22PVCPtlCca" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zZdswlJHkgk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span id="xdx_8B6_zOu81QUSNM14"><span id="xdx_8B9_z5VqDXCbLAj8" style="display: none">Schedule of activity of promissory notes payable to related parties</span></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220331_zEpBD8JOdVtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z7yUc6EqGMJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Related Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:
    </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzwx0_zqUTXq10H9Ma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,619</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,619</span></td></tr>
  <tr id="xdx_409_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzwx0_zJ6hDiJV9zjk" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 1.25% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,347</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,347</span></td></tr>
  <tr id="xdx_402_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzwx0_zUnNTqWaL2ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at the U.S. bank prime rate plus 1%</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td></tr>
  <tr id="xdx_409_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzwx0_zDb7OtsjEEE5" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Interest at 0.5% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,000</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzwx0_z8JuCR6UvbAc" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,475,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,475,000</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzwx0_zDmVlwLqu6Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Related Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,041,966</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,041,966</span></td></tr>
  <tr style="background-color: White">
    <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_za17SXqU78A2" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>
















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>







<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zqEsnuhd2D35" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B2_zgsqeXLqdxB5" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zPVz5L7tZpne" style="width: 18%; text-align: right" title="Balance at beginning">2,254,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable">(10,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)">(20,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">(10,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zWWPpIyXAFG" style="text-align: right" title="Balance at beginning">2,213,368</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory note received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PromissoryNoteReceived_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zF3C8qyN6DId" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received">199,395</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zLhWNc9XbLo8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">2,412,763</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zYorNWnpVhEe" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zeiGCHUTgwtd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B5_zkQN3p7cBnN3" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220331_zNynpsuSazw9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zoMPkDQGjw68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzzz1_zyh2G4Vwtkja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td></tr>
  <tr id="xdx_403_ecustom--Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzzz1_zYikQA7NoUc2" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td></tr>
  <tr id="xdx_407_ecustom--Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzzz1_zNIYEiuDdGKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td></tr>
  <tr id="xdx_409_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzzz1_zb9LS1pXmKu8" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td></tr>
  <tr id="xdx_40F_ecustom--FixedInterest_i01I_pp0p0_maTPNPTzzz1_zACJq6XXMU2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&#160;&#160;&#160;&#160;&#160;&#160;
    Fixed interest</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">199,395</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzzz1_zILcMTBjvb08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td></tr>
  <tr id="xdx_40E_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzzz1_zeSh7VKeTUag" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,412,763</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,213,368</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AC_zXa60Fv8Cds4" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received an advance from a shareholder for Singapore dollars (&#8220;SGD&#8221;) $270,000 (US$199,395), with a fixed interest
amount of SGD$8,000, which will mature and be repayable on July&#160;31, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>
























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the interest payable activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--InterestAndOtherIncomeTableTextBlock_z8qw3QLtv2Ti" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B7_z1mwe2QR2N9c">Schedule of interest payable activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zCkIGnDbRA" style="width: 18%; text-align: right" title="Beginning Balance">3,575,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable">10,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable">527,336</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares">(3,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220331_zJI75QwAXNT5" style="text-align: right" title="Beginning Balance">4,110,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable">137,536</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220331_zEeUohQ0Jvzf" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance">4,248,183</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zKWFLCJ2ERNb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable is due to related and non-related parties as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zngSYBij7SG4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BC_zdAoRKh1I1Zi" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220331_zzGN8XqsD4J3" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zmDZQm0Yeo75" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,279,462</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,200,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,968,721</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,910,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,248,183</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,110,647</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zhAcVepCBgvg" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March&#160;31, 2022, the Company incurred interest expense of $<span id="xdx_901_eus-gaap--InterestExpense_c20220101__20220331_pp0p0" title="Interest expense">550,636</span> (2021&#160;- $<span id="xdx_907_eus-gaap--InterestExpense_pp0p0_c20210101__20210331_zHbg6VQoQKa7" title="Interest expense">479,367</span>) as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$384,922
                                            (2021&#160;- $314,737) incurred on lines of credit payable as shown in note&#160;5; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$137,536
                                            (2021&#160;- $132,218) incurred on promissory notes (notes&#160;4(a) and 4(b));</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$26,138
                                            (2021&#160;- $31,963) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--OtherExpenses_pp0p0_c20220101__20220331_zkROgaZ8LqFl" title="Interest on other">2,040</span>
                                            (2021&#160;- $<span id="xdx_905_eus-gaap--OtherExpenses_pp0p0_c20210101__20210331_zI5hx791WXc6" title="Interest on other">449</span>) interest on other items.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821679416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_LineOfCreditTextBlock', window );">Lines of credit</a></td>
<td class="text"><p id="xdx_806_ecustom--LineOfCreditTextBlock_z8WW1df1mPuc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zsLSRV5VDhv6">Lines of credit</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of lines of credit activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zpkGAS38diMc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B6_zWfW50S2ATl8">Schedule of lines of credit activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_z24upRkNbaUi" style="width: 18%; text-align: right" title="Balance at beginning">11,914,092</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit">1,149,279</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">1,402,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(456,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220331_z3slIMhliBH1" style="text-align: right" title="Balance at beginning">14,008,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220331_pp0p0" style="text-align: right" title="Advances received on lines of credit">299,695</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220331_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">384,922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(80,376</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220331_zPHIUwXPxjF8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">14,613,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zXdDI8tmADid" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common of the Company at a price of $0.05 per share until December&#160;31, 2026
(note&#160;7).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2022, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduledOfLineOfCreditTableTextBlock_zgG2R27AbvB5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details1)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B5_zk1NL8eJYqFb" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_909_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,283,100</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,481,047</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_906_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,764,147</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,705,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">143,927</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,848,927</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90E_ecustom--BorrowingLimit_c20220331_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_z2nrwRqt5h2l" title="Principal Borrowed">12,988,100</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--AccruedInterest_c20220331_pp0p0" title="Accrued Interest">1,624,974</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--TotalOutstanding_c20220331_pp0p0" title="Total Outstanding">14,613,074</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,220,700</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,208,582</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,429,282</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,467,705</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">111,846</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,579,551</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed">12,688,405</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest">1,320,428</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding">14,008,833</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A7_zYHrQSNSsK8b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LineOfCreditTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LineOfCreditTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821702232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital stock</a></td>
<td class="text"><p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zEe4BQCfLo79" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_zfGnN0o2Tef7">Capital
stock</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            capital stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000,000
shares of common stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            stock </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000
shares of preferred stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended March&#160;31, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription rights to its shareholders to purchase shares of common stock of the Company at a price of $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022. On March 21, 2022, the Company recognized share subscriptions receivable of $25 pursuant to its registration statement and issued a total of 500 shares of common stock for gross proceeds of $25. </span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"/>


























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"/>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration was exchanged.</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021) by an additional 100-day period related to the closing of the rights offering. The Company had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The Company further extended the offering period to October 29, 2021. The Company filed a post-effective amendment to further extend the rights offering from October 29, 2021 to March 15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company collected subscriptions of $1,124,832 pursuant to its registration statement and issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000 of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized as obligation to issue shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000 shares of common stock at a price of $0.015 per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 47px">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into two shares for debt agreements with two creditors to issue an aggregate 4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: </span></td></tr>
  </table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"/>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Accounts payable	-	$ 194,186</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Promissory notes &#8211; Principal 	-	$ 20,000</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;&#160;&#160;&#160;&#160;&#160;
Line of credit &#8211; Accrued interest	-	$ 3,000</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement of
$1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer letters
have not been executed.</span></p>


















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821624232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_AdditionalPaidInCapitalTextBlock', window );">Additional paid-in capital</a></td>
<td class="text"><p id="xdx_80D_ecustom--AdditionalPaidInCapitalTextBlock_z5G0pTW8pNn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_824_zasfWQYNeLs">Additional paid-in capital </span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4AsrMRxgbsl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zHqaRUZv2zE8" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331_zewLNedBE0Mf" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331_zw4kCVbN6Bx4" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zWNNMMwvmpLk" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,362,701,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zgEEMAaN1VV4" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220331_zHmrvw6LI0s4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220331_zesSSuXLCIEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></span></td>
    <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z2PtN5CBTQX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(800,000)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_z2NZ6l5srZq2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.015)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220331_zaEWQZ3qhqte" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(60,000,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--CancelledPerShares_iN_di_c20220101__20220331_zfWtAN6ZUcK5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.036)</span></td>
    <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_zBdTfkGX0N81" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,900,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zPadCdABhMd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.034)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331_zotG3w7078N7" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,437,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331_zRLctlaqtyI5" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zHTFB09Gag54" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zoeY6EO3MTuf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20220331_zaesLuaQsSgg" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,223,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220331_zjaJZEbvpYu" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zd6wd95993Pc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,221,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zuZFtakjibz2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  </table>
<p id="xdx_8AE_zMrUk1TIaVta" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the period ended March&#160;31, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022 and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended March 31, 2022, $59,639 related
to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the period ended March&#160;31, 2022, the Company recorded a total of $319,789 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at March&#160;31, 2022, 2,000,000 (December&#160;31, 2021, 1,000,000) options have vested to date. The fair value of the options
granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952 relates
to stock options that have performance vesting conditions. During the period ended March&#160;31, 2022, $52,238 (December 31, 2021 -
$248,189) related to stock options with time-based vesting conditions and $56,648 (December 31, 2021 - $nil) related to stock options
with performance-based vesting conditions was recognized. The remaining fair value of $1,349,169 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended March 31, 2022, $17,319 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $150,092 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 14, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended March 31, 2022, $27,279 (December&#160;31, 2021 - $88,540) related to the stock
options with time-based vesting conditions was recognized. The remaining fair value of $1,449,993 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 12, 2021, the Company&#8217;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended March 31, 2022,
$4,908 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,359,484 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. <span style="background-color: white">As
at March&#160;31, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended March 31, 2022, $101,758 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December 31, 2021 - $nil) related to stock options with performance-based
vesting conditions was recognized. The remaining fair value of $780,535 has not been recorded.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.</span></p>
































<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Outstanding</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
options outstanding at March&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_zXyF1qSyHaA4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)">
<tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 34%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zkVIYPp57eL5">Schedule of Options Outstanding</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zQsaFIIvJWr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zl4xtWNPQi2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zr4Wcw7RdAdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zmHvyfXiJebl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zgLs8PRH1n58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zuB2YrhLIFDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zybLnZ4vXcAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zgEjmXKdrEz6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zalLDSP4XOl1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.057</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zbp4OhtGBVOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zOwsU8uNShw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zZ4OmKr38U3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.058</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zkYoTUsy5208" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_z0PPixvI4lUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zN3qGefbsynh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.029</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zoZ45sHd4bsh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zj03nMyoGAo6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zYu3AIfwwwZ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zIaRCzZbb5s8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_z2JRbqTxybvf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zklzM95CraAa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zZ1qnIhiBEIj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zEPV00fsnNj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zaWIcrryeUS4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zkPX8zVPvGVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_z52H4LGqLVX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zARMDYYHzy6i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zHTRgqGlz7m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zzfFfIYf8hkk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zzdFiIe5gsCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zV7sxGltCkT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zogzpfnNvnCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0800">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zDuoxYcooD0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zo4E4PiALeei" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zWSiVmLtXb8a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_z7ZiIdxyXyo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zpcfaDrpz5m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zqN9iJDcu1wf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zDRfzBphbFw8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zq0qBs1Twby1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zbTWTqpS5MH9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zl6qtF2V2MM" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zGmfHtkNgHt7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_z1Kf3JRQhxRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zhYgls60Am65" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zQ0Aerh0O109" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zxenfCtZrkVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zA3N5LA2uIHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zX7pOLNTkCh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zfc0wyb8O68a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zRjNxgKHP5Jd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zh3Wt2L1NuCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zwpMJuVp5nj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zDU8BvH17f8b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zKAa7B6Z8XD1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zCDwMRtekFd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zjL78NqsiRo2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_z5YDeIQZpPv9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zuHJ4HlsCkn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zGsHop79GxN8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2026</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zsT0xxlYigng" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zBDYCjLDrjL7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zr6r5QjsGYo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zyS5zUv1LCfa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zUe8uxzfYWAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zhchiY59Uxz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zbbShHY3NPji" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zGg6Hin4Z35h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_z6p1JyOrzRUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,437,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.053</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_zm33HCasP58b" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231_zMqQhVKS0fUc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231_zAEAP0IWAbm1" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.054</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_z0xzPIGTBlFl" title="Weighted Average Remaining Contractual Life">2.13</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zAHKFdt9AiIh" title="Weighted Average Remaining Contractual Life">2.37</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_8A3_zI74RFUIKmjk" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the stock options granted and vested was allocated as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyT8ZkXatug8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zy1rzAdhTFJa">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220101__20220331_z4Gj6U4kzXJ8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20210101__20210331_zekMmOUqJ8L5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2022</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2021</b></span></p></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzUxR_zJridlSPNIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Product development expense</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">62,168</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">36,145</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTzUxR_zxmDo3iumBW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,225</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzUxR_zkBCgczs96vj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">248,662</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--Total_iT_pp0p0_mtTzUxR_zz1CaEDkDKb9" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">319,789</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">51,370</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zO9OQwO4eqOa" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4IzhzKCld6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B8_zQW9iFHK9oxf" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210331_zIllHMW2kIlh" title="Risk-free interest rate">0.87</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210331_zBTwLtyacena" title="Expected life">4.8</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20210331_zwnm8CDud4bl" title="Expected dividends">0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210331_z53wjH06Pabe" title="Expected volatility">278</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20210331_zr55srGLE1Xb" title="Forfeiture rate">0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A9_zRfTyVliV4Y4" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
were no options granted during the three months ended March&#160;31, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z8vUfO4d1DFf" title="Weighted average fair value options granted">0.06</span><span style="background-color: white">.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_AdditionalPaidInCapitalTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_AdditionalPaidInCapitalTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821579704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related party transactions and balances</a></td>
<td class="text"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zXVruptj3RRa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_zdJ8G7ijWuqb">Related
party transactions and balances</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zQUXSUyS9JA3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_z7VjfLqxIxM9" style="display: none">Schedule of related party transactions</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220101_20220331" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20210101_20210331" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">79,292</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">78,982</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">384,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">314,737</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">12,200</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1026">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(v)). These offer letters expired on December&#160;31, 2021 without the
parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821613352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z5tuN6GBzpC6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82C_zcqhqNyrsTlg">Commitments
and contingencies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18.9pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,262,582, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $285,457 related to one
of these promissory notes.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            contract</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#8217; notice and the payment of two years&#8217; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
                                            revenue bonus</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#8217;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of business</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
more than 50% of the Company&#8217;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2%
                                            of sales price up to $24,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3%
                                            of sales price between $25,000,000 and $49,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4%
                                            of sales price between $50,000,000 and $199,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
                                            of sales price in excess of $200,000,000.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            commitment</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a lease agreement for the Singapore office with a remaining obligation of $12,185.</span></p>
















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074822022856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Operating segments</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zA6kjmROGMdi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82C_z2t8Xc5SkrQf">Operating
segments</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one operating segment, development of diabetes hardware and software. The Company&#8217;s geographical segments are summarized
as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zIF2be3Qw0uj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BD_zvt8Eosy7jOj" style="display: none">Schedule of Operating Segments</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,908</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">125,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">110,527</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">131,980</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">73,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_c20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">267,378</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">193,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1064">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zoPOWkgbWfOe" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue">1,043</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zG9dcS0Nqmbc" style="width: 12%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1070">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1072">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zZHp1S9rdUil" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1074">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue">1,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20210331_zyVWquK0WsIc" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1078">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss">(1,063</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zYn8O0Pl7JTd" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1082">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(84,392</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zkmDBUtj6r8l" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1086">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,319,394</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zWOf7HWrExd2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,016,923</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,404,849</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331_z9dBKEw4wXKl" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,016,923</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A2_zfdIe8bTjpGh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821596184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent event<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent event</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zVZZquQljiie" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_z1zM1shZff79">Subsequent
event </span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2022, the Company provided termination notice to a contractor and as a result the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 will be cancelled, unvested, effective June&#160;30, 2022.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821713368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z5BEFGJr9pFi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B4_z28ZlB8TmLGj">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220331" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzeC1_zRDjvbYfKH5g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">993,063</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">806,059</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzeC1_zRig40cBAsE5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">328,948</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,087</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzeC1_zrrPzSJmGf8b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,352</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzeC1_z6HbOLyJjiCi" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,323,363</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,130,546</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816460072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock', window );">Summary of activities of promissory notes payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_zrwYo1dp2O7i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold">
<span id="xdx_8B5_zXEdeNkXGMY8">Summary of activities of promissory notes payable</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z4f3AlIM6lx5" style="width: 18%; text-align: right" title="Carrying value at beginning">3,031,966</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zM27yHEB3gqj" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">10,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021 and March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zJFrk3pWfv9b" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending">3,041,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock', window );">Schedule of activity of promissory notes payable to related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zZdswlJHkgk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span id="xdx_8B6_zOu81QUSNM14"><span id="xdx_8B9_z5VqDXCbLAj8" style="display: none">Schedule of activity of promissory notes payable to related parties</span></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220331_zEpBD8JOdVtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z7yUc6EqGMJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Related Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:
    </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzwx0_zqUTXq10H9Ma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,619</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,619</span></td></tr>
  <tr id="xdx_409_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzwx0_zJ6hDiJV9zjk" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 1.25% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,347</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,347</span></td></tr>
  <tr id="xdx_402_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzwx0_zUnNTqWaL2ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at the U.S. bank prime rate plus 1%</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td></tr>
  <tr id="xdx_409_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzwx0_zDb7OtsjEEE5" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Interest at 0.5% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,000</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzwx0_z8JuCR6UvbAc" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,475,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,475,000</span></td></tr>
  <tr id="xdx_401_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzwx0_zDmVlwLqu6Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Related Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,041,966</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,041,966</span></td></tr>
  <tr style="background-color: White">
    <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock', window );">Schedule of Promissory Notes Payable to Unrelated Parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zqEsnuhd2D35" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B2_zgsqeXLqdxB5" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zPVz5L7tZpne" style="width: 18%; text-align: right" title="Balance at beginning">2,254,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable">(10,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)">(20,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">(10,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zWWPpIyXAFG" style="text-align: right" title="Balance at beginning">2,213,368</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory note received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PromissoryNoteReceived_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zF3C8qyN6DId" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received">199,395</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zLhWNc9XbLo8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">2,412,763</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock', window );">Schedule of activity of promissory notes payable to unrelated parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zeiGCHUTgwtd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B5_zkQN3p7cBnN3" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220331_zNynpsuSazw9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zoMPkDQGjw68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzzz1_zyh2G4Vwtkja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td></tr>
  <tr id="xdx_403_ecustom--Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzzz1_zYikQA7NoUc2" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td></tr>
  <tr id="xdx_407_ecustom--Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzzz1_zNIYEiuDdGKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td></tr>
  <tr id="xdx_409_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzzz1_zb9LS1pXmKu8" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td></tr>
  <tr id="xdx_40F_ecustom--FixedInterest_i01I_pp0p0_maTPNPTzzz1_zACJq6XXMU2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&#160;&#160;&#160;&#160;&#160;&#160;
    Fixed interest</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">199,395</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzzz1_zILcMTBjvb08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td></tr>
  <tr id="xdx_40E_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzzz1_zeSh7VKeTUag" style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,412,763</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,213,368</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncomeTableTextBlock', window );">Schedule of interest payable activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--InterestAndOtherIncomeTableTextBlock_z8qw3QLtv2Ti" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B7_z1mwe2QR2N9c">Schedule of interest payable activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zCkIGnDbRA" style="width: 18%; text-align: right" title="Beginning Balance">3,575,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable">10,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable">527,336</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares">(3,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220331_zJI75QwAXNT5" style="text-align: right" title="Beginning Balance">4,110,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable">137,536</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220331_zEeUohQ0Jvzf" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance">4,248,183</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock', window );">Schedule of Interest payable due to related and non-related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zngSYBij7SG4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BC_zdAoRKh1I1Zi" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220331_zzGN8XqsD4J3" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zmDZQm0Yeo75" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,279,462</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,200,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,968,721</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,910,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,248,183</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,110,647</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821562504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of lines of credit activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zpkGAS38diMc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)">
  <tr style="vertical-align: bottom">
    <td style="display: none; font-weight: bold"><span id="xdx_8B6_zWfW50S2ATl8">Schedule of lines of credit activity</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_z24upRkNbaUi" style="width: 18%; text-align: right" title="Balance at beginning">11,914,092</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit">1,149,279</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">1,402,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(456,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220331_z3slIMhliBH1" style="text-align: right" title="Balance at beginning">14,008,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220331_pp0p0" style="text-align: right" title="Advances received on lines of credit">299,695</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220331_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">384,922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit (note&#160;6(b))</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(80,376</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, March&#160;31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220331_zPHIUwXPxjF8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">14,613,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduledOfLineOfCreditTableTextBlock', window );">Schedule of lines of credit</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduledOfLineOfCreditTableTextBlock_zgG2R27AbvB5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details1)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B5_zk1NL8eJYqFb" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_909_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,283,100</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,481,047</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_906_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,764,147</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,705,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">143,927</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,848,927</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90E_ecustom--BorrowingLimit_c20220331_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_z2nrwRqt5h2l" title="Principal Borrowed">12,988,100</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--AccruedInterest_c20220331_pp0p0" title="Accrued Interest">1,624,974</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_901_ecustom--TotalOutstanding_c20220331_pp0p0" title="Total Outstanding">14,613,074</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,220,700</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,208,582</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,429,282</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,467,705</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">111,846</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,579,551</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed">12,688,405</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest">1,320,428</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding">14,008,833</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduledOfLineOfCreditTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduledOfLineOfCreditTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816505112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of share-based compensation, stock options, activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4AsrMRxgbsl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zHqaRUZv2zE8" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331_zewLNedBE0Mf" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331_zw4kCVbN6Bx4" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zWNNMMwvmpLk" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,362,701,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zgEEMAaN1VV4" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220331_zHmrvw6LI0s4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220331_zesSSuXLCIEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></span></td>
    <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z2PtN5CBTQX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(800,000)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_z2NZ6l5srZq2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.015)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220331_zaEWQZ3qhqte" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(60,000,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--CancelledPerShares_iN_di_c20220101__20220331_zfWtAN6ZUcK5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.036)</span></td>
    <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_zBdTfkGX0N81" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,900,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zPadCdABhMd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.034)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331_zotG3w7078N7" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,437,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331_zRLctlaqtyI5" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zHTFB09Gag54" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zoeY6EO3MTuf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20220331_zaesLuaQsSgg" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,223,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220331_zjaJZEbvpYu" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zd6wd95993Pc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,221,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zuZFtakjibz2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ScheduleofOptionsOutstandingTableTextBlock', window );">Schedule of Options Outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_zXyF1qSyHaA4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)">
<tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 34%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zkVIYPp57eL5">Schedule of Options Outstanding</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zQsaFIIvJWr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zl4xtWNPQi2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zr4Wcw7RdAdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zmHvyfXiJebl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zgLs8PRH1n58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zuB2YrhLIFDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zybLnZ4vXcAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zgEjmXKdrEz6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zalLDSP4XOl1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.057</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zbp4OhtGBVOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zOwsU8uNShw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zZ4OmKr38U3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.058</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zkYoTUsy5208" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_z0PPixvI4lUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zN3qGefbsynh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.029</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zoZ45sHd4bsh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zj03nMyoGAo6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zYu3AIfwwwZ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zIaRCzZbb5s8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_z2JRbqTxybvf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zklzM95CraAa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zZ1qnIhiBEIj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zEPV00fsnNj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zaWIcrryeUS4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zkPX8zVPvGVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_z52H4LGqLVX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zARMDYYHzy6i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zHTRgqGlz7m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zzfFfIYf8hkk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zzdFiIe5gsCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zV7sxGltCkT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zogzpfnNvnCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0800">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zDuoxYcooD0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zo4E4PiALeei" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zWSiVmLtXb8a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_z7ZiIdxyXyo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zpcfaDrpz5m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zqN9iJDcu1wf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zDRfzBphbFw8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zq0qBs1Twby1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zbTWTqpS5MH9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zl6qtF2V2MM" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zGmfHtkNgHt7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_z1Kf3JRQhxRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zhYgls60Am65" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zQ0Aerh0O109" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zxenfCtZrkVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zA3N5LA2uIHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zX7pOLNTkCh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zfc0wyb8O68a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zRjNxgKHP5Jd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zh3Wt2L1NuCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zwpMJuVp5nj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zDU8BvH17f8b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zKAa7B6Z8XD1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zCDwMRtekFd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zjL78NqsiRo2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_z5YDeIQZpPv9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zuHJ4HlsCkn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zGsHop79GxN8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2026</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zsT0xxlYigng" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zBDYCjLDrjL7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zr6r5QjsGYo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zyS5zUv1LCfa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zUe8uxzfYWAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zhchiY59Uxz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zbbShHY3NPji" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zGg6Hin4Z35h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_z6p1JyOrzRUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,437,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.053</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_zm33HCasP58b" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231_zMqQhVKS0fUc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231_zAEAP0IWAbm1" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.054</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_z0xzPIGTBlFl" title="Weighted Average Remaining Contractual Life">2.13</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zAHKFdt9AiIh" title="Weighted Average Remaining Contractual Life">2.37</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Fair Value of Stock Options Granted-Allocation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyT8ZkXatug8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zy1rzAdhTFJa">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220101__20220331_z4Gj6U4kzXJ8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20210101__20210331_zekMmOUqJ8L5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2022</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31, 2021</b></span></p></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzUxR_zJridlSPNIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Product development expense</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">62,168</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">36,145</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTzUxR_zxmDo3iumBW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,225</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzUxR_zkBCgczs96vj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">248,662</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--Total_iT_pp0p0_mtTzUxR_zz1CaEDkDKb9" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">319,789</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">51,370</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4IzhzKCld6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B8_zQW9iFHK9oxf" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210331_zIllHMW2kIlh" title="Risk-free interest rate">0.87</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210331_zBTwLtyacena" title="Expected life">4.8</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20210331_zwnm8CDud4bl" title="Expected dividends">0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210331_z53wjH06Pabe" title="Expected volatility">278</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20210331_zr55srGLE1Xb" title="Forfeiture rate">0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofOptionsOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofOptionsOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821624232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of related party transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zQUXSUyS9JA3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_z7VjfLqxIxM9" style="display: none">Schedule of related party transactions</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220101_20220331" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20210101_20210331" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">79,292</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">78,982</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">384,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">314,737</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Related party transactions included within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">12,200</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1026">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816560248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Operating Segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zIF2be3Qw0uj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BD_zvt8Eosy7jOj" style="display: none">Schedule of Operating Segments</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,908</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">125,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">110,527</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">131,980</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">73,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_c20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">267,378</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">193,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March&#160;31, 2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1064">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zoPOWkgbWfOe" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue">1,043</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zG9dcS0Nqmbc" style="width: 12%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1070">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1072">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zZHp1S9rdUil" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1074">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue">1,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20210331_zyVWquK0WsIc" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1078">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss">(1,063</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zYn8O0Pl7JTd" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1082">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(84,392</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zkmDBUtj6r8l" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1086">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,319,394</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zWOf7HWrExd2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,016,923</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,404,849</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331_z9dBKEw4wXKl" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(1,016,923</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821987816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation, nature of operations and going concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 1,404,849<span></span>
</td>
<td class="nump">$ 1,016,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">25,371,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,312,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">103,419,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,015,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 12,988,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,688,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PrincipalBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PrincipalBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821984968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 993,063<span></span>
</td>
<td class="nump">$ 806,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">328,948<span></span>
</td>
<td class="nump">322,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,352<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,323,363<span></span>
</td>
<td class="nump">$ 1,130,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821256504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details) - Related Party [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Carrying value at beginning</a></td>
<td class="nump">$ 3,031,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.', window );">Transferred from promissory notes payable pursuant to private transaction</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Carrying value at ending</a></td>
<td class="nump">$ 3,041,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ALRT_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ALRT_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074816369848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract', window );"><strong>Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_NotePayablewithInterestat1PercentInterestperMonth', window );">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</a></td>
<td class="nump">$ 720,619<span></span>
</td>
<td class="nump">$ 720,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestAt1.25PerMonth', window );">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</a></td>
<td class="nump">51,347<span></span>
</td>
<td class="nump">51,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth', window );">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Iv.InterestAt0.5PerMonth', window );">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</a></td>
<td class="nump">695,000<span></span>
</td>
<td class="nump">695,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth', window );">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</a></td>
<td class="nump">1,475,000<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesRelatedParty', window );">Total Promissory Notes Payable to Related Parties</a></td>
<td class="nump">$ 3,041,966<span></span>
</td>
<td class="nump">$ 3,041,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestAt1.25PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestAt1.25PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Iv.InterestAt0.5PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Iv.InterestAt0.5PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NotePayablewithInterestat1PercentInterestperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NotePayablewithInterestat1PercentInterestperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074814454920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Reclassified to interest payable</a></td>
<td class="nump">$ 137,536<span></span>
</td>
<td class="nump">$ 132,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember', window );">Un Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Balance, December&#160;31, 2020</a></td>
<td class="nump">2,412,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,213,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Balance at beginning</a></td>
<td class="nump">2,213,368<span></span>
</td>
<td class="nump">$ 2,254,353<span></span>
</td>
<td class="nump">2,254,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Reclassified to interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock', window );">Extinguished through issuance of shares of common stock (note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.', window );">Transferred from promissory notes payable pursuant to private transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNoteReceived', window );">Promissory note received</a></td>
<td class="nump">199,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Balance at ending</a></td>
<td class="nump">$ 2,412,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,213,368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNoteReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNoteReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821993032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 3) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract', window );"><strong>Unsecured promissory notes payable to unrelated lenders, past maturity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand', window );">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</a></td>
<td class="nump">$ 1,317,456<span></span>
</td>
<td class="nump">$ 1,317,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand', window );">ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month</a></td>
<td class="nump">425,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011', window );">iii.&#160;&#160;&#160; Interest at 0.625% per month</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Noninterestbearing', window );">iv.&#160;&#160;&#160;&#160; Non-interest-bearing</a></td>
<td class="nump">270,912<span></span>
</td>
<td class="nump">270,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_FixedInterest', window );">v.&#160;&#160;&#160;&#160;&#160;&#160; Fixed interest</a></td>
<td class="nump">199,395<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth', window );">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TotalPromissoryNotesPayableToUnrelatedParties', window );">Total Promissory Notes Payable to Unrelated Parties</a></td>
<td class="nump">$ 2,412,763<span></span>
</td>
<td class="nump">$ 2,213,368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_FixedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_FixedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Noninterestbearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Noninterestbearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TotalPromissoryNotesPayableToUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TotalPromissoryNotesPayableToUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074814455400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 4) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Beginning Balance</a></td>
<td class="nump">$ 4,110,647<span></span>
</td>
<td class="nump">$ 3,575,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ReclassifiedFromPromissoryNotesPayable', window );">Reclassified from promissory notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables', window );">Interest incurred on promissory notes payable</a></td>
<td class="nump">137,536<span></span>
</td>
<td class="nump">527,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestPayableRetiredThroughIssuanceOfShares', window );">Interest payable retired through issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Ending Balance</a></td>
<td class="nump">$ 4,248,183<span></span>
</td>
<td class="nump">$ 4,110,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableRetiredThroughIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableRetiredThroughIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ReclassifiedFromPromissoryNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ReclassifiedFromPromissoryNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821830632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 5) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestPayableRelativesOfDirectors', window );">Related parties</a></td>
<td class="nump">$ 1,279,462<span></span>
</td>
<td class="nump">$ 1,200,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestPayabletoNonrelatedParties', window );">Unrelated parties</a></td>
<td class="nump">2,968,721<span></span>
</td>
<td class="nump">2,910,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestPayableCurrentAndNoncurrents', window );">Interest payable</a></td>
<td class="nump">$ 4,248,183<span></span>
</td>
<td class="nump">$ 4,110,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableCurrentAndNoncurrents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableCurrentAndNoncurrents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableRelativesOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableRelativesOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayabletoNonrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayabletoNonrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821967096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 550,636<span></span>
</td>
<td class="nump">$ 479,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Interest on other</a></td>
<td class="nump">$ 2,040<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821935144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Balance at beginning</a></td>
<td class="nump">$ 14,008,833<span></span>
</td>
<td class="nump">$ 11,914,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal', window );">Advances received on lines of credit</a></td>
<td class="nump">299,695<span></span>
</td>
<td class="nump">1,149,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest', window );">Interest incurred on lines of credit</a></td>
<td class="nump">384,922<span></span>
</td>
<td class="nump">1,402,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RepaymentOfInterestOnLinesOfCredit', window );">Repayment of interest on lines of credit</a></td>
<td class="num">(80,376)<span></span>
</td>
<td class="num">(456,725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Balance at ending</a></td>
<td class="nump">$ 14,613,074<span></span>
</td>
<td class="nump">$ 14,008,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentOfInterestOnLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentOfInterestOnLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074743583000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Details1) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 14,300,000<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">12,988,100<span></span>
</td>
<td class="nump">12,688,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">1,624,974<span></span>
</td>
<td class="nump">1,320,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 14,613,074<span></span>
</td>
<td class="nump">$ 14,008,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember', window );">Chairman And C E O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestRate', window );">Interest Rate</a></td>
<td class="text">1%
    per Month<span></span>
</td>
<td class="text">1%
    per Month<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RepaymentTerms1', window );">Repayment Terms</a></td>
<td class="text">Due
    on Demand<span></span>
</td>
<td class="text">Due
    on Demand<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 10,283,100<span></span>
</td>
<td class="nump">$ 10,220,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">1,481,047<span></span>
</td>
<td class="nump">1,208,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 11,764,147<span></span>
</td>
<td class="nump">$ 11,429,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Security1', window );">Security</a></td>
<td class="text">General
    Security over Assets<span></span>
</td>
<td class="text">General
    Security over Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Purpose1', window );">Purpose</a></td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember', window );">Wife Of Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestRate', window );">Interest Rate</a></td>
<td class="text">1%
    per Month<span></span>
</td>
<td class="text">1%
    per Month<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RepaymentTerms1', window );">Repayment Terms</a></td>
<td class="text">Due
    on Demand<span></span>
</td>
<td class="text">Due
    on Demand<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 2,705,000<span></span>
</td>
<td class="nump">$ 2,467,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">143,927<span></span>
</td>
<td class="nump">111,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 2,848,927<span></span>
</td>
<td class="nump">$ 2,579,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Security1', window );">Security</a></td>
<td class="text">General
    Security over Assets<span></span>
</td>
<td class="text">General
    Security over Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Purpose1', window );">Purpose</a></td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_BorrowingLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_BorrowingLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PrincipalBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PrincipalBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Purpose1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Purpose1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentTerms1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentTerms1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Security1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Security1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TotalOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TotalOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074817422152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period</a></td>
<td class="nump">5,497,001,500<span></span>
</td>
<td class="nump">5,362,701,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average Exercise Price, beginning</a></td>
<td class="nump">$ 0.006<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, per share</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised per share</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations', window );">Cancelled</a></td>
<td class="num">(60,000,000)<span></span>
</td>
<td class="num">(29,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_CancelledPerShares', window );">Cancelled per share</a></td>
<td class="num">$ (0.036)<span></span>
</td>
<td class="num">$ (0.034)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period</a></td>
<td class="nump">5,437,001,500<span></span>
</td>
<td class="nump">5,497,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average Exercise price, ending</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period</a></td>
<td class="nump">5,223,701,500<span></span>
</td>
<td class="nump">5,221,701,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercisable, end of period</a></td>
<td class="nump">$ 0.004<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_CancelledPerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_CancelledPerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074742885400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,437,001,500<span></span>
</td>
<td class="nump">5,497,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.053<span></span>
</td>
<td class="nump">$ 0.054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">2 years 1 month 17 days<span></span>
</td>
<td class="text">2 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member', window );">Options 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member', window );">Options 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">20,500,000<span></span>
</td>
<td class="nump">40,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member', window );">Options 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member', window );">Options 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">6,650,000<span></span>
</td>
<td class="nump">6,650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member', window );">Options 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">4,925,001,500<span></span>
</td>
<td class="nump">4,925,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.002<span></span>
</td>
<td class="nump">$ 0.002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.057<span></span>
</td>
<td class="nump">$ 0.058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member', window );">Options 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">3,350,000<span></span>
</td>
<td class="nump">3,350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member', window );">Options 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.030<span></span>
</td>
<td class="nump">$ 0.030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.029<span></span>
</td>
<td class="nump">$ 0.030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member', window );">Options 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member', window );">Options 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">57,000,000<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member', window );">Options 10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">19,400,000<span></span>
</td>
<td class="nump">19,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member', window );">Options 11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member', window );">Options 12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member', window );">Options 13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member', window );">Options 14 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member', window );">Options 15 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member', window );">Options 16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member', window );">Options 17 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member', window );">Options 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member', window );">Options 19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">87,300,000<span></span>
</td>
<td class="nump">87,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member', window );">Options 20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">56,500,000<span></span>
</td>
<td class="nump">56,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member', window );">Options 21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member', window );">Options 22 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member', window );">Options 23 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ExercisePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ExercisePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_IntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_IntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_OpenOptionContractsWrittenNumbersOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_OpenOptionContractsWrittenNumbersOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821838104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Product development expense</a></td>
<td class="nump">$ 62,168<span></span>
</td>
<td class="nump">$ 36,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalAndContractServicesExpense', window );">Professional expense</a></td>
<td class="nump">8,959<span></span>
</td>
<td class="nump">15,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">248,662<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_Total', window );">Fair value of the stock options granted</a></td>
<td class="nump">$ 319,789<span></span>
</td>
<td class="nump">$ 51,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Total">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Total</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalAndContractServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalAndContractServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821830504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 3)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.87%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividends | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">278.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue', window );">Forfeiture rate | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821624792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value options granted</a></td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074821946456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RelatedPartyTransactionIncludedWithinInterestExpense', window );"><strong>Related party transactions included within interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany', window );">Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</a></td>
<td class="nump">$ 79,292<span></span>
</td>
<td class="nump">$ 78,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse', window );">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</a></td>
<td class="nump">384,922<span></span>
</td>
<td class="nump">314,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses', window );"><strong>Related party transactions included within selling, general and administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany', window );">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</a></td>
<td class="nump">62,400<span></span>
</td>
<td class="nump">62,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany', window );">Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</a></td>
<td class="nump">11,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers', window );">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</a></td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RelatedPartyTransactionIncludedWithinInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RelatedPartyTransactionIncludedWithinInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140074743711160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">$ 267,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(1,404,849)<span></span>
</td>
<td class="num">(1,016,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ALRT_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">9,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(1,063)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SG', window );">SINGAPORE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">125,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(84,392)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">131,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (1,319,394)<span></span>
</td>
<td class="num">$ (1,016,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ALRT_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ALRT_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>sfsalr10q051222_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ALRT="http://alrt.com/20220331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="alrt-20220331.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2022-05-16</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-03-31">0001087022</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-03-31">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0018">false</dei:DocumentTransitionReport>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0032">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0033">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0038">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0053"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-03-31"
      id="xdx2ixbrl0103"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0104"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0143"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0182"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0236"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-03-31"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:FixedInterest
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-01to2022-03-31"
      id="xdx2ixbrl0588"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-03-31"
      id="xdx2ixbrl0590"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-01to2022-03-31"
      id="xdx2ixbrl0596"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-03-31"
      id="xdx2ixbrl0598"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options11Member"
      id="xdx2ixbrl0788"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options11Member"
      id="xdx2ixbrl0790"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options11Member"
      id="xdx2ixbrl0792"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options12Member"
      id="xdx2ixbrl0800"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options12Member"
      id="xdx2ixbrl0802"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options12Member"
      id="xdx2ixbrl0804"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options13Member"
      id="xdx2ixbrl0812"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options13Member"
      id="xdx2ixbrl0814"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options13Member"
      id="xdx2ixbrl0816"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0977"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl1023"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl1026"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_OtherMember"
      id="xdx2ixbrl1064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31_custom_OtherMember"
      id="xdx2ixbrl1066"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31_country_SG"
      id="xdx2ixbrl1070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_country_US"
      id="xdx2ixbrl1072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31_country_US"
      id="xdx2ixbrl1074"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl1078"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_custom_OtherMember"
      id="xdx2ixbrl1082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_country_SG"
      id="xdx2ixbrl1086"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-03-31">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2022-01-01to2022-03-31">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-03-31">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-03-31">000-30414</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-03-31">ALR TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-03-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-03-31">88-0225807</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-03-31">7400 Beaufont Springs Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-03-31">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-03-31">Richmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-03-31">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-03-31">23225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-03-31">(804)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-03-31">554-3500</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-03-31">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-05-16" decimals="INF" unitRef="Shares">542716844</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">179937</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:Cash>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">25</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">87416</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77295</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Assets contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">267378</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1323363</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">2412763</ALRT:PromissoryNotesPayableUnrelatedLender>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:PromissoryNotesPayableUnrelatedLender>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4248183</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrent>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">14613074</ALRT:LinesOfCreditFromRelatedParties>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:LinesOfCreditFromRelatedParties>
    <us-gaap:Liabilities contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">25639349</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24505360</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">542716844</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">542716844</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">542716</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">542716</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">77517579</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77171627</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-12340</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-11409</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-103419926</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-25371971</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-24312143</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">267378</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">1043</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">594</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">449</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">128220</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">112042</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">171617</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">217228</us-gaap:ProfessionalFees>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">554825</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">208286</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-854662</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-537556</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-854213</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-537556</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">550636</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">479367</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-550636</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-479367</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-1404849</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-931</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-1405780</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:ComprehensiveIncomeNetOfTax>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">542716400</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">521414066</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.00</ALRT:LossPerShareBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.00</ALRT:LossPerShareBasicAndDiluted>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-1404849</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:ProfitLoss>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-62168</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-36145</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">248662</ALRT:StockbasedCompensationgeneralSellingAndAdministration>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">8959</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">15225</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">384922</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">314737</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">26138</ALRT:NoncashImputedInterestExpenses>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">31963</ALRT:NoncashImputedInterestExpenses>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">10121</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-16330</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">192817</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">151345</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">137536</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">132218</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-353768</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-318960</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">299695</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">192331</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">199395</us-gaap:ProceedsFromConvertibleDebt>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">80376</ALRT:RepaymentOfLinesOfCreditInterest>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">218398</ALRT:RepaymentOfLinesOfCreditInterest>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">536832</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">418714</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">510765</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-931</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">64015</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">191805</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66190</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">179937</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">257995</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zTayP8eBYsmc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82B_zCDqO5jIcOVa"&gt;Basis
of presentation, nature of operations and going concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ALR
Technologies Inc. (the &#x201c;Company&#x201d;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On May&#160;16,
2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#x201c;ALRT SG&#x201d;), under the &lt;i&gt;Companies
Act&lt;/i&gt; of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes Solution Centre, Inc.,
under the &lt;i&gt;Business Corporations Act &lt;/i&gt;of Alberta. The Company has developed its Diabetes Solution, which is a comprehensive approach
to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring
and diabetes test supplies. The Company is seeking commercial opportunities to deploy the Diabetes Solution in the United States (&#x201c;U.S.&#x201d;),
Canada and Singapore.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#x201c;U.S. GAAP&#x201d;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the three-month
periods ended March&#160;31, 2022 and 2021 of $&lt;span id="xdx_909_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220331_z9rdDcY8lih2" title="Net loss"&gt;1,404,849&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210331_zCtcBlxJmWX9" title="Net loss"&gt;1,016,923&lt;/span&gt;, respectively. As of March&#160;31, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $&lt;span id="xdx_90A_ecustom--WorkingCapitalDeficit_c20220331_pp0p0" title="Working capital deficit"&gt;25,371,971&lt;/span&gt; (December&#160;31, 2021&#160;- $&lt;span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit"&gt;24,312,143&lt;/span&gt;), accumulated
deficit of $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220331_z4NEhN78wNmi" title="Accumulated deficit"&gt;103,419,926&lt;/span&gt; (December&#160;31, 2021&#160;- $&lt;span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_ztc0fby9smlf" title="Accumulated deficit"&gt;102,015,077&lt;/span&gt;), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#x2019;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $25,639,349 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#x2019;s product line, and
ultimately, the Company&#x2019;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of March&#160;31,
2022, the total principal balance outstanding was $&lt;span id="xdx_90E_ecustom--PrincipalBorrowed_c20220331_pp0p0" title="Principal Borrowed"&gt;&lt;span id="xdx_90F_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_zi5hej5HjyAe" title="Principal Borrowed"&gt;12,988,100&lt;/span&gt;&lt;/span&gt;. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#x2019;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#x2019;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the Company&#x2019;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rates. The Company
will seek to obtain creditors&#x2019; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#x2019;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#x2019;s capital
requirements will depend on many factors, including the success of the Company&#x2019;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-1404849</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:ProfitLoss>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">25371971</ALRT:WorkingCapitalDeficit>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24312143</ALRT:WorkingCapitalDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-103419926</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">12988100</ALRT:PrincipalBorrowed>
    <ALRT:PrincipalBorrowed contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">12988100</ALRT:PrincipalBorrowed>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zVgTkNMBGndl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82E_zwxRiiaUTT44"&gt;Significant
accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALRT SG, which
was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unaudited condensed consolidated financial statements as of March&#160;31, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have
been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate
to make the information not misleading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all adjustments necessary to present fairly the financial position as of March&#160;31, 2022 and December&#160;31,
2021, and the results of operations and cash flows as of March&#160;31, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations for the three-month period ended March&#160;31, 2022 are not necessarily indicative of the results to be expected
for the full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;





</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zEQ6MIQdQtn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_826_z2grHBCKSNoi"&gt;Accounts
payable and accrued liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the accounts payable and accrued liabilities is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z5BEFGJr9pFi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B4_z28ZlB8TmLGj"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220331" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzeC1_zRDjvbYfKH5g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;993,063&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzeC1_zRig40cBAsE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzeC1_zrrPzSJmGf8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,352&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzeC1_z6HbOLyJjiCi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,323,363&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z5BEFGJr9pFi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B4_z28ZlB8TmLGj"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220331" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzeC1_zRDjvbYfKH5g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;993,063&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzeC1_zRig40cBAsE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;328,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzeC1_zrrPzSJmGf8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,352&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzeC1_z6HbOLyJjiCi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,323,363&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">993063</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">806059</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">328948</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">322087</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1352</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2400</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1323363</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_807_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zNKIeQt3W5Tg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_828_zkWw3w9zE4V6"&gt;Interest,
advances and promissory notes payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_zrwYo1dp2O7i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;
&lt;span id="xdx_8B5_zXEdeNkXGMY8"&gt;Summary of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z4f3AlIM6lx5" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zM27yHEB3gqj" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021 and March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zJFrk3pWfv9b" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z22PVCPtlCca" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zZdswlJHkgk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span id="xdx_8B6_zOu81QUSNM14"&gt;&lt;span id="xdx_8B9_z5VqDXCbLAj8" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220331_zEpBD8JOdVtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_z7yUc6EqGMJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzwx0_zqUTXq10H9Ma" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,619&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,619&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzwx0_zJ6hDiJV9zjk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 1.25% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,347&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,347&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzwx0_zUnNTqWaL2ng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at the U.S. bank prime rate plus 1%&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzwx0_zDb7OtsjEEE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Interest at 0.5% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;695,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;695,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzwx0_z8JuCR6UvbAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,475,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,475,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzwx0_zDmVlwLqu6Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,041,966&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,041,966&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 59%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_za17SXqU78A2" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.&lt;/span&gt;&lt;/p&gt;
















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;







&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zqEsnuhd2D35" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B2_zgsqeXLqdxB5" style="display: none"&gt;Schedule of Promissory Notes Payable to Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zPVz5L7tZpne" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zWWPpIyXAFG" style="text-align: right" title="Balance at beginning"&gt;2,213,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory note received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PromissoryNoteReceived_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zF3C8qyN6DId" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received"&gt;199,395&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zLhWNc9XbLo8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,412,763&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zYorNWnpVhEe" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zeiGCHUTgwtd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span id="xdx_8B5_zkQN3p7cBnN3" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220331_zNynpsuSazw9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20211231_zoMPkDQGjw68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured
    promissory notes payable to unrelated lenders, past maturity:&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzzz1_zyh2G4Vwtkja" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzzz1_zYikQA7NoUc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month &lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzzz1_zNIYEiuDdGKh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at 0.625% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzzz1_zb9LS1pXmKu8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FixedInterest_i01I_pp0p0_maTPNPTzzz1_zACJq6XXMU2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v.&#160;&#160;&#160;&#160;&#160;&#160;
    Fixed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;199,395&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzzz1_zILcMTBjvb08" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzzz1_zeSh7VKeTUag" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,412,763&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,213,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AC_zXa60Fv8Cds4" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received an advance from a shareholder for Singapore dollars (&#x201c;SGD&#x201d;) $270,000 (US$199,395), with a fixed interest
amount of SGD$8,000, which will mature and be repayable on July&#160;31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the interest payable activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--InterestAndOtherIncomeTableTextBlock_z8qw3QLtv2Ti" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&lt;span id="xdx_8B7_z1mwe2QR2N9c"&gt;Schedule of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zCkIGnDbRA" style="width: 18%; text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220331_zJI75QwAXNT5" style="text-align: right" title="Beginning Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable"&gt;137,536&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220331_zEeUohQ0Jvzf" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,248,183&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zKWFLCJ2ERNb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
payable is due to related and non-related parties as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zngSYBij7SG4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BC_zdAoRKh1I1Zi" style="display: none"&gt;Schedule of Interest payable due to related and non-related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220331_zzGN8XqsD4J3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20211231_zmDZQm0Yeo75" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,279,462&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unrelated parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,968,721&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,248,183&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zhAcVepCBgvg" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period ended March&#160;31, 2022, the Company incurred interest expense of $&lt;span id="xdx_901_eus-gaap--InterestExpense_c20220101__20220331_pp0p0" title="Interest expense"&gt;550,636&lt;/span&gt; (2021&#160;- $&lt;span id="xdx_907_eus-gaap--InterestExpense_pp0p0_c20210101__20210331_zHbg6VQoQKa7" title="Interest expense"&gt;479,367&lt;/span&gt;) as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$384,922
                                            (2021&#160;- $314,737) incurred on lines of credit payable as shown in note&#160;5; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$137,536
                                            (2021&#160;- $132,218) incurred on promissory notes (notes&#160;4(a) and 4(b));&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$26,138
                                            (2021&#160;- $31,963) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_903_eus-gaap--OtherExpenses_pp0p0_c20220101__20220331_zkROgaZ8LqFl" title="Interest on other"&gt;2,040&lt;/span&gt;
                                            (2021&#160;- $&lt;span id="xdx_905_eus-gaap--OtherExpenses_pp0p0_c20210101__20210331_zI5hx791WXc6" title="Interest on other"&gt;449&lt;/span&gt;) interest on other items.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock>
    <ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_zrwYo1dp2O7i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;
&lt;span id="xdx_8B5_zXEdeNkXGMY8"&gt;Summary of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z4f3AlIM6lx5" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zM27yHEB3gqj" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021 and March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zJFrk3pWfv9b" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3031966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3041966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zZdswlJHkgk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span id="xdx_8B6_zOu81QUSNM14"&gt;&lt;span id="xdx_8B9_z5VqDXCbLAj8" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220331_zEpBD8JOdVtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_z7yUc6EqGMJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzwx0_zqUTXq10H9Ma" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,619&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,619&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzwx0_zJ6hDiJV9zjk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 1.25% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,347&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,347&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzwx0_zUnNTqWaL2ng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at the U.S. bank prime rate plus 1%&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzwx0_zDb7OtsjEEE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Interest at 0.5% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;695,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;695,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzwx0_z8JuCR6UvbAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,475,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,475,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzwx0_zDmVlwLqu6Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,041,966&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,041,966&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 59%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1475000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1475000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesRelatedParty>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesRelatedParty>
    <ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zqEsnuhd2D35" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B2_zgsqeXLqdxB5" style="display: none"&gt;Schedule of Promissory Notes Payable to Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zPVz5L7tZpne" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zWWPpIyXAFG" style="text-align: right" title="Balance at beginning"&gt;2,213,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory note received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PromissoryNoteReceived_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zF3C8qyN6DId" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received"&gt;199,395&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220331__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zLhWNc9XbLo8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,412,763&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2020-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2254353</us-gaap:NotesPayable>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10985</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-20000</ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2213368</us-gaap:NotesPayable>
    <ALRT:PromissoryNoteReceived
      contextRef="From2022-01-012022-03-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">199395</ALRT:PromissoryNoteReceived>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-03-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2412763</us-gaap:NotesPayable>
    <ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zeiGCHUTgwtd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span id="xdx_8B5_zkQN3p7cBnN3" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220331_zNynpsuSazw9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20211231_zoMPkDQGjw68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured
    promissory notes payable to unrelated lenders, past maturity:&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzzz1_zyh2G4Vwtkja" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzzz1_zYikQA7NoUc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month &lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Vi.InterestAt0.625PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzzz1_zNIYEiuDdGKh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at 0.625% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzzz1_zb9LS1pXmKu8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FixedInterest_i01I_pp0p0_maTPNPTzzz1_zACJq6XXMU2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v.&#160;&#160;&#160;&#160;&#160;&#160;
    Fixed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;199,395&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzzz1_zILcMTBjvb08" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzzz1_zeSh7VKeTUag" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,412,763&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,213,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1317456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1317456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">425000</ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">425000</ALRT:Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011 contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011>
    <ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011 contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.625PerMonthWith125000DueJanuary152011>
    <ALRT:Noninterestbearing contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:Noninterestbearing contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:FixedInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">199395</ALRT:FixedInterest>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">50000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">50000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">2412763</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <us-gaap:InterestAndOtherIncomeTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--InterestAndOtherIncomeTableTextBlock_z8qw3QLtv2Ti" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&lt;span id="xdx_8B7_z1mwe2QR2N9c"&gt;Schedule of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zCkIGnDbRA" style="width: 18%; text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220331_zJI75QwAXNT5" style="text-align: right" title="Beginning Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable"&gt;137,536&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220331_zEeUohQ0Jvzf" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,248,183&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:InterestAndOtherIncomeTableTextBlock>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3575326</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ReclassifiedFromPromissoryNotesPayable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">10985</ALRT:ReclassifiedFromPromissoryNotesPayable>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">527336</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <ALRT:InterestPayableRetiredThroughIssuanceOfShares
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-3000</ALRT:InterestPayableRetiredThroughIssuanceOfShares>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">137536</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4248183</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zngSYBij7SG4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BC_zdAoRKh1I1Zi" style="display: none"&gt;Schedule of Interest payable due to related and non-related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220331_zzGN8XqsD4J3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20211231_zmDZQm0Yeo75" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,279,462&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unrelated parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,968,721&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,248,183&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1279462</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1200170</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">2968721</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2910477</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4248183</ALRT:InterestPayableCurrentAndNoncurrents>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</ALRT:InterestPayableCurrentAndNoncurrents>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">550636</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">479367</us-gaap:InterestExpense>
    <us-gaap:OtherExpenses
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">2040</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">449</us-gaap:OtherExpenses>
    <ALRT:LineOfCreditTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_806_ecustom--LineOfCreditTextBlock_z8WW1df1mPuc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_827_zsLSRV5VDhv6"&gt;Lines of credit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of lines of credit activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zpkGAS38diMc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&lt;span id="xdx_8B6_zWfW50S2ATl8"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Lines of Credit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_z24upRkNbaUi" style="width: 18%; text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220331_z3slIMhliBH1" style="text-align: right" title="Balance at beginning"&gt;14,008,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220331_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;299,695&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220331_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;384,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(80,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220331_zPHIUwXPxjF8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;14,613,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zXdDI8tmADid" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common of the Company at a price of $0.05 per share until December&#160;31, 2026
(note&#160;7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March&#160;31, 2022, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduledOfLineOfCreditTableTextBlock_zgG2R27AbvB5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B5_zk1NL8eJYqFb" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_909_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_901_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,283,100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,481,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_906_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,764,147&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,705,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;143,927&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,848,927&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90E_ecustom--BorrowingLimit_c20220331_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90D_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_z2nrwRqt5h2l" title="Principal Borrowed"&gt;12,988,100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90C_ecustom--AccruedInterest_c20220331_pp0p0" title="Accrued Interest"&gt;1,624,974&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_901_ecustom--TotalOutstanding_c20220331_pp0p0" title="Total Outstanding"&gt;14,613,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2021, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest"&gt;1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zYHrQSNSsK8b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:LineOfCreditTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zpkGAS38diMc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&lt;span id="xdx_8B6_zWfW50S2ATl8"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Lines of Credit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_z24upRkNbaUi" style="width: 18%; text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220331_z3slIMhliBH1" style="text-align: right" title="Balance at beginning"&gt;14,008,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220331_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;299,695&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220331_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;384,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(80,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, March&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220331_zPHIUwXPxjF8" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;14,613,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11914092</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1149279</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1402187</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-456725</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">299695</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">384922</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-80376</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">14613074</us-gaap:LongTermLineOfCredit>
    <ALRT:ScheduledOfLineOfCreditTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduledOfLineOfCreditTableTextBlock_zgG2R27AbvB5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B5_zk1NL8eJYqFb" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_909_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_901_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,283,100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,481,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_906_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,764,147&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--InterestRate_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--BorrowingLimit_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--RepaymentTerms1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--PrincipalBorrowed_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,705,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--AccruedInterest_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;143,927&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--TotalOutstanding_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,848,927&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--Security1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Purpose1_c20220101__20220331__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90E_ecustom--BorrowingLimit_c20220331_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90D_ecustom--PrincipalBorrowed_iI_pp0p0_c20220331_z2nrwRqt5h2l" title="Principal Borrowed"&gt;12,988,100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90C_ecustom--AccruedInterest_c20220331_pp0p0" title="Accrued Interest"&gt;1,624,974&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_901_ecustom--TotalOutstanding_c20220331_pp0p0" title="Total Outstanding"&gt;14,613,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2021, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest"&gt;1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduledOfLineOfCreditTableTextBlock>
    <ALRT:InterestRate contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10283100</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">1481047</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2022-03-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">11764147</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2022-01-012022-03-31_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">4000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2705000</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">143927</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2022-03-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2848927</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2022-01-012022-03-31_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">14300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">12988100</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1624974</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">14613074</ALRT:TotalOutstanding>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10220700</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">1208582</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">11429282</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">4000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2467705</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">111846</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2579551</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">12688405</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1320428</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:TotalOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zEe4BQCfLo79" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_823_zfGnN0o2Tef7"&gt;Capital
stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 17.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Authorized
                                            capital stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common
                                            stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000,000
shares of common stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
                                            stock &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500,000,000
shares of preferred stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the period ended March&#160;31, 2022:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; background-color: white; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription rights to its shareholders to purchase shares of common stock of the Company at a price of $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022. On March 21, 2022, the Company recognized share subscriptions receivable of $25 pursuant to its registration statement and issued a total of 500 shares of common stock for gross proceeds of $25. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"/&gt;


























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"/&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration was exchanged.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021) by an additional 100-day period related to the closing of the rights offering. The Company had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The Company further extended the offering period to October 29, 2021. The Company filed a post-effective amendment to further extend the rights offering from October 29, 2021 to March 15, 2022. On such case-by-case basis, the Company allowed for the exercise of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (August 12, 2022) following the expiration date of March&#160;15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company collected subscriptions of $1,124,832 pursuant to its registration statement and issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000 of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized as obligation to issue shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000 shares of common stock at a price of $0.015 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 47px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 25px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company entered into two shares for debt agreements with two creditors to issue an aggregate 4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"/&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&#160;&#160;&#160;&#160;&#160;
Accounts payable	-	$ 194,186&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&#160;&#160;&#160;&#160;&#160;
Promissory notes &#x2013; Principal 	-	$ 20,000&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&#160;&#160;&#160;&#160;&#160;
Line of credit &#x2013; Accrued interest	-	$ 3,000&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement of
$1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer letters
have not been executed.&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ALRT:AdditionalPaidInCapitalTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80D_ecustom--AdditionalPaidInCapitalTextBlock_z5G0pTW8pNn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_824_zasfWQYNeLs"&gt;Additional paid-in capital &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
options&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4AsrMRxgbsl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zHqaRUZv2zE8" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three
                                            Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331_zewLNedBE0Mf" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331_zw4kCVbN6Bx4" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zWNNMMwvmpLk" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,362,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zgEEMAaN1VV4" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0588"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0590"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;165,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220331_zHmrvw6LI0s4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220331_zesSSuXLCIEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0598"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z2PtN5CBTQX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(800,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_z2NZ6l5srZq2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.015)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220331_zaEWQZ3qhqte" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(60,000,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CancelledPerShares_iN_di_c20220101__20220331_zfWtAN6ZUcK5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.036)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_zBdTfkGX0N81" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,900,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zPadCdABhMd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331_zotG3w7078N7" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,437,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331_zRLctlaqtyI5" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zHTFB09Gag54" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zoeY6EO3MTuf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20220331_zaesLuaQsSgg" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,223,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220331_zjaJZEbvpYu" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zd6wd95993Pc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,221,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zuZFtakjibz2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zMrUk1TIaVta" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;During
the period ended March&#160;31, 2022:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022 and from June&#160;30, 2022 to June&#160;30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended March 31, 2022, $59,639 related
to the 1,000,000 options that vested immediately was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;During
the period ended March&#160;31, 2022, the Company recorded a total of $319,789 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at March&#160;31, 2022, 2,000,000 (December&#160;31, 2021, 1,000,000) options have vested to date. The fair value of the options
granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952 relates
to stock options that have performance vesting conditions. During the period ended March&#160;31, 2022, $52,238 (December 31, 2021 -
$248,189) related to stock options with time-based vesting conditions and $56,648 (December 31, 2021 - $nil) related to stock options
with performance-based vesting conditions was recognized. The remaining fair value of $1,349,169 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended March 31, 2022, $17,319 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $150,092 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
April 14, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended March 31, 2022, $27,279 (December&#160;31, 2021 - $88,540) related to the stock
options with time-based vesting conditions was recognized. The remaining fair value of $1,449,993 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
May 12, 2021, the Company&#x2019;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 27, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended March 31, 2022,
$4,908 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,359,484 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. &lt;span style="background-color: white"&gt;As
at March&#160;31, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended March 31, 2022, $101,758 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December 31, 2021 - $nil) related to stock options with performance-based
vesting conditions was recognized. The remaining fair value of $780,535 has not been recorded.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.&lt;/span&gt;&lt;/p&gt;
































&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
options outstanding at March&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_zXyF1qSyHaA4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 34%"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zkVIYPp57eL5"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November
    27, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January
    31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zQsaFIIvJWr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zl4xtWNPQi2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zr4Wcw7RdAdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    13, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zmHvyfXiJebl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zgLs8PRH1n58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zuB2YrhLIFDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March
    14, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zybLnZ4vXcAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zgEjmXKdrEz6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zalLDSP4XOl1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zbp4OhtGBVOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zOwsU8uNShw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zZ4OmKr38U3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.058&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zkYoTUsy5208" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_z0PPixvI4lUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zN3qGefbsynh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zoZ45sHd4bsh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zj03nMyoGAo6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zYu3AIfwwwZ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zIaRCzZbb5s8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_z2JRbqTxybvf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zklzM95CraAa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zZ1qnIhiBEIj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zEPV00fsnNj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zaWIcrryeUS4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zkPX8zVPvGVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_z52H4LGqLVX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zARMDYYHzy6i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zHTRgqGlz7m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zzfFfIYf8hkk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0790"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zzdFiIe5gsCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zV7sxGltCkT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zogzpfnNvnCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August
    16, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0800"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0804"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zDuoxYcooD0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zo4E4PiALeei" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zWSiVmLtXb8a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_z7ZiIdxyXyo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zpcfaDrpz5m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zqN9iJDcu1wf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    3, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zDRfzBphbFw8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zq0qBs1Twby1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zbTWTqpS5MH9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    24, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zl6qtF2V2MM" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zGmfHtkNgHt7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_z1Kf3JRQhxRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zhYgls60Am65" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    11, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zQ0Aerh0O109" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zxenfCtZrkVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zA3N5LA2uIHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zX7pOLNTkCh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zfc0wyb8O68a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zRjNxgKHP5Jd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zh3Wt2L1NuCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zwpMJuVp5nj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zDU8BvH17f8b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zKAa7B6Z8XD1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zCDwMRtekFd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zjL78NqsiRo2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_z5YDeIQZpPv9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zuHJ4HlsCkn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zGsHop79GxN8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zsT0xxlYigng" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zBDYCjLDrjL7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zr6r5QjsGYo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zyS5zUv1LCfa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zUe8uxzfYWAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zhchiY59Uxz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zbbShHY3NPji" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zGg6Hin4Z35h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_z6p1JyOrzRUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,437,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_zm33HCasP58b" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231_zMqQhVKS0fUc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231_zAEAP0IWAbm1" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_z0xzPIGTBlFl" title="Weighted Average Remaining Contractual Life"&gt;2.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zAHKFdt9AiIh" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A3_zI74RFUIKmjk" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the stock options granted and vested was allocated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyT8ZkXatug8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BD_zy1rzAdhTFJa"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220101__20220331_z4Gj6U4kzXJ8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20210101__20210331_zekMmOUqJ8L5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzUxR_zJridlSPNIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Product development expense&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;62,168&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;36,145&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTzUxR_zxmDo3iumBW7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,225&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzUxR_zkBCgczs96vj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;248,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Total_iT_pp0p0_mtTzUxR_zz1CaEDkDKb9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319,789&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;51,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zO9OQwO4eqOa" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4IzhzKCld6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B8_zQW9iFHK9oxf" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210331_zIllHMW2kIlh" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210331_zBTwLtyacena" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20210331_zwnm8CDud4bl" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210331_z53wjH06Pabe" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20210331_zr55srGLE1Xb" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zRfTyVliV4Y4" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;There
were no options granted during the three months ended March&#160;31, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z8vUfO4d1DFf" title="Weighted average fair value options granted"&gt;0.06&lt;/span&gt;&lt;span style="background-color: white"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:AdditionalPaidInCapitalTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4AsrMRxgbsl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zHqaRUZv2zE8" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three
                                            Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331_zewLNedBE0Mf" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331_zw4kCVbN6Bx4" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zWNNMMwvmpLk" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,362,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zgEEMAaN1VV4" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0588"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0590"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;165,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220331_zHmrvw6LI0s4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220331_zesSSuXLCIEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0598"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z2PtN5CBTQX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(800,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_z2NZ6l5srZq2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.015)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220331_zaEWQZ3qhqte" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(60,000,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CancelledPerShares_iN_di_c20220101__20220331_zfWtAN6ZUcK5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.036)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_zBdTfkGX0N81" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,900,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zPadCdABhMd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331_zotG3w7078N7" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,437,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331_zRLctlaqtyI5" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zHTFB09Gag54" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zoeY6EO3MTuf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20220331_zaesLuaQsSgg" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,223,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220331_zjaJZEbvpYu" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zd6wd95993Pc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,221,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zuZFtakjibz2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5497001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">5362701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">165000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.050</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.015</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">60000000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:CancelledPerShares>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">29900000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.034</ALRT:CancelledPerShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">5437001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5497001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">5223701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5221701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <ALRT:ScheduleofOptionsOutstandingTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_zXyF1qSyHaA4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 34%"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zkVIYPp57eL5"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November
    27, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January
    31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zQsaFIIvJWr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zl4xtWNPQi2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zr4Wcw7RdAdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    13, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zmHvyfXiJebl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zgLs8PRH1n58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_zuB2YrhLIFDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March
    14, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zybLnZ4vXcAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zgEjmXKdrEz6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zalLDSP4XOl1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zbp4OhtGBVOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zOwsU8uNShw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_zZ4OmKr38U3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.058&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zkYoTUsy5208" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_z0PPixvI4lUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zN3qGefbsynh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zoZ45sHd4bsh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zj03nMyoGAo6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_zYu3AIfwwwZ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zIaRCzZbb5s8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_z2JRbqTxybvf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_zklzM95CraAa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zZ1qnIhiBEIj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zEPV00fsnNj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_zaWIcrryeUS4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zkPX8zVPvGVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_z52H4LGqLVX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zARMDYYHzy6i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zHTRgqGlz7m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_zzfFfIYf8hkk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0790"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zzdFiIe5gsCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zV7sxGltCkT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_zogzpfnNvnCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August
    16, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0800"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0804"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zDuoxYcooD0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zo4E4PiALeei" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_zWSiVmLtXb8a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_z7ZiIdxyXyo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zpcfaDrpz5m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_zqN9iJDcu1wf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    3, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zDRfzBphbFw8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zq0qBs1Twby1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_zbTWTqpS5MH9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    24, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zl6qtF2V2MM" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zGmfHtkNgHt7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_z1Kf3JRQhxRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_zhYgls60Am65" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    11, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zQ0Aerh0O109" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zxenfCtZrkVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_zA3N5LA2uIHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zX7pOLNTkCh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zfc0wyb8O68a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_zRjNxgKHP5Jd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zh3Wt2L1NuCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zwpMJuVp5nj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_zDU8BvH17f8b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zKAa7B6Z8XD1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zCDwMRtekFd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_zjL78NqsiRo2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_z5YDeIQZpPv9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zuHJ4HlsCkn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_zGsHop79GxN8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zsT0xxlYigng" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zBDYCjLDrjL7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_zr6r5QjsGYo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zyS5zUv1LCfa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zUe8uxzfYWAh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_zhchiY59Uxz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zbbShHY3NPji" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_zGg6Hin4Z35h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_z6p1JyOrzRUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,437,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220331_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_zm33HCasP58b" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231_zMqQhVKS0fUc" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231_zAEAP0IWAbm1" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_z0xzPIGTBlFl" title="Weighted Average Remaining Contractual Life"&gt;2.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zAHKFdt9AiIh" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:ScheduleofOptionsOutstandingTableTextBlock>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options1Member"
      decimals="INF"
      unitRef="Shares">5600000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="Shares">5600000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">20500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">40500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">6650000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">6650000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options5Member"
      decimals="INF"
      unitRef="Shares">4925001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.057</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="Shares">4925001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.058</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options6Member"
      decimals="INF"
      unitRef="Shares">3350000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="Shares">3350000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.029</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">57000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">77000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">19400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">19400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="Shares">2500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="Shares">1000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options15Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options18Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="Shares">20000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">87300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">87300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">56500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">56500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">26000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">26000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">16000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">17500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-03-31_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">50000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-03-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-03-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">50000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">5437001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.005</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.053</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">5497001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.054</ALRT:IntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-03-31">P2Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-12-31">P2Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyT8ZkXatug8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BD_zy1rzAdhTFJa"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220101__20220331_z4Gj6U4kzXJ8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20210101__20210331_zekMmOUqJ8L5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzUxR_zJridlSPNIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Product development expense&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;62,168&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;36,145&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTzUxR_zxmDo3iumBW7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,225&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzUxR_zkBCgczs96vj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;248,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Total_iT_pp0p0_mtTzUxR_zz1CaEDkDKb9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;319,789&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;51,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">62168</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">36145</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">8959</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">15225</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">248662</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <ALRT:Total
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">319789</ALRT:Total>
    <ALRT:Total
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">51370</ALRT:Total>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zK4IzhzKCld6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B8_zQW9iFHK9oxf" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210331_zIllHMW2kIlh" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210331_zBTwLtyacena" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20210331_zwnm8CDud4bl" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210331_z53wjH06Pabe" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20210331_zr55srGLE1Xb" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.0087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-03-31">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">2.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zXVruptj3RRa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_829_zdJ8G7ijWuqb"&gt;Related
party transactions and balances&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zQUXSUyS9JA3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_z7VjfLqxIxM9" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220101_20220331" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20210101_20210331" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;79,292&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;78,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;384,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;314,737&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within selling, general and administrative expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1026"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(v)). These offer letters expired on December&#160;31, 2021 without the
parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.&lt;/span&gt;&lt;/p&gt;




















</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zQUXSUyS9JA3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_z7VjfLqxIxM9" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220101_20220331" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20210101_20210331" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;79,292&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;78,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;384,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;314,737&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within selling, general and administrative expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1026"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">79292</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">78982</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">384922</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">314737</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">62400</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">62400</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">11091</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">12200</ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z5tuN6GBzpC6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_82C_zcqhqNyrsTlg"&gt;Commitments
and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18.9pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contingencies
                                            &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,262,582, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $285,457 related to one
of these promissory notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commitments
                                            &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
                                            contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#x2019; notice and the payment of two years&#x2019; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incentive
                                            revenue bonus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#x2019;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sale
                                            of business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
more than 50% of the Company&#x2019;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2%
                                            of sales price up to $24,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3%
                                            of sales price between $25,000,000 and $49,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4%
                                            of sales price between $50,000,000 and $199,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5%
                                            of sales price in excess of $200,000,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
                                            commitment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a lease agreement for the Singapore office with a remaining obligation of $12,185.&lt;/span&gt;&lt;/p&gt;
















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zA6kjmROGMdi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_82C_z2t8Xc5SkrQf"&gt;Operating
segments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has one operating segment, development of diabetes hardware and software. The Company&#x2019;s geographical segments are summarized
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zIF2be3Qw0uj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zvt8Eosy7jOj" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;125,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;131,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_c20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;267,378&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1064"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zoPOWkgbWfOe" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1066"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;1,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zG9dcS0Nqmbc" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1070"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1072"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zZHp1S9rdUil" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1074"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;1,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20210331_zyVWquK0WsIc" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1078"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;(1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zYn8O0Pl7JTd" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1082"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(84,392&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zkmDBUtj6r8l" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1086"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,319,394&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zWOf7HWrExd2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,016,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,404,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331_z9dBKEw4wXKl" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,016,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zfdIe8bTjpGh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zIF2be3Qw0uj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zvt8Eosy7jOj" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;125,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;131,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_c20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;267,378&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended March&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1064"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zoPOWkgbWfOe" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1066"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;1,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zG9dcS0Nqmbc" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1070"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1072"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zZHp1S9rdUil" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1074"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;1,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20210331_zyVWquK0WsIc" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1078"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;(1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__custom--OtherMember_zYn8O0Pl7JTd" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1082"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(84,392&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--SG_zkmDBUtj6r8l" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1086"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,319,394&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331__srt--StatementGeographicalAxis__country--US_zWOf7HWrExd2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,016,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,404,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20210331_z9dBKEw4wXKl" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(1,016,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="AsOf2022-03-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">9908</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">9547</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-03-31_country_SG"
      decimals="0"
      unitRef="USD">125490</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_SG"
      decimals="0"
      unitRef="USD">110527</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-03-31_country_US"
      decimals="0"
      unitRef="USD">131980</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">73143</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">267378</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_country_SG"
      decimals="0"
      unitRef="USD">1043</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">1043</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">-1063</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_country_SG"
      decimals="0"
      unitRef="USD">-84392</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_country_US"
      decimals="0"
      unitRef="USD">-1319394</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_country_US"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-1404849</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1016923</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zVZZquQljiie" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_829_z1zM1shZff79"&gt;Subsequent
event &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 27, 2022, the Company provided termination notice to a contractor and as a result the contractor&#x2019;s 30,000,000 stock options
exercisable at $0.05 will be cancelled, unvested, effective June&#160;30, 2022.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>51
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M/,;0JN9!<;<_19L+I<%S_HHV9^=(@R)U83IC;%7WH+CQFQ*.X3/R/ HN\.O
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MX??E?H=J?Z+%QFSRO BM16(.0\X"+O,'X/Y*"'TXR7^@W"<<_0=02P,$%
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M& 7TQ@"^+P4<7=J!N=!V_\"8_0-02P,$%     @ .F^P5-+.(PW, @  10D
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M!9%\UBA;B6SHZ'K@T)/>8@:+KHA8'09AF,.S-?J,ISF;EZV.5#4"'?)78_4
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M!I&D8S7 J*U4"#W"1"3,^A<H@Y@UMINB?-) 6XB![F$>2AGB3I^22J+_D)7
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M4+@TQ*678.LX.&UMP!@6'TL4F!P;8']G4:OVA0\X3-++/P%02P,$%     @
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M"]W*^LP5SD]JW'X/]-;639Y;N. 54W+/;@+.4%89;3A)!*SH+LX4#BO*6-$
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MH3>S&U;TD8+**M#Z6E)3W EV@_&S9_$74$L#!!0    ( #IOL%0\RT[\NP8
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M_4D[?UZFWP3\P,T)&R<12^,T_0;>N(]O[/'&!_#>?&VD6[,_;N;6&:3 G]_
MG/28$X\Y^;><?5.=RNS"UCP35T/4D17F3@RO3T]8"SOPL -^Q&X:5V@C_Q+Y
M(-LT.9 0UE6E59!E21S%<?\WL 4'+M,+EGFIH(7$<@7CK.:&W?&R$23P-#Z)
MXX35 G5*6B<#"?!;5(8P!G:#YG0O>-U)_0@^FQ^Q=]8VNS&QUXV1:CEPA2!I
MJ7,F**48$B(K^HRXH-@_*O:>JP8]A"6SL!XQ4@0I-5=K)KT!\L5H6Z/^&\M6
MA3!BCF>.Y1*Y(.>-@TP2)U&<3J/I>8K&-+>9D;5O%X;*V3*GH6&#\X4N<V'\
M6MW *S0#=H!KW&\ZQ)UW1F8]*=--3GZ!:&MO!2^913.&$7%?2]P!]*V8FYUX
MR5GQM1'*E6M(NL 6M )AR30(>K9L@Y4,[A[/U\?T2XU,VFW2>(D&#0@T>K\N
M[H7)I/4>TW,/TH;;*"=+=H.(2I9TACYPA3:.ANW0H-81!4W4@>W,".(T\C8R
M[@0 .OC\$.U*J^,MVBF_I$)D,<OYVK+G-\T2#9(E:?#@"*Y3#$BC-@#0QSUJ
M3C81QQYNPE*:[,LC(S*]5%2 (? M5RT]%O*.S\NPJ^F4TL(V7+DN;8Q84JX%
M)ZR#%YX>KO*'''6:B@  J+)#Z41[LD0N6\KH3(C<MA9/-NMF+5!Z(0]>P[5J
MC@QK"R?9+9Q)6(ZP??%ANSX;,ZXRG)I 1?GPS5)X@4V" DYHW(0@5]R">-2&
M6HH\=!-8;3,E[8QNDNP/Z)"Z(8W]4ZFDD^#E/#[&9G<MX7D 2EN@(^\1CO8\
MEV0=\DF\I6!$R5MP0LU*;2D]VO)LDTTOT,>P' JQ\ZO@>9OG[QN46$<D06&H
M* . H+F'$)-D_-!']I*YC;YH# #,1N46HG>D\QZF/F9.TSZFY\'\#HHL0Y_3
MUAT+:/L9AW%D6>XS#0C;EO;%S19&5X\L_=]+?JB7(-7E]N9@-&M3>[MM4.4F
M49).HMDX_6\M(SV-)N>GT>EX^H.=(XG&P?X+=)%PLG=%T<M1 <R%4!N!Y+[9
ML']H-K'W=J-YHB?H>2F7(2@*E")I709S=]O$A;X*O6V74^_E)E^[J:5;AO&(
M9QC\T+QF;7 'Z'E\,">;)_-@QS/LA*"!1RJROM(=++&<BSG ED;X#0LIYF60
ML6A/.@P.(7+J64N(+BF7)M'D.YQ<<+DS5TW/'CSU'O"'L>0AI'0:1R !+O=]
MN2]+*B43\LN+)F=1,CNEZU+RN2S15.$.? $<59=>7+!G3Y+9^,7@)LMT0V'6
M?.U/P&/VE"7G$P_0RMRBK2!>C>-&:0>D9T]F:9*\P'PI529KY#!II2'X5NEG
M3,N> <]:KP)[I@G,8P=0J:0Y]HK8H,&>$[NDI*=ZI7W!1.7*ATC'X^@TF6SO
M+2^M[DJ,Z)?.BY?0;(>^[<WLNR>8K+9V=)#VX_*A+=VW&VC0@&ND+7H_DVB:
MH%3/SDBAWJ73]X2.CVX?L%6$IP>/1@#VG-38[,C';=OCI@\P3)LY4?98E9(9
MK_2A07#C\P*5ES7D<FCI/<.HZ'ZNVC^?/S[T>B_\4?38/MC?74Q[XK8V=T"D
M3<)4\[VDG; ;V[6_KKT[3Q&&FUPHZU-"65W*W(\3"ZDP%$G_\M)VZ/8$W(IF
M4'"<QK ;^F@@#&,1V_<2.MIXB:^$6?I/%51]*+/P/M^O]E]#;L)'@ ?Q\"D%
MW"\E^F I%E"-3\ZFPW 8=C=.U_Z3P%P[IRM_60B.DY$$\'RAP55[0P;Z;T37
M?P-02P,$%     @ .F^P5-'+AE2)#0  M#,  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&ULQ5M9<]LX$G['KT!Y-5MQ%2WSII3#58Z3[,[43I**LS.U
MC[ (2=Q0I 8D[7A__78#/, #LAQ[:AX22P30:'1_?1)Z?9>+;\66\Y)^WZ59
M\>9D6Y;[E^?GQ6K+=ZR8YWN>P<@Z%SM6PE>Q.2_V@K-8+MJEYZYMA^<[EF0G
M%Z_EL\_BXG5>E6F2\<^"%M5NQ\3]6Y[F=V].G)/FP9=DLRWQP?G%ZSW;\&M>
M_GO_6<"W\Y9*G.QX5B1Y1@5?OSFY=%Z^]7&^G/!;PN\*[3/%D]SD^3?\\G/\
MYL1&AGC*5R528/#GEE_Q-$5"P,8?-<V3=DM<J']NJ'^09X>SW+""7^7I[TE<
M;M^<+$YHS->L2LLO^=T_>7V> .FM\K20_],[-=>-3NBJ*LI\5R\&#G9)IOZR
M[[4<M 4+V[# K1>XDF^UD>3R'2O9Q6N1WU&!LX$:?I!'E:N!N21#I5R7 D83
M6%=>7,9Q@N)A*=VS)#Y+,KIB^Z1DZ>OS$NCCK/-53>NMHN4::'GTUSPKMP5]
MG\4\[J\_![Y:YMR&N;?N08*_,C&GGF-1UW;= _2\]K">I.<]?-C/]6&OI@[;
M(^ZWQ'U)W'\621ZDA9;XLMBS%7]S J96<''+3RZB.3'O0:_+?/6-Y'L<+N@E
MJ:V,YFM:X!!50\H,DO*>)@5E!5WG*=AE\9)<@[G'5<KE@BT3_ S!'M-5O@,'
M4#!<;/5(%59+C'S="LZ)KGX*REMM47L$M4?_PYD@:N0=7_'=#1?-H$,^5OB=
MP-:?Z@/\+LV)Q^3RE@OP#O3]=RY62<'I9Y&L.'WT"O*I*HN297&2;2QRPS=)
MEL%'/.Z>BR2/:6#YR\BR;<<*;)O.J#T'QP9/O="UHMY3G_Q#L SVHF?PY(PZ
M80#K;/RG9@0V:7:/B9KS8J$FG,*W%S#%"4[)%<M6X(^ SHO0;B@T$[SPE+YP
ME]9R\-@_[1^%9W'_$-[P$,'TT1H6V4W*QV1<UQN>6CYU1D_?50(8(>66-ZMY
M'P#2?%_23QE1CYR%>F117',% &/9/=WE<;).8%W4BJ(!&@4CN$WRJDCOZ::6
M?)E31C.) N2;Q;=)D0O -)PC@?WWR$16 GZS4@!.<>SFGO+O)9>"D_S>\J)$
M$-1\5[!$M ]++G: \;MM CQOV2VG65[2&\XSNN.E1=<BW]%KOB]K,-OR5([D
M0(>X>@K\#G'ORJF2S"]5QAL*+L[5'WCSAV3'=DKD+BKF&,EE*",PW;@"UP%>
MX1,("#GS:VY!4HT8G$8;K7.Y2\HMBDRF!(!@E+'R2TK\*P5K*4-@4G!,#A2I
M 7OS&CST ?!8=!8LK=!; K&4H9'#(7"-,X)*N66EY!V()+L=CQ.8#Z>_ V<G
M^"H70'U.WZ_77.8#!\6Z:NW3[3#9<X& I]:&*&P\DY9M4><1\[V H-3<12N=
MB4E!<W):GQS1F632+2/^5UR4#,-!!_?YD9;9/W,C(["N,L?  L1GGK.THL62
MR@VZ> ",XF<^Y*V!3A-[6N0T$ 0Z"#,+/JS2*FX0T"A9F@0^4#YAU9ZR9YKX
M8*3_WJ'O(>;41QX9I/1'O["LPB#I*O4[?5&T!@//ZNB)MK/ZHTH$1QMBFXW@
M&S@Y]=Q.WQ@\)7,@JAVL40  /3*P1HQ=*%&I4E"*FHYP+I+OFE'"02Y3*?QN
M=[0\>(9" "Y035(6><\6<T%+R)K;Z-U8YKP-E-H9W"';9,BVW!'4C+.',@2<
M(W#S,5T=_M/BT.G^RNZI$TF7Z,.Q"Y35$*(=HR]&JK0Z&)RVW$B'7?L!X"P&
M+<WI5Y#EFB7@XUE:\8%T2><@ ?<%G6&H"RW7!Z<(,U4<F 619[E+MX:\/'7?
MPJ4#DKMK>FB ._"4L(4#T%D&+3UR@)ZNYC'!Q_A2UW*]Q80DZ1F9N?["<A;+
M4]VH^QQ)_W_$X8+0"OWI;>@L2U+S%F088LP[-7Y]DR7_0\_^M1=Q^LH&<7O^
MTG+")0BTZ,)Y%Q? )WS@-T(Y!?>)3B%XDD^80U(-J7\G=0[TM1A>8LJM>PPI
M= D4EBG3NI>P1]JUB5%E8A_SK &_MH')8HC18FC/8N#OS 6GX/C.([ (7$%T
M,8 DB*S(LT_)4Z#X.( $H#"P;C,\+D%?*77\"6S\_6\+UXE>%?1MSH3,IM\!
M)E3JR?9[D=_6N)%BZ\O2""(M+6A11(Y'$>2T)? [<MVXWQKRGQ\,.>28D/,*
M=NHG9X]WRF.(01()Y=;"<2W2>64O<*P0,&,$RB.]L@L*=I;'T"//YI7=R'(C
MDR4L  :^?3K,M/KIU;-;@^6#NUPNO0/V(#W+E*<\: UUO3*-_V%28DU5,;!$
MR]Y(4V,Q/&Q1I5 >0XD&#R##%!RDH>\%U4V7.&+^!*:9Q/H4SH_*^A[*GG[(
M-&LSA/U%E^@B-\-LM?8C2GTX@Q0@6 EAW8)PJZ*Z^2_(?I@L3N%UVAQ9UWGJ
M1->H<6"KI+75P+>6OBU!A^AI@&-AYRDIL;Y2H*(Q5_6,Q 1(#0:3 M)_8#U-
MOF']!H\S242.U]8TKD"5OP**4**W^.P2Q:E(CL&P XU![P_&\EI.;46N:YX<
MZY2?K":#UX2L#E01V8N_5!6RI^%&4[KH*NW(\B<+9^G;T/KJ[AYONGL]\_*\
M!W;Z<V*T8T0'.=X1Z"V?4,;GO!+/4!(2<TGXZ-#K1;[EV@N](')#RXF"HZL%
M8@ZZ'E0>H,$'2#U3O"4S\$VVJ3I90H(13D?;9\L]R;@X"9:6O_ /1%L=(\YT
M#W :K[[ER28U;&+V87ILK5(,DK"/$X[[IGIU4?<OF^DJ#-=9LMM4'%]UQ.J%
MC&I99?4[.BE2?!FB>!,<!-E$YQC8D)M?;4%N.S1 K'? -Q5[2 UXTZE%@UI5
M0O"L!)[RKE5.7X!,P9.?3MK1EL5MVS!K$P[90M(,A?2#(HH<_I6%;B/N(K(6
MGB_9T[N.-.Z0>:@SA?LG(!R!1EUWV/2.I93U='&J-2R[5O 1#<C'-Q=ER[)I
MNJO"J-I4P/"T?V_4S2 8-"U[')_PPC\8?SL/2X[SL(_R?JBWF6?[5@C%(2IU
M7:6IWBPMU7PIB4$SW= _N,M[Q?L1809*Y6%['T^=&6)A0(;G'[VL"%]1IY/L
M<9%E,I1(L'>0:Y<28Y^RUYG,Z* -3Z91/7J!(/>MS7;\+N"H>'$)6![W&YT#
M_48($+)[]?2JEFANP_8]0)>MA];%TK>"MM?XY*H6:CE[N1A1(V-JSU;3.A!P
MHL 49>O1I_5W5*M1O3CX@5;C""3F-.51M7.TL*T /*LYEK>\.I/QO%>>R$B(
M>=QT<'^PW6ZL3LS.<BC*<"I6PX$XN# X/D9M+6BO(7QDJW[4'9D$.=Q+M!PO
M@F@:MI%TX'2K?9[UCL4Q:N*>$#Y5(.O88.!%.<;J&E/;3JJ/UL9#Q>+#KS^>
M11]_7K48>) O@O'\9=7BD2_QC*\NUY60_9.9$T90M'C/^>9RF!MJMS%DN[Q9
MHJ>>HPACN"4@<V/3M9SF!9ZV(1G<LAE?K7DO4W7R#A.(AD!S-X6HNS0_0U:7
M9$6R(K])=!PWC7R$6EE>PJE3/A>2M%"_!>,$ZJ_O&T>"YA4LJ47@X:OVP$#%
M-PT%LC BCE?3&%S'Z3$R/1(H29*ZL>_3T H#;:)73SPP$JAW Z2I>B#_6[K!
MX-:-6U\0B@Z.+H:D/*@-IP]D&AEQX^KG]NJ_[G+ZN6=CXXR$]5K'ZXM-DX9Q
M*) 4FI=.-(B&5Z3J,R]I9!AR[#X)9]GVAD9<F(8:9#0TU&4L_#>ZLM5NJBH9
MXH2C-6X??]J:-K4FXU6.<:>Z4B!>J^; <$#32-#2<!ODND9=F4:"-OH1QVF$
MK5UY&6+./-:BKFYH.K89.*8A!1SO"!)#-DPDH"#W#-@S#8%RAKXTH$$XK7^@
M8QH".A* ;5_/#8UV8!KJP:LEY)@):87B0X<*:6 ;Z9B&@,Y7>3=H^K:AFNL9
M+E2J49^,[FM^:5/IJ[K/@)?3_I6L.77G#@2&N1<9WD?W,_JVV=#5AIC(, BI
M*QGL30'V Q+^K2$L;]2VP;"^\7EVJ:C ,W7IE4Y?>E4!\:$9#H36/*X@AXOY
M+4_SO4Q0F]QD1D/(@<,%?/!"RP'C@MEK7A3J/4PS;6$M@R76\2[@_EI=O+/H
MAF<@UI2J/@UD:$D!,L4&4K.PH'C5(PQ=*IOB[BORX4C! C_UA; 9#; I;$N]
M-'E8A;3+?L8)6=T6RD3(^]J4$34MZ4_<-)83&7;I!EMK/;1U4JSP(K0L0,<]
M.E2YEIU61;/N;<I@3]![GF)FKK)W3+YQPBZ/>4H50W5UH:""@W<U9-N7$*PH
MJIWBL(^D:^T&]6=V+]5Z><<$9- ]6%D2;NK(EQTQ,L#1*%$D7Y+BV]E:W0"I
M6X4"4[R/YY=@7XN(_H29'U0'P$"*)H0#_GS1/96M)\BK"[5&7W";0U*<I'A+
M',?<: &C'W*QYDE908+:[41_0K$+3F3BFN6']*4NK.R4,4SU"Y0*1T+64+3N
ME<##71XL%R0FI/\)Z9Q.W?D_UWY)L>-B(W\O4@ TH093/ZIHG[8_2;E4O\3H
MIJO?L\#9-I NTY2O8:D]CX(3*M1O1-27,M_+WV7<Y&69[^3'+6<Q%S@!QM<Y
M%,[U%]R@_:'.Q?\!4$L#!!0    ( #IOL%1=X6L%OP0   ,,   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;*U6VV[C-A!]UU<0;E D@."+[,1.ZAC(
M91?=A\4&R7;[4/2!ED86$8ET23J._[YG*%FQL[F@W7U(+%&<F7/.7,CIVMA[
M5Q!Y\5B5VIUW"N^79[V>2PNJI.N:)6E\R8VMI,>K7?3<TI+,@E%5]I)^_Z17
M2:4[LVE8N[&SJ5GY4FFZL<*MJDK:S2659GW>&72V"[=J47A>Z,VF2[F@._)_
M+&\LWGJMETQ5I)TR6EC*SSL7@[/+$>\/&[XI6KN=9\%,YL;<\\NG[+S39T!4
M4NK9@\3/ UU16;(CP/BG\=EI0[+A[O/6^\? '5SFTM&5*?]4F2_..Y..R"B7
MJ]+?FO7OU/ Y9G^I*5WX+];UWE&_(]*5\Z9JC(&@4KK^E8^-#CL&D]<,DL8@
M";CK0 'EM?1R-K5F+2SOAC=^"%2#-< IS4FY\Q9?%>S\[)9*Z2D32VG]1G@K
MM9-!+R>DSD"XE#HE-^UY!&.37MHXOJP=)Z\X'HK/1OO"B0\ZHVS?O@>0+=)D
MB_0R>=/A9VF[8CB(1=)/DC?\#5OFP^!O^ [SF\#\ZR[SOR[F#E*D_N\WXHS:
M.*,09_3S%7[;\:0K&M_1.[ZC._1RMBI)F!R=]!J>Z&MAB?;R)J!Z6K2RB_=V
M#*(WZ"J=EBLV62M?*(UW3Y:<%_2(&>/H+/KT;$6@;Y?65,HY8S="&T]PX]P*
M3KRIJ:"I'?/R!8FK0BJTJ@[LKPI%N?CP2.F*-XDO>:Y2LNU>4RVEWH@#,3Z-
MD].$'R;QZ21Y$06+'\*DEC+E06\CYQ 4*/YO8-Y:*"?<TJP0Y$ ,)Z/X-&$@
MP\$H'@_'_T5,##I@7,1B09JL+(-[F6%D**[E *3AX\ZB*[C W(*!R G$?H1&
MFEK.!T3B919J1R?Y(%6YIU0K^TD2C_K]]B&Z0[4BR3AH0,8^(!:JV(EO-["Q
M2P,.%'!=*XN1;EH@=V A\9UPLLR=RA1[::(UVOY0>0P&<?]T@(=??YDD@^0W
M9$5S :A0@U*DS<X476%-64*+^>:]Z*JJH ]3RF6ERHVHJ)J3=1POB9.@2Q-/
M;.LQ>JD;=@IQM[,5N1CGA,;!6C%<!HG<R_HH!("]A2<RVY9BT%)D6ZD+B:4Y
M$1_$J;&HNTCZP(H>TT+J!5)3F97VL5@7"O, =<U?ZT4A%Q@;(4*C3 .QBX%"
M45M)I3/;[@:\2OD O23O61E.Z=HTA66PL"Z &&G_&6,@,GE.EOL!BY5@VP5
M+SA#23_N]\.?< 4"UG,  *$<#NCT'LWXI /7;RT,M]=*N2*P@,G!(#Y&,0W'
M8S;X+I, &[4C<9O6I57LSXAK2D.%M)-6'+*9.#F<'QT^'!T%*4.Q@4>K&3H>
M*0S-^;T#GARXIS':J$D(#().T($SXN"F# 6$5'W1S:P?3.K3(-YK%/"E<"#P
MXCZ*'%1?B/^,511.F*U\3Z&WTHT&(06O2">>2]<5%RYJDIQQ&NMG2(1&S7@.
M<I5I9TJ5A;;)E<9IJ3 ZG<="8!V_P";T N+6_5 +1EGWI:M";^=B5I%=A.NG
M0U@T17U':U?;&^Y%?;%[VEY?CR']0F'NEY3#M-\='W>$K:^<]8LWRW#-FQN/
M2V-X+'!+)\L;\#TWD*IYX0#MO7_V+U!+ P04    "  Z;[!443?"6^X%  #!
M#0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6RM5]MNW#80?==7$%NG
M@ %E+_)N?*EMP'92- ]&@CAI'XH^4-+LB@U%JB3E]?;K>X;2RNLKBJ(/7NO"
MF3ES9N:0.EU;]]U71$'<U=KXLU$50G,RF?BBHEKZL6W(X,W2NEH&W+K5Q#>.
M9!F-:CW)IM-WDUHJ,SH_C<\^N_-3VP:M#'UVPK=U+=WFDK1=GXUFH^V#+VI5
M!7XP.3]MY(IN*'QK/CO<308OI:K)>&6-<+0\&UW,3B[GO#XN^%71VN]<"\XD
MM_8[WWPLST93!D2:BL >)/[=TA5IS8X XZ_>YV@(R8:[UUOO/\?<D4LN/5U9
M_9LJ0W4V.AJ)DI:RU>&+7?]"?3X+]E=8[>.O6'=K%]E(%*T/MNZ-@:!6IOLO
M[WH>=@R.IB\89+U!%G%W@2+*]S+(\U-GU\+Q:GCCBYAJM 8X9;@H-\'AK8)=
M.+^R=:T"6 Y>2%.*PIJ@S(I,H<B?3@)"\,))T;N[[-QE+[@[$-=P4'GQP914
M/K2? -J +]OBN\Q>=7@MW5@<S%*13;/L%7\'0[X'T=_!O\SW:C=?\5[Y0EO?
M.A*_7^0^.#3-'Z]$G0]1YS'J_/]B^55W/*@GOI$%G8TPB9[<+8W.C\=B)TSR
M)$PB]Q]FFWRM*(%)(\U&5-+CKQ2A<D3BS[9<]6A7&&P?A H802W96@0K["VY
MLB71.%LK[ZW;"&,#==G)HG ME4*90( 7TNZI6-K6A4H4CDH5K(LQ2V@,MTKB
MJ)$;CBGL$NM?BO!L@+'X:D4I Z7 3V(W)]@(=JU@A4?PC17^!> Q0V!Y[+^O
M6:M+D1/T*_\3FL(T+#DA<E%;K $,1->TDEIH)7.E5=@ D@U2,V][LS1[EZ6+
MHRS]KT J>4O 0 :AM=Y@86%71OU-96]76 <V1;[99:(#MDO+$\? LY<=+=+Y
MXG ;/=;94/(BU+'X9)+W5%"=@X,LBT,Z1;6WLCCTD5@C)L58Y=!2NZ52K/ K
MZ;9!>WZ$S-$',5JYTY3WC"X6LW1Q^"Y-T.I>^=B>O6GC%-J\02UD;=NNK_8.
MIM-T.IT^VT4=![U# <"](VZL[?65NE5:W& '0[QQDN\_F#DU%M?28"_C6X84
M!40\GC/)@^G!#Z.5SDG364#Z,1[7$+P;51K:B*M*FA2_BI;BPQT5+>]@XM-R
MJ0IN.I:O2BKL36:+[](RA[AYK] +&+(ABVTK)-\P;BX^0MKU\'Z+-HT .#+@
M:,T-'Z=G+YMWU#4QM&EKS#-V=X@/T'CFZP6@7?<-;!3PG%/"P96)?29#G,V
MS;ZC(%3*A0V(W_@??SC*9H<_<0O 5\PY%O=>*\+:B@U)-RQE<*BZEQJG#'!9
MQ<'=S9&3NH^?)A)YEI2CL^RZZ_N! PY8*2]\8UN,0(T=F:U574/$8!UGD GJ
MLE1&!87@[/TQLP)NF#)N;P;<-6&+'1ZR6@##!B)H<.J(JSKM;A&5#=Y&@UBP
ML;C0WJ:B?;V.:"R*#Y96X^2%5CM)9OOBHRG &ZJ#6+=D(+"Y-8B!A),'1>=5
M07=L2#%[(PQ.B. 4I2ZXY7T\EBTA"3%*]R9*]^91R_5U\:P?95OPIK)3\+)U
M/ ;,L59+2I-.!^#-"[6\+P37(#"V+N\AS;YA=AH\VQ<W0,.ZE;<>6R<\?5PF
MM8V$P-5B^N8EB#AO%=\%Z)?>$R.%C;>Z?&8JP ).QCYV,!<LRANG CVQZ%?S
M-J[@+6N%/;53"#Y 8CY-QQG.HFP I2KH$2+&H!A C\/W=?0GK#+9&\ZNX[RS
M;ALN%(8T/3X^YC_1Z!:*A,4'3Q;G%-:\AT#M>*0'1=R;'S\VA_W\9?O%]*']
M[/BQ@]NQ6#RQA]K37<%UB9([';R,(^!/O*<FQ2"LSPBH)A!Y3VPL +-W SYE
MPY6V47RZ]I"84?Y B;M#KM5*QB\"#C[+TMG18BR>.^1-=H[5-;E5_'C@]L=N
MTIVPAZ?#]\E%=RR_7]Y]W. 8N\*F!]Q+F$['AXN1<-T'0W<3;!,/Z;D-$(1X
M6>$;BQPOP/NEQ1[8WW" X:OM_!]02P,$%     @ .F^P5%?X2QDG P  ]@8
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M9@(  "<%   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;*64P6[;, Q
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M"BQ%J^C.[#[AOIYSS\N-<N$-N\XW?1=!WCHR]3Z8,ZBE[K[B<7\.1P'3Y(6
M=!^0AKR[C4*6'P2)Q<R:'5COS30OA%)#-"<GM?\I:[*\*CF.%NLV<_C0HB;
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MXTG4,"Z#Y=R?;?1RKCHKN(2-)J9K&J9?UB#4;A$DP>'@GF]KZPZBY;QE6W@
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M;F&_3MB!XK7Y(G#'E>)K\[IB-&=",P!]P;GJ!EI!_XGH_%]02P,$%     @
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M+&N:^&B\ -U7FNJRWWB X3_$ZB]02P,$%     @ .F^P5$C$7L;# @  0P8
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MISQ((\#[M1!ZMS$!NM^-Z1]02P,$%     @ .F^P5/JM+1'> @  E0<  !D
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M5.;-2LB2:A/*M:]J";1PH)+[. @2OZ2L\K+4[2UDEHI&<U;!0B+5E"65K_?
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M2=4D^AQ!B6O6"+K7N^_8Y3/R?(46-OS#KHM-(B@:2UIV8*= <M5^V6M7AP-
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M WJ_4$15=MR56GU!C?\!4$L#!!0    ( #IOL%1Y_5] F ,  "X+   9
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MFMD]2T8JH((PBCCD4VONWBUC;6\,?A+8BZ,QTI%L&'O1D_ML:CE:$)202LV
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M&ZGD\/9%:2>2U:8I;YA4+=X,"_4( ]<&:C]GZN!T$^V@?]9G?P!02P,$%
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M##H' Z^#_2YQYM\+O4'XX%7^[P>>[ \[[</KM/O3[R6YP<7P5?KO=?[QA07
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MFU,NR')F! N8>[* H>0<[]PI5V Y,Z(&C$9<05I_X\Q(&["EF&OFM!R"6D@
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M%E1_O\^R\O5)O8'+S5)N_@%02P,$%     @ .F^P5(+0/WC& @  /P<  !D
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M?.% 60/<7TMI]A/KH'LSD[]02P,$%     @ .F^P5&?FLM!\ @  DP8  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULC55A;YLP$/TK)]1)K;0& FE"
M*X+4M)VV#Y6B5MT^N_@(5HW-;"=II/WXV8:P3$IHOX#/OO?N^6P>V5:J-UTA
M&GBON=#SH#*FN0E#7518$SV2#0J[4DI5$V-#M0IUHY!0#ZIY&$?1-*P)$T&>
M^;FERC.Y-IP)7"K0Z[HF:K= +K?S8!SL)Y[8JC)N(LRSAJSP&<U+LU0V"GL6
MRFH4FDD!"LMY<#N^6:0NWR?\9+C5!V-P.WF5\LT%/^@\B)P@Y%@8QT#L:X-W
MR+DCLC)^=YQ!7](!#\=[]F]^[W8OKT3CG>2_&#75/$@#H%B2-3=/<OL=N_U<
M.;Y"<NV?L&USD^L BK4VLN[ 5D'-1/LF[UT?#@'C$X"X \1>=UO(J[PGAN29
MDEM0+MNRN8'?JD=;<4RX0WDVRJXRBS/Y+:7,M8=P: BCETQ 01IF;'Q^CX8P
MKB&YR$)C:SE$6'2\BY8W/L&;P*,4IM+P("C2__&AU=@+C?="%_$@X2-1(TC&
M7R&.XO'+\SV<GUV<00BZ(@KU0(&D[T3B"R0?=V+9=>*N[<0 ^:0GGWCRR0GR
M)Z;?+DN%"$P8M((-*&+P6%^'B:)1.OLR(.BJ%W0UR//PWMCO BEP5AZ5,0R?
MP Z)TG -=7O,XQ0HV0V=P[17-OV<,LHVC**@&O[ V3&)+<_4\SCSV>11%FZ.
ME)[UI6>?*[V1G!C&F=D=JSM,$L_2410-G5':RTD'F:SME,C,6J&_+*X-)RY\
MJRO]L!_A@5'4J%;>#C44<BU,ZQG];.^XMZW1_$MO[=I^CRLF-' L+30:S>R%
M4:T%MH&1C;>=5VFLB?EA9?\:J%R"72^E-/O %>C_0_E?4$L#!!0    ( #IO
ML%3XAGZA%P(  '($   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;(64
MVXZ;,!"&7V6$>M%*;4P(>]"*(.70JKW85;2K=J\G,("UQJ:V$[9O7]L0FE;:
M] 8\]LPW_PQCLE[I%],067AMA33+J+&VNV/,% VU:&:J(^E.*J5;M,[4-3.=
M)BQ#4"M8$L?7K$4NHSP+>SN=9^I@!9>TTV .;8OZUYJ$ZI?1/#IM//*ZL7Z#
MY5F'-3V1_=[MM+/81"EY2])P)4%3M8Q6\[MUZOV#PP].O3E;@Z]DK]2+-[Z5
MRRCV@DA083T!W>M(&Q+"@YR,GR,SFE+ZP//UB?XEU.YJV:.AC1+/O+3-,KJ-
MH*0*#\(^JOXKC?5<>5ZAA E/Z ??]":"XF"L:L=@IZ#E<GCCZ]B'LX D?2,@
M&0.2H'M(%%1NT6*>:=6#]MZ.YA>AU!#MQ''I/\J3U>Z4NSB;K\J2^_:@@ YY
M^8E+*+#CUMGOMV21"P,/J#7ZYGW(F'4Y?20K1OYZX"=O\.<)W"MI&P.?94GE
MWP#FQ$Z*DY/B=7*1N*5B!HOY1TCB9/X.&)@&-9D+Y,74BT4@+_[?B]W8B\W0
MBPOP=(*G 9Z^ 7\.\T$EX)&T&W>HD&LXHC@0J,ZG-5!KE/;?)@T]&>"W >XO
MVC&/9_%UQH[GDMC9'+2DZS#M!@IUD'88B6EWNE"K88[^N ^W\1YUS9TD094+
MC6<W5Q'H8<('PZHN3-5>63>C8=FXGP)I[^#.*Z7LR? )IM],_AM02P,$%
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ .F^P5.)+/S>% P  )1L
M  \   !X;"]W;W)K8F]O:RYX;6S%F5U/VS 4AO^*E:M-8FN3E/(ABL2'MB%-
M U'$+7*3T];"L3/;*8-?OY-$U1P^CG9SU!O:V,9]<MR^CY.</%GWN+#V4?RI
MM/&S9!U"?3P:^6(-E?1?;0T&>Y;653+@H5N-?.U EGX-$"H]RL;CZ:B2RB2G
M)]NY;MPH/K !BJ"LP<:VX5[!D__7WQZ*C?)JH;0*S[.D>Z\A$94RJE(O4,Z2
M<2+\VC[]L$Z]6!.DGA?.:CU+TK[C'EQ0Q9OF>0MY)Q>^:PER<2L19)9,QSCA
M4CD?NA'=_!(9-X"#^Z,FV&]*!W"7,L!W9YM:F54[#9[%*#J-K@[;U[Z(Q^Y_
MRFB72U7 I2V:"DSHZ^A MX#&KU7M$V%D!;/DPF[ M>>#'W!5]N<6$"JJE#M6
MV.&NR@Z/$\648#R4 M]YJU6)'*4XEUJ: D0$F1&0V0XA'[((,B<@\YU SEL<
M_-<(<D) 3G8(.:CD/@&YSPMY+KWRPBX%QI+'H=V(/>P,C0-A(\@I 3GEA9RK
ME5$X5IJ 05/8Q@2,$U%C30L%/H(\(" />"'/>C O:ODL\9.%-&5+ZQI<=*TB
MR$,"\I 7\LI@)H,/>T*6FS9U?(=9.ULI[^/E/B(@CW@A?RH#W7>R<%"J$(?W
MF$KO,?/O6=8*W8D MGB,H4BE,#OEK,0*82-RU5*57Y011<\9$U(^29F%<MLV
MXD^@EBX\B^"D\;+;T/1?O1B3,DK*KI2J4J$=U',5M@L9,*\2)J6,DC(KY;H&
M)[OL\[#J6&,R2B,ILT?FS<+#[P8'"=C@WYB+,D?*K XRE0<23BEWI,SR('-Y
MB$G9(V76QZMD%I_NVIKZSS$?)8Z4V1P?IV&'&N^P*9-DS"8A(W&PVAGEEHS9
M+6_3YKT%S\B+%6:YD-O7824IN63,<J%3*(\Q*;UDS'JA4VB 2;DF8W8-C3F)
M,2GU9,SJH3'W8TQ*/=E.U3.-,2GU9+N\<GDXB#$I V7,!J(Q#^/;)Y2!<F8#
MT9A',29EH)S90&_V&Y<0I-(#_^24?W)F_WP$F X(R3MEW.HAMD0(&V-2ZLF9
MU4-B#F\[4NK)F=5#8\:&S"GUY-Q7/21F;,B<4D_.?<N,Q(P-F5/JR9G50V_7
M!XM.J2=G5L][V_5W\G)">6?2>6>T?2Q3PA(#KOR%\WML+Z0N;IQH7_K;2I/]
M]G)OV6A]@6W7YJ>5Y?8IS_8)U>E?4$L#!!0    ( #IOL%0\8?4:C0$  $\8
M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-V4V.@D 0AN&K$ Y@
M6U7X-U%7LW$[\0)$6S&"$+HGH[<?HPO]S"QF8_I;D6Y"\:X>",R_?%W&0WL*
MU:$+V;FI3V&15S%V'\Z%3>6;,@S:SI^N9W9MWY3QNNSWKBLWQW+OG0Z'8]<_
MS\B7\^>9V?K2^?],;'>[P\9_MIOOQI_B'X/=3]L?0^5]S+-UV>]]7.3N7#^V
M@[L=9'"=G&>K[2+O5UO)7>H@A2!-'V009.F#"@@JT@>-(&B4/F@,0>/T01,(
MFJ0/FD+0-'W0#()FZ8-DB#(."9)>L";06I!K(?!:$&PA$%N0;"$P6Q!M(5!;
MD&TA<%L0;B&06Y!N(;!;$&\AT%M1;R706U%O)=!;7UZV"?16U%L)]%;46PGT
M5M1;"?16U%L)]%;46PGT5M1;"?16U%L)]#;4VPCT-M3;"/0VU-L(]+:7CR4$
M>AOJ;01Z&^IM!'H;ZFT$>AOJ;01Z&^IM!'H;ZFT$>A>H=_%.O4.\U#X\>NYK
MO/\[J8[7:_WC]K?E?1.?%\4-9P?_#Y:_4$L#!!0    ( #IOL%28Q"$EH@$
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #IOL%1O"W5][P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #IO
ML%297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ .F^P5.',%03D!   ,Q0  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #IO
ML%05*U(PI 0  ,P0   8              " @2@-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    "  Z;[!4TLXC#<P"  !%"0  &
M        @($"$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ .F^P5"S'2Z:A!   +1   !@              ("!!!4  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #IOL%0J%^4Y6@4  #43   8
M              " @=L9  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    "  Z;[!4&O8.,& (  !O$P  &               @(%K'P  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ .F^P5&CAOG"_!
M50L  !@              ("! 2@  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( #IOL%0*ZL*4A0(  /@%   8              " @?8L
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  Z;[!4P).B
M>2,'   P%@  &               @(&Q+P  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ .F^P5+#K-A/(!    @T  !D
M ("!"C<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  Z
M;[!4/,M._+L&   O$@  &0              @($)/   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #IOL%31RX94B0T  +0S   9
M          " @?M"  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#
M%     @ .F^P5%WA:P6_!    PP  !D              ("!NU   'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  Z;[!443?"6^X%  #!
M#0  &0              @(&Q50  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM
M;%!+ 0(4 Q0    ( #IOL%17^$L9)P,  /8&   9              " @=9;
M  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ .F^P5$^!
M])5F @  )P4  !D              ("!-%\  'AL+W=O<FMS:&5E=',O<VAE
M970Q-BYX;6Q02P$"% ,4    "  Z;[!4VI?^.70"  "8!0  &0
M    @('180  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M #IOL%3^A()2A 4  "(3   9              " @7QD  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ .F^P5-VM^2OT P  $ L  !D
M             ("!-VH  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    "  Z;[!4+G&&LKL%   N$@  &0              @(%B;@  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #IOL%3TZ+;X:P,
M $\(   9              " @51T  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ .F^P5$C$7L;# @  0P8  !D              ("!
M]G<  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  Z;[!4
M^JTM$=X"  "5!P  &0              @('P>@  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( #IOL%17+RG[90(  &D&   9
M      " @05^  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ .F^P5-I'^EF  @  O04  !D              ("!H8   'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  Z;[!4H5/4 28#  !-"0
M&0              @(%8@P  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( #IOL%1Y_5] F ,  "X+   9              " @;6&  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ .F^P5(VQ=(PU
M P  Y0D  !D              ("!A(H  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    "  Z;[!49TD]7-<"  #B!P  &0
M@('PC0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #IO
ML%3%LGZP40(  ,P%   9              " @?Z0  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ .F^P5#6<#Q]> @  S04  !D
M         ("!AI,  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    "  Z;[!4IPENN[X"  #D!P  &0              @($;E@  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #IOL%26!-O"<00  " 5
M   9              " @1"9  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ .F^P5#25.CYM P  "0T  !D              ("!N)T
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  Z;[!479O)
M]GD(   X10  &0              @(%<H0  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( #IOL%2"T#]XQ@(  #\'   9
M  " @0RJ  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M.F^P5&?FLM!\ @  DP8  !D              ("!":T  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    "  Z;[!4^(9^H1<"  !R!   &0
M            @(&\KP  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( #IOL%36S'8GG ,  )$*   9              " @0JR  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ .F^P5(SJ@5&Y P
M Q   !D              ("!W;4  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    "  Z;[!4^?(N<PL#  "+$   #0              @ '-
MN0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #IOL%27BKL<P    !,"   +
M              "  0.]  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( #IOL%3B
M2S\WA0,  "4;   /              "  >R]  !X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    "  Z;[!4/&'U&HT!  !/&   &@              @ &>P0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  Z;[!4F,0A
M):(!  "F&   $P              @ %CPP  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     ,  P  <-   VQ0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>82</ContextCount>
  <ElementCount>182</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>30</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Basis of presentation, nature of operations and going concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern</Role>
      <ShortName>Basis of presentation, nature of operations and going concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Accounts payable and accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts payable and accrued liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Interest, advances and promissory notes payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable</Role>
      <ShortName>Interest, advances and promissory notes payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Lines of credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCredit</Role>
      <ShortName>Lines of credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Capital stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/CapitalStock</Role>
      <ShortName>Capital stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Additional paid-in capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapital</Role>
      <ShortName>Additional paid-in capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related party transactions and balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>Related party transactions and balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Operating segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegments</Role>
      <ShortName>Operating segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Subsequent event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts payable and accrued liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</Role>
      <ShortName>Interest, advances and promissory notes payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Lines of credit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditTables</Role>
      <ShortName>Lines of credit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCredit</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Additional paid-in capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalTables</Role>
      <ShortName>Additional paid-in capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapital</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Related party transactions and balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables</Role>
      <ShortName>Related party transactions and balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Operating segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegmentsTables</Role>
      <ShortName>Operating segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/OperatingSegments</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative</Role>
      <ShortName>Basis of presentation, nature of operations and going concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accounts payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Interest, advances and promissory notes payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails</Role>
      <ShortName>Interest, advances and promissory notes payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative</Role>
      <ShortName>Interest, advances and promissory notes payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Lines of credit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditDetails</Role>
      <ShortName>Lines of credit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCreditTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Lines of credit (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditDetails1</Role>
      <ShortName>Lines of credit (Details1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCreditTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Additional paid-in capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails</Role>
      <ShortName>Additional paid-in capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Additional paid-in capital (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails1</Role>
      <ShortName>Additional paid-in capital (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Additional paid-in capital (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails2</Role>
      <ShortName>Additional paid-in capital (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Additional paid-in capital (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails3</Role>
      <ShortName>Additional paid-in capital (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Additional paid-in capital (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative</Role>
      <ShortName>Additional paid-in capital (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Related party transactions and balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails</Role>
      <ShortName>Related party transactions and balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sfsalr10q051222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Operating segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegmentsDetails</Role>
      <ShortName>Operating segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/OperatingSegmentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sfsalr10q051222.htm">sfsalr10q051222.htm</File>
    <File>alrt-20220331.xsd</File>
    <File>alrt-20220331_cal.xml</File>
    <File>alrt-20220331_def.xml</File>
    <File>alrt-20220331_lab.xml</File>
    <File>alrt-20220331_pre.xml</File>
    <File>sfsalr10q051222ex31_1.htm</File>
    <File>sfsalr10q051222ex32_1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="202">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>57
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sfsalr10q051222.htm": {
   "axisCustom": 0,
   "axisStandard": 4,
   "contextCount": 82,
   "dts": {
    "calculationLink": {
     "local": [
      "alrt-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "alrt-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sfsalr10q051222.htm"
     ]
    },
    "labelLink": {
     "local": [
      "alrt-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "alrt-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "alrt-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 288,
   "entityCount": 1,
   "hidden": {
    "http://alrt.com/20220331": 13,
    "http://fasb.org/us-gaap/2022": 23,
    "http://xbrl.sec.gov/dei/2022": 9,
    "total": 45
   },
   "keyCustom": 64,
   "keyStandard": 118,
   "memberCustom": 28,
   "memberStandard": 2,
   "nsprefix": "ALRT",
   "nsuri": "http://alrt.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://alrt.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:LineOfCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Lines of credit",
     "role": "http://alrt.com/role/LinesOfCredit",
     "shortName": "Lines of credit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:LineOfCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Capital stock",
     "role": "http://alrt.com/role/CapitalStock",
     "shortName": "Capital stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:AdditionalPaidInCapitalTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Additional paid-in capital",
     "role": "http://alrt.com/role/AdditionalPaid-inCapital",
     "shortName": "Additional paid-in capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:AdditionalPaidInCapitalTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Related party transactions and balances",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalances",
     "shortName": "Related party transactions and balances",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Commitments and contingencies",
     "role": "http://alrt.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Operating segments",
     "role": "http://alrt.com/role/OperatingSegments",
     "shortName": "Operating segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Subsequent event",
     "role": "http://alrt.com/role/SubsequentEvent",
     "shortName": "Subsequent event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "shortName": "Accounts payable and accrued liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables",
     "shortName": "Interest, advances and promissory notes payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Lines of credit (Tables)",
     "role": "http://alrt.com/role/LinesOfCreditTables",
     "shortName": "Lines of credit (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://alrt.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Additional paid-in capital (Tables)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalTables",
     "shortName": "Additional paid-in capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Related party transactions and balances (Tables)",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables",
     "shortName": "Related party transactions and balances (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Operating segments (Tables)",
     "role": "http://alrt.com/role/OperatingSegmentsTables",
     "shortName": "Operating segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)",
     "role": "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative",
     "shortName": "Basis of presentation, nature of operations and going concern (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "ALRT:WorkingCapitalDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accounts payable and accrued liabilities (Details)",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "Accounts payable and accrued liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2020-12-31_custom_RelatedPartyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Interest, advances and promissory notes payable (Details)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
     "shortName": "Interest, advances and promissory notes payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2020-12-31_custom_RelatedPartyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:NotePayablewithInterestat1PercentInterestperMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1",
     "shortName": "Interest, advances and promissory notes payable (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:NotePayablewithInterestat1PercentInterestperMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInInterestPayableNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2",
     "shortName": "Interest, advances and promissory notes payable (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2021-01-012021-12-31_custom_UnRelatedPartyMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInInterestPayableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3",
     "shortName": "Interest, advances and promissory notes payable (Details 3)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4",
     "shortName": "Interest, advances and promissory notes payable (Details 4)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://alrt.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestPayableRelativesOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5",
     "shortName": "Interest, advances and promissory notes payable (Details 5)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestPayableRelativesOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative",
     "shortName": "Interest, advances and promissory notes payable (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OtherExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermLineOfCredit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Lines of credit (Details)",
     "role": "http://alrt.com/role/LinesOfCreditDetails",
     "shortName": "Lines of credit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:LongTermLineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfLineOfCreditTableTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:BorrowingLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Lines of credit (Details1)",
     "role": "http://alrt.com/role/LinesOfCreditDetails1",
     "shortName": "Lines of credit (Details1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfLineOfCreditTableTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:BorrowingLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Additional paid-in capital (Details)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails",
     "shortName": "Additional paid-in capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofOptionsOutstandingTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ALRT:OpenOptionContractsWrittenNumbersOfShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Additional paid-in capital (Details 1)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails1",
     "shortName": "Additional paid-in capital (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofOptionsOutstandingTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ALRT:OpenOptionContractsWrittenNumbersOfShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Additional paid-in capital (Details 2)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails2",
     "shortName": "Additional paid-in capital (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Additional paid-in capital (Details 3)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails3",
     "shortName": "Additional paid-in capital (Details 3)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Additional paid-in capital (Details Narrative)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative",
     "shortName": "Additional paid-in capital (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Related party transactions and balances (Details)",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails",
     "shortName": "Related party transactions and balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://alrt.com/role/StatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Operating segments (Details)",
     "role": "http://alrt.com/role/OperatingSegmentsDetails",
     "shortName": "Operating segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "AsOf2022-03-31_custom_OtherMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://alrt.com/role/StatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "ALRT:StockbasedCompensationproductDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000006 - Disclosure - Basis of presentation, nature of operations and going concern",
     "role": "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern",
     "shortName": "Basis of presentation, nature of operations and going concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - Significant accounting policies",
     "role": "http://alrt.com/role/SignificantAccountingPolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Accounts payable and accrued liabilities",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilities",
     "shortName": "Accounts payable and accrued liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Interest, advances and promissory notes payable",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable",
     "shortName": "Interest, advances and promissory notes payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q051222.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 30,
   "tag": {
    "ALRT_AccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_AdditionalPaidInCapitalTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AdditionalPaidInCapitalTextBlock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_BorrowingLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing Limit"
       }
      }
     },
     "localname": "BorrowingLimit",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_CancelledPerShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CancelledPerShares",
        "negatedLabel": "Cancelled per share"
       }
      }
     },
     "localname": "CancelledPerShares",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_ChairmanAndCEOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chairman And C E O [Member]"
       }
      }
     },
     "localname": "ChairmanAndCEOMember",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company"
       }
      }
     },
     "localname": "ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_DisclosureAdditionalPaidinCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "DisclosureAdditionalPaidinCapitalAbstract",
     "nsuri": "http://alrt.com/20220331",
     "xbrltype": "stringItemType"
    },
    "ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Advances And Promissory Notes Payable"
       }
      }
     },
     "localname": "DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract",
     "nsuri": "http://alrt.com/20220331",
     "xbrltype": "stringItemType"
    },
    "ALRT_DisclosureLinesOfCreditAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines Of Credit"
       }
      }
     },
     "localname": "DisclosureLinesOfCreditAbstract",
     "nsuri": "http://alrt.com/20220331",
     "xbrltype": "stringItemType"
    },
    "ALRT_ExercisePrices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "localname": "ExercisePrices",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguished through issuance of shares of common stock (note 6)"
       }
      }
     },
     "localname": "ExtinguishedThroughIssuanceOfSharesOfCommonStock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_FixedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 5.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "v.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fixed interest"
       }
      }
     },
     "localname": "FixedInterest",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 1.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
        "verboseLabel": "i.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1% per month"
       }
      }
     },
     "localname": "I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 2.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ii.\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 0.667% per month"
       }
      }
     },
     "localname": "Iii.InterestAt0.667PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest, advances and promissory notes payable"
       }
      }
     },
     "localname": "InterestAdvancesAndPromissoryNotesPayableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_InterestAt1.25PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 2.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestAt1.25PerMonth",
        "negatedLabel": "ii.\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1.25% per month"
       }
      }
     },
     "localname": "InterestAt1.25PerMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cost of borrowed funds accounted for as interest that was charged against earnings during the period.",
        "label": "Interest incurred on promissory notes payable"
       }
      }
     },
     "localname": "InterestExpenseIncurredonPromissoryNotesandOtherPayables",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lines of credit"
       }
      }
     },
     "localname": "InterestExpenseOnLinesOfCredit",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse"
       }
      }
     },
     "localname": "InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company"
       }
      }
     },
     "localname": "InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableCurrentAndNoncurrents": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestPayableCurrentAndNoncurrents",
        "verboseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrents",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableRelativesOfDirectors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.",
        "label": "Related parties"
       }
      }
     },
     "localname": "InterestPayableRelativesOfDirectors",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableRetiredThroughIssuanceOfShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest payable retired through issuance of shares"
       }
      }
     },
     "localname": "InterestPayableRetiredThroughIssuanceOfShares",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayabletoNonrelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.",
        "label": "Unrelated parties"
       }
      }
     },
     "localname": "InterestPayabletoNonrelatedParties",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate"
       }
      }
     },
     "localname": "InterestRate",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_IntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic Value"
       }
      }
     },
     "localname": "IntrinsicValue",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_Iv.InterestAt0.5PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 4.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iv.\u00a0\u00a0\u00a0\u00a0 Interest at 0.5% per month"
       }
      }
     },
     "localname": "Iv.InterestAt0.5PerMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LineOfCreditTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines of credit"
       }
      }
     },
     "localname": "LineOfCreditTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCredit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_LinesOfCreditFromRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines of credit from related parties"
       }
      }
     },
     "localname": "LinesOfCreditFromRelatedParties",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LossPerShareBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share, basic and diluted"
       }
      }
     },
     "localname": "LossPerShareBasicAndDiluted",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_NoncashImputedInterestExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash imputed interest expense"
       }
      }
     },
     "localname": "NoncashImputedInterestExpenses",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Noninterestbearing": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 4.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iv.\u00a0\u00a0\u00a0\u00a0 Non-interest-bearing"
       }
      }
     },
     "localname": "Noninterestbearing",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 3.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "iii.\u00a0\u00a0\u00a0 Interest at the U.S. bank prime rate plus 1%"
       }
      }
     },
     "localname": "NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_NotePayablewithInterestat1PercentInterestperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 1.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "i.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1% per month"
       }
      }
     },
     "localname": "NotePayablewithInterestat1PercentInterestperMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_OpenOptionContractsWrittenNumbersOfShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options"
       }
      }
     },
     "localname": "OpenOptionContractsWrittenNumbersOfShare",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_Options10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 10 [Member]"
       }
      }
     },
     "localname": "Options10Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options11Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 11 [Member]"
       }
      }
     },
     "localname": "Options11Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options12Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 12 [Member]"
       }
      }
     },
     "localname": "Options12Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options13Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 13 [Member]"
       }
      }
     },
     "localname": "Options13Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options14Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 14 [Member]"
       }
      }
     },
     "localname": "Options14Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options15Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 15 [Member]"
       }
      }
     },
     "localname": "Options15Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options16Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 16 [Member]"
       }
      }
     },
     "localname": "Options16Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options17Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 17 [Member]"
       }
      }
     },
     "localname": "Options17Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options18Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 18 [Member]"
       }
      }
     },
     "localname": "Options18Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 19 [Member]"
       }
      }
     },
     "localname": "Options19Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 1 [Member]"
       }
      }
     },
     "localname": "Options1Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options20Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 20 [Member]"
       }
      }
     },
     "localname": "Options20Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options21Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 21 [Member]"
       }
      }
     },
     "localname": "Options21Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options22Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 22 [Member]"
       }
      }
     },
     "localname": "Options22Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options23Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 23 [Member]"
       }
      }
     },
     "localname": "Options23Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 2 [Member]"
       }
      }
     },
     "localname": "Options2Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 3 [Member]"
       }
      }
     },
     "localname": "Options3Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 4 [Member]"
       }
      }
     },
     "localname": "Options4Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 5 [Member]"
       }
      }
     },
     "localname": "Options5Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 6 [Member]"
       }
      }
     },
     "localname": "Options6Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 7 [Member]"
       }
      }
     },
     "localname": "Options7Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options8Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 8 [Member]"
       }
      }
     },
     "localname": "Options8Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options9Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 9 [Member]"
       }
      }
     },
     "localname": "Options9Member",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_PrincipalBorrowed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Borrowed"
       }
      }
     },
     "localname": "PrincipalBorrowed",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative",
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNoteReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note received"
       }
      }
     },
     "localname": "PromissoryNoteReceived",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 6.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month past maturity"
       }
      }
     },
     "localname": "PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableToRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to related parties"
       }
      }
     },
     "localname": "PromissoryNotesPayableToRelatedParties",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:"
       }
      }
     },
     "localname": "PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_PromissoryNotesPayableUnrelatedLender": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to unrelated parties"
       }
      }
     },
     "localname": "PromissoryNotesPayableUnrelatedLender",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 5.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity"
       }
      }
     },
     "localname": "PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "PromissoryNotesRelatedParty",
        "totalLabel": "Total Promissory Notes Payable to Related Parties"
       }
      }
     },
     "localname": "PromissoryNotesRelatedParty",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Purpose1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose"
       }
      }
     },
     "localname": "Purpose1",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_ReclassifiedFromPromissoryNotesPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassified from promissory notes payable"
       }
      }
     },
     "localname": "ReclassifiedFromPromissoryNotesPayable",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_RelatedPartyTransactionIncludedWithinInterestExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions included within interest expense:"
       }
      }
     },
     "localname": "RelatedPartyTransactionIncludedWithinInterestExpense",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions included within selling, general and administrative expenses:"
       }
      }
     },
     "localname": "RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent paid to a company controlled by the spouse of the Chairman and immediate family members"
       }
      }
     },
     "localname": "RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentOfInterestOnLinesOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of interest on lines of credit"
       }
      }
     },
     "localname": "RepaymentOfInterestOnLinesOfCredit",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentOfLinesOfCreditInterest": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RepaymentOfLinesOfCreditInterest",
        "negatedLabel": "Repayment of lines of credit interest"
       }
      }
     },
     "localname": "RepaymentOfLinesOfCreditInterest",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentTerms1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment Terms"
       }
      }
     },
     "localname": "RepaymentTerms1",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company"
       }
      }
     },
     "localname": "SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest payable due to related and non-related parties"
       }
      }
     },
     "localname": "ScheduledOfInterestPayableDueToRelatedTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduledOfLineOfCreditTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of lines of credit"
       }
      }
     },
     "localname": "ScheduledOfLineOfCreditTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of activity of promissory notes payable to unrelated parties"
       }
      }
     },
     "localname": "ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofOptionsOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Outstanding"
       }
      }
     },
     "localname": "ScheduleofOptionsOutstandingTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of activity of promissory notes payable to related parties"
       }
      }
     },
     "localname": "ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Promissory Notes Payable to Unrelated Parties"
       }
      }
     },
     "localname": "ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_Security1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security"
       }
      }
     },
     "localname": "Security1",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period.",
        "label": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations",
        "negatedLabel": "Cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_StockbasedCompensationProfessionalFees": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation-professional fees"
       }
      }
     },
     "localname": "StockbasedCompensationProfessionalFees",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_StockbasedCompensationgeneralSellingAndAdministration": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation-selling, general and administrative"
       }
      }
     },
     "localname": "StockbasedCompensationgeneralSellingAndAdministration",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_StockbasedCompensationproductDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "StockbasedCompensationproductDevelopmentCosts",
        "negatedLabel": "Stock-based compensation-product development costs"
       }
      }
     },
     "localname": "StockbasedCompensationproductDevelopmentCosts",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of activities of promissory notes payable"
       }
      }
     },
     "localname": "SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_Total": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "totalLabel": "Fair value of the stock options granted"
       }
      }
     },
     "localname": "Total",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TotalOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Outstanding"
       }
      }
     },
     "localname": "TotalOutstanding",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TotalPromissoryNotesPayableToUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TotalPromissoryNotesPayableToUnrelatedParties",
        "totalLabel": "Total Promissory Notes Payable to Unrelated Parties"
       }
      }
     },
     "localname": "TotalPromissoryNotesPayableToUnrelatedParties",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred from promissory notes payable pursuant to private transaction"
       }
      }
     },
     "localname": "TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_UnRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Un Related Party [Member]"
       }
      }
     },
     "localname": "UnRelatedPartyMember",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory notes payable to unrelated lenders, past maturity:"
       }
      }
     },
     "localname": "UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_Vi.InterestAt0.625PerMonthWith125000DueJanuary152011": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 3.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iii.\u00a0\u00a0\u00a0 Interest at 0.625% per month"
       }
      }
     },
     "localname": "Vi.InterestAt0.625PerMonthWith125000DueJanuary152011",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares of common stock outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_WifeOfChairmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wife Of Chairman [Member]"
       }
      }
     },
     "localname": "WifeOfChairmanMember",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://alrt.com/20220331",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_SG": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE"
       }
      }
     },
     "localname": "SG",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r266",
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r97",
      "r98",
      "r161",
      "r162",
      "r235",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r97",
      "r98",
      "r161",
      "r162",
      "r235",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts payable and accrued liabilities",
        "totalLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r18",
      "r209"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r12",
      "r29",
      "r30",
      "r31",
      "r227",
      "r237",
      "r238"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss\u00a0\u2013 cumulative translation differences"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r10",
      "r209"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r4",
      "r61",
      "r80",
      "r85",
      "r92",
      "r103",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r181",
      "r185",
      "r195",
      "r207",
      "r209",
      "r214",
      "r225"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Current and Total Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets",
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r1",
      "r64",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of presentation, nature of operations and going concern"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r3",
      "r209",
      "r239",
      "r240"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "periodStartLabel": "Cash, beginning of period"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets",
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r54",
      "r196"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash, end of period"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r110",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common shares, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of subscription receivable from investors who have been allocated common stock.",
        "label": "Share subscription receivable"
       }
      }
     },
     "localname": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r9",
      "r209"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r45",
      "r221",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive loss for the period"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r47",
      "r61",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r195"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r60",
      "r63",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r200",
      "r215",
      "r216",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r60",
      "r63",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r28",
      "r189",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of foreign exchange on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r46",
      "r61",
      "r80",
      "r84",
      "r88",
      "r91",
      "r94",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r195"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r43",
      "r80",
      "r84",
      "r88",
      "r91",
      "r94",
      "r213",
      "r219",
      "r223",
      "r233"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before other item"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Increase in interest payable",
        "verboseLabel": "Reclassified to interest payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2",
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Decrease (increase) in prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and income classified as other.",
        "label": "Schedule of interest payable activity"
       }
      }
     },
     "localname": "InterestAndOtherIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r41",
      "r79",
      "r198",
      "r199",
      "r222"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r218",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r61",
      "r86",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r182",
      "r185",
      "r186",
      "r195",
      "r207",
      "r208"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r15",
      "r61",
      "r103",
      "r195",
      "r209",
      "r217",
      "r229"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r20",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r20",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payment applied to interest.",
        "label": "Interest incurred on lines of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityPeriodicPaymentInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payment applied to principal.",
        "label": "Advances received on lines of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r20",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r25",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "periodEndLabel": "Balance at ending",
        "periodStartLabel": "Balance at beginning"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r54",
      "r55",
      "r57"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r35",
      "r37",
      "r40",
      "r44",
      "r57",
      "r61",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r80",
      "r84",
      "r88",
      "r91",
      "r94",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r194",
      "r195",
      "r220",
      "r231"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Loss",
        "totalLabel": "Net Loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total Other Item"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Item"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r7",
      "r216",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Balance, December\u00a031, 2020",
        "periodEndLabel": "Balance at ending",
        "periodStartLabel": "Balance at beginning"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r17",
      "r62",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "periodEndLabel": "Carrying value at ending",
        "periodStartLabel": "Carrying value at beginning"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r80",
      "r84",
      "r88",
      "r91",
      "r94"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedTotalLabel": "Operating Loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r29",
      "r32",
      "r33",
      "r34",
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Exchange difference on translating foreign operations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r49",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Interest on other"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 3.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred shares, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r8",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred shares, outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r8",
      "r209"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r2",
      "r16",
      "r104",
      "r105"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from promissory notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sales of shares of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r52",
      "r60"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalAndContractServicesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 2.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.",
        "label": "Professional expense"
       }
      }
     },
     "localname": "ProfessionalAndContractServicesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r241",
      "r242"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r35",
      "r37",
      "r40",
      "r53",
      "r61",
      "r65",
      "r70",
      "r71",
      "r80",
      "r84",
      "r88",
      "r91",
      "r94",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r180",
      "r183",
      "r184",
      "r187",
      "r188",
      "r194",
      "r195",
      "r223"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net loss",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative",
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r205",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related party transactions and balances"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r179",
      "r212",
      "r254"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Product development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 1.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Product development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r159",
      "r209",
      "r228",
      "r236",
      "r238"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets",
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r42",
      "r61",
      "r77",
      "r78",
      "r83",
      "r89",
      "r90",
      "r96",
      "r97",
      "r100",
      "r103",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r195",
      "r223"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule of Fair Value of Stock Options Granted-Allocation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of lines of credit activity"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of related party transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r42",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r80",
      "r81",
      "r87",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Operating Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r163",
      "r169",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of share-based compensation, stock options, activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r80",
      "r82",
      "r88",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96",
      "r99",
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Operating segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "verboseLabel": "Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.",
        "label": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted average fair value options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period",
        "periodStartLabel": "Outstanding, beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Average Exercise price, ending",
        "periodStartLabel": "Average Exercise Price, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "negatedLabel": "Exercised per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Granted, per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r58",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r158",
      "r159",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r9",
      "r13",
      "r14",
      "r61",
      "r102",
      "r103",
      "r195",
      "r209"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r59",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r159",
      "r160",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Capital stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r255": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r256": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r257": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r258": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r259": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r260": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r261": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r262": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r263": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r264": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r265": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r266": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r267": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r268": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r269": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r270": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r271": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r272": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r273": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r274": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0001903596-22-000293-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001903596-22-000293-xbrl.zip
M4$L#!!0    ( #IOL%0[H,(G,P\   *C   1    86QR="TR,#(R,#,S,2YX
M<V3M7=U3&SD2?[ZKNO]ASD^YJC5F;""!#;ME3,BQ:S"'(6SMRY8\(]NJC$=>
M26/P_?77FN_O&0_.1KE)'E(@=;>Z^Z>/;FDDWO_\LK*T#6:<4/N\HQ\<=C1L
M&]0D]N*\\SCM#J>CZ^N.]O-/__B[!O_>_[/;U:X(MLPS[9(:W6M[3G_4;M$*
MGVD?L8T9$I3]J'U"EB-+Z!6Q,--&=+6VL,!0X;5TIAT?Z(.9UNW6D/L)VR9E
MC_?7H=RE$&M^UNL]/S\?V'2#GBG[S \,NJHG<"J0<'@H[?#ET/]7C_V&<"-D
M/CWA:_[VY9[\MIC8[YRKW^W3FRERKIYF$_/E^/>W&%L78O6I/[NW?F7;Y\T1
MGKY[W/XZOG263_^9WMQX3;[GQA*OD 9@V/R\(^WSS7L>'%"VZ/4/#_7>;S?C
MJ4O7\0C/7BQB?\XCUT]/3WMN;4":H7R9,2L0/>C)ZAGB.)0,M:2$GMA<(-M(
MT)LB9(@3'_>\R@0IR24]\4A)0&KB%!W'QL&";GI0 ?3]?D#H\.X"H75(/$=\
MY@KU*Q+$G(DL(12FB;IBN\8\E]2K2C"8@J48$EZ#ZIZLECR'W4.]V]<#SN'X
M_B%D0A83LB>[L@\' Z#"%EYA6UQ1MKK$<^18H/Z?#K+(G&"SHPG$%EC(KLG7
MR, EDH*^C6R;PA" <>B7R++UFD ?AX*_O9>=X8Q1"S^ PIK\ 09?5JZLZ(TH
M3!X=C9CG'>]'*0'DN3),/"<V<1OR1YBN=>5X<J1!\*/+\KZ7)HZ)<#@V)_9/
M[L]KACGPN9J/H<!G]$D*F QD&8ZU&T^D2BZ+7Q!X:&>?72!+CIWI$F/!/=\E
MB\I]V ?'R2D,ATZT36R#=O(G3BUB0IVI^2(U3Z;VYM%&CDF@YE_M=O@=8F#3
M$@L"FN9X/UE?#L7@M5!H;Q+-M0^:T'M\,I^L9?P +?F#HJ"N')*C>I!$LC4Z
MUR+IK1XG<8>/$%]>6?0Y!XNHJAR*XR902.&:*[W54%P@3L#5=S%S;B%J93@^
M%(:V^9%"I [N-#"S@\FL 6<YD"=RU8:HUZ(<Y, O;AL2K;B[?]!LMQU93J,!
MA6Q36\BV-,-KK'583LG"AF#-0+88&@9U; '>N(/^;Q <#*]2DG)TWJ;1B0G3
M4"A-6_OB6N=_WZ.PLF_1S,+0]Z&$.=@<$S0C%C0<P%"+LAR-=VDT IG:VA/J
M#@CDB=6L2&[K8+FV!093Q-#<R.A(SDEWC*X(YY1M;ZG  0P>-O7)RP$Z30,4
M"/Y!0[YH%Z)U*%RSI?0 O];A!$*Q7/49AK78PR)95.IO_3#M;Y=9+A*&R]XZ
M?X[0F@AD304U/ON9<[RDW)MZVIL^K\8E<^M\.31-5SBR[A QN\3VW>%/YT6U
MY3[N9Z;P4 Y, JX@S? DM<[A]]B203MDK6+[P)#-D1$$E'Z6ZR^E=0C+81BD
M8?!% @8@4Q,QH>Z$/?/%M@Z3$5VMB' S*/ NA/0RW,-V%%V6$91C<)29;B)1
MKM.-N+#6>=Y/J.S%%"]<GWC^SA:7>_DX[>50@,9]":US[=29<?RG Z9\V,!_
M?IJ4*BQW:R9MC=@U+/E;Y]0Z^<V#K-DA'_+IRZ'(Y*AULR+MC2>_?3M M?.=
M.&"[,I6CELEE=TR5V@O>.)X@Q0'*JR@'(9.OCI/Y4WN=7!3>)V:P<II2U_<S
MJ6MQ(M!>%&H$^G% ZI.78Y-)A&MF!^T%*A.5QF$IJBP'(9,I9P/7]OJ[R4',
M)1:(6/P6,5F_P<V/=#*2RI',)-NO.N+1WOC-:V'[[<._3O#LNZE^M!TPE*.9
M2=OKA]M^ ^V#JW;HG,!L9ZYRX#([ 3M'W-_QJXF$W@Q O0+!S*9#4P0U_3N&
M56#TFV'8K\ PLUO1&,/^=PRKP!@TPW!0@>'K]RX"# ??,:P"XZ@9AD<5&+[V
MJ#["\.@[AE5@'#?#\+@<PT%F#Z4QAL??,:P"(Y4W-F<OQS2S]](8TQ:GA^/X
M3G BI\BM*4<DLQ$S3F\2MS8OR/.F7NSHBOA^D-DH*?)T"\/WHLWVY"Y'!5&Y
M^[,[&R5;\JWM\Q4^UFLA4342,GL5-:!H8U);X>9^+3 J4M9!9MNA#A@MS$XK
MW#RH!49%[CG(?NU0 XP6IID5;DY%L[6IR\')?J!? YP6QZDU#FP3Z_L.].5
M9;+_VB>\K5WW,Z>X"60*:TMQ.,ID\'F'O/]_+I?_R2<1[O%<<Y]2.)/W]\\[
MG,C'+#I^V9+A^7E'HM -[MG_ :8=O*RL@$2*+GE*P04N[0V_X4 $8D9&2N:I
M!Q BSV3E,5XO4#X0((B0[/$39)FX?(:>T=N'R1::[6HRL&#K"]HZEO+W:B3T
MOEV-3'78+V3J*&IEKP;#T-G5X.1H^T+V7H:-Q,WU7[+H14]9^+^GG[MX#X93
M)C0[\V9&V4,GWA,M8VJXHDI8Y&_=@*\KB[IZOSO0#UZX&6FZBQ*1&W93(N!K
MH$3!<RMY[?,B<OF#VYGJ-EKP;$MIH[D\/6P)'I0T5B'^R,LK='#%[*1$]<LQ
M1>I4<;J_\T:=P/V A&UWZ0AQEN"79FA$S_/4 R*@]T#@_J36I-D&O2#;>&$7
M\-_V\?*;\?W#'_'H^0:O9O)Q':E@,JX.:XAER0WU\XY@CIPEY;--9S![$FH^
MN).\Z7@?:74T;](/GRDZ,^D*$?M:X)6D!-N<&8?YU9'4'QEUUN<=3QP!DC*5
M'^UBI0OJ5%![M$2$K9 M;T1]F"35+JA30>TG,L>3>:!@4NV".A74GJS=1$U/
M*IPI54C5?JZJ?155'>2J.E!1U:-<58]45/4X5]5C%54]R57U1$55W^:J^E9%
M5=_EJOI.155/<U4]55%5_3!_#3A44MF"!4O)%4O/7[)T)=<L/7_1TI5<M?3\
M94M7<MW2\Q<N7<F52\]?NG0EURX]?_'2E5R]]/SE2U=R_=+S%S!=R16LG[^"
M]95<P?KY*UA?R16L7Y!T*;F"]?-7L+YB*YA88I92-%&D@I(%;Q30V.:1^YB-
MIW]MZDK3O%UZ$53Y)\CG'<-_Z\PSV*M<41L+Q+9?S-Q'FWD&C+%M1FC5)5;5
MV''\(\LK,"8?U&HR50U\PF2Q!$V'&\S0 M\Z<F!-YM,E8JY%= 6-N6^[31PA
M-91_7$%>KS6&MGE)+$?(9]S]';S]R-IY3'L4W&UF'YA3SN\P<]4NL+2<Y!63
MTMH7N@<S7$?+ S13_@4+;'.WR36CIF.(2[S!%EU+CA'E(NS(NS+M8.I?VZ_S
M#5FX?^7#FF++@JXG[RB;*V(3+@(ER[Q0S=S<&R:>_>7.@+EYCKG\BR;(NL*X
MH@_D4*MJ;G"AX\.+U!Y/[''R$5#/S$HJ5<V[I;:!^/)ZM9;S3<J,$,5**E7-
MN\=KM)5%DWD"D<"$Z$BQDD[9V2GZ(JWV+:?A3$XT1FC^JT0@_Z? ,XW77,%@
M*MSCD*U^^@N_B O+?7PV.8QWXGS%"BT",7OM!HD>7 QU 9ER<$H]PW?"TH@5
M52H'2O*;[?"3[6)X*AF4 RJI\77XP%@:LQITBL W=58KF*0G\Z$AR,9]%T8^
M/E3XC&#&U-<(4,4'QA*;CH5I@=YN=DHVF-/Y!47,I/-+PK A*.,%/MFCP&_$
M1P\TW*7PL_AFKJDA1SF/^#U_F[%)Q(VIXY-72%+,*^9D'H0:P;US)]JV*_?#
MCKSJ69Y8LJM,+256S#8Z]S>^8SM257VZ!H<B5CY1]ED^JA=<-9L3(\I_BRI5
MW:F\@Y#'(&MD75#&Z'.T&9=7H:H1[IVR.6;0BMPFSE\R[AS&'5#N@8)I&Y@B
M8C?1#@*K]R))V02Y])1$!AJ3*,(844O.HPQ9Y+_8O-@./P8;=8;#8.T9+AAV
MQ4_LH64]+/&0<RS_%!S\*'>XD+V%Z7AB7^(5#.=T=*^")LJE#=(5OB>>B5@&
MBQL2^AUF!I &):#3#;7%,MJ5VIU1U;$<[CP(_:!_?)>RM+"VL3E?>E<Q1"9"
M12SQX_0"V9]A^ECA>^C;=Y;# ZQ*P&T@0EF8-P<1EH<'6:"+ZU4UJ>A4ELMY
M"IN"QO(Y%,QN%QBYLT=FR*:[P1>3_HVX,WYII, G*1)5#?OP(B]*.X1#Z/NP
M!,[%\IK+@,+ N<>Z@;4-^%0]C4@"=X\-#!W7S(<U5JML8!4.P\K="N_;#)Z.
MAUXA0+DPYCHV<^O!O.V>*TFU)O8-8L9RH/</#T]C<5DX\3?E5G6X7Q.26,I.
M3MX&9CU!L'8L'U2(V3>!>7N&V3$8>'24JKN$H2"__G#-/QK:YDF*X!?'VO;?
M0>4)1,)YSE5#%U6A^I3R3A1A2N_H?>D?L.079#O0H Y^T?7 M0UY577%+;6)
M;\[,"R)B1^#9&E7-N"(OT3%]8$&Z4%7E\]>"J;=07&P_0D<"K3"6.Q6C)<'S
M#R]0)V/ R7Q.#)P._V(3:GE4N:\F5'7L Q7(JGNP$&X-[<BDJO$03UF(<S(G
M97M<T?<@-:E5#353W^A<V]"UP<'NIU=Q2V!E<C^"]BWBZ1V'!ORJNR0\9A20
M+A:E%&D_U&7Z9HS/;C@6FIQ+JNHX3VDO*"S<^3-;+<IOQ,R1')VV@'A4?JKG
M_5)D:!&MJJ;&OLT++"GX"K,6I;+9=*"RW-9,0^>7?>T<USL4 UECLHK<GBE5
MOB<]8+;B>J;;A,5?V\_^7[M*1_#98E4][4:-L4/M1#29+%?5A."<+>PF\8*O
MW4'N'+:F'(>ZQ7[_VJH%]UB27_P/&614"Y=TMHU([KR!-WQ&S/0_A1A)=+TG
M_*);!/N5^;4O!7GJ6*"J?T,G-#2W1HTK0!/PN^?.$>2Y<NN5/\%P$-CV[F9Q
M/PJ.+H'6IO_:>$!VSPS"\1V#W#[$(E.J!@XP^\-(Y<3XA"PG'B@D2]50UIWO
M$Y._PCE2P7O-D/M:CHE-N:%)[%1B',4037C5.\1(WV-*I?LRXX7T-_[!2OR%
MN+RM,O=P3GZ-4GA7:K]MJ-J[RJ^(A5MJM4T%@G\3/EU3A^-"U^ZW#55=6_30
MNC?Z8&1XP\^_;.E_1Y6Y<YF^]+9OJ<H-=EB7N6/)TW5Y!W.7;N'E(5[W"F\0
M;1"Q_/Z5'/!_03O*)O53:(=MKRB;8K:1<<20?UJ/*$3KH ]V;WI[>VH0#8&#
M$)3C*31&3 )\#]0;>PUFV:_1L+(HW,-O\JY1V&7<D)3*0/MBFV/I]6H%^H"?
MKM"*6/YKK;&)84_2%/#7^Y[WDB_\^#]02P,$%     @ .V^P5+HJ[?8L#@
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MPB7>JA0G:H>UTS K>Y2EWP CR*?(^0&\5<8=L!A1.VR:AEE9*]?VOEWQ#$T
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M)D5>_7),?J&54/[PVSE\+*[PV(&V:Y@6\Y<XKS*@I?O[&Y7@NRYDHC)'%>X
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M+.V2&)=Q'@8)PW*)?^O&*FAD;1-$"K=+$D[0*Z+(T$G)PA0JSE 5IX3Y/S!
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M\71XDL[[W7'+T25Z(V% 3"$_#K<I4R?G.#8L_>:^IZ-UA<6.SL4S]IJGQH?
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MLR. #?3>@^T';6V[V$#HM5<JW2,H*]]X'W3"&K]*0P2#'&(:T/^_2CL7E]U
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M36QD^"J<-\85-XJ/1IN;7RUSRB+R'G4F Q(??"JC=DQ<S" KZ7G\'$<P'?W
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MU/#D[)[,/JS0[6/9P]+RIH4<6 !^G!G6'J[-+K>:D!4,B<C&[(OERX-5-NL
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MNG1G$X&: .J]%_L((]AXH YL$8Q233><?>\%"2W7"VXM)G[_J-WJM/F-_5C
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MB(1WO&F-M]\0P,NM@8B_1]UX2'A$@GRZ()XG @8M'Z3E5>V!L'_ A%W.9P^
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MO9M/K#J<C8* (ZSGH=@.*_&J$:3Y&27AI ,+5U\0Z4H(E4>I.5K^UK;D(@$
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MI,U1D[#T4^HZ;#L2:3487_Q ,$B<<(<*G5D;6,Z(Q>(X\^*BIK$477WL.26
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M$G=$6%'^\\T\C2Q/Y'X\KI!N-DQYW\1@!YZ M0@3)*FV]BA0>T=F+E#[?9U
M[>.70&T3*W+'!<S58C'RG0OR2#RZ$EJ75L6[?+*]2*C;R/XC$L7:K_T)HWQ-
M"<ZIJLA2HT$/.>=9"VBBKRN<IAFG*>9=)%5/+<J4L$>QG="6](3V/^C<8&8@
MH<LT+G4Y)1X?<_Z9^'S-$%2/G"5?- 2?PH_2"M9HD(-.JE4#KI9?4;66EUBR
M+J6_.\RD4QD&&H(?BE'Z^X#MI'I?]*'.ONCD95^$]@I6O)VX8H1H"EIT\>2S
M^M.'O,?:FV305^W:_F+UV]\5L;G'*-S"JFS@37U4P#</>L?7O3#ZH6]MS:Q2
M!HZ$XPOWT77X\K@G\Z>EXJ#WJ1@">UY:NN'R*Q7)TD3-@3VNS;*/'^:N?)\(
M';HJI@>Z5Y3-B!MRK /N7W)F79:D[),DBM3>M;24G*8I78>=FK870NWW@?VM
MQ9)3D&H']6,=!W4[YHNCBI=UOZ";\2\ON,G=&N?NC(XQ(7]*)[:9U)"MRIU(
M22OX8>'ZGA,9<( $-]Q.GEF>2(H:*,LE?2K:E71 ;E3XB(,P,^3 \IW!0SIH
MP]I)+5RR2?B6VY[MA9*N9[L5+2N_=NV+BROB?'/#A>MOCDKD]P5BK'I#(8<S
M0>64KXY9'[/N0G*R7QN+:\:E&P24K6]I2((D[_X]C4GG"VZPJ^LK[K(6+IE=
M/A$[$K\;SV:N31AOP>V4Y:_E 3X=?A([^JJ.7NQ#"/O2'V[S8_KBXGQ\-1(Y
MF^XIF%S>X#_<8+JBD=1<=/M)['"S5O2G R%TI#\R=A.;***78J.HO&"E?LJX
M+$*S[8]@!Y.UN/8T!+HCK3CGA$6>B):[(B0PT=RDFF\R S838/3(]W/I%%"N
M3-U_%KL\<AW-V9<P.M*E*=_8L_4599N FU'P=75.V8IRE28B^LIEQ.:CC6=3
MSJ/%?TZFT4/ '33>[YXF9K#YM@>!#NS<8'6T#4U<G2UP?BB\_:VZQ_%?5%3T
MX'Y[F=CKY9)/D]@A7[K>.GF"(E_8VAD<NR1VO06M36"13SO&*R(66'\^)?.X
M3)3J;./T;?%L8]M]$*3]L8\Q4C[N")^?<=2[]OA"W@/IL-1>$"?RN!+=D4?B
M1R2XXFI[R67*?,L[CX*0+KD"<<VZH?[\AEL6!Y2_NNFX_4C[JI-O\0RS(=/X
M.; -Z;[1I\BN/V)/5*"5"5**BJ\+2D>9N ,69M0C2-?X6#7X/WZ?<M3C0_C/
MA,Z9M5JX-G>;JE-O\_:*YL]1J&J.N\G*K1-88KBRU$C3< ORY<V1!:;&MBP'
M.2,=9=P6@?'JE^+9%FCGMFILROO."KY:#2X)B/UZ3A_?V#3B^]EUHLOI/W:J
MG/[@]^GG"G#37XK?H1U5F<":H1<=T"]3.:#B=V@^=0U =[R@AS\EBX1\,[3Y
M/?JM7K-=7F$WD^<:70@;[O1[TC[<H[4JB2+KZ+*X)>&US_U_<D,#A4 *S?!O
MIUJ52B4(1D<QZ6_$?T0T/?_)_P-02P,$%     @ .V^P5+JSN *\#   T0T
M  T   !I;6%G95\P,#$N:G!GG99Y/)1MV\?/R3Z%)F7),C=C7T+6&.:6#))$
M,5),XDZX$6*49;*UN,N$1+K'3LDR5"1+LF<IRPB5R S9HK&/:<SU3/?G>=_W
M\]R?]X_G>8[K<_US'<=U7N?W.(_?<5S0*/0%[#Z*M<4"& P&SG$O 'T"E@ N
M(" HP \7%!3<"8?O%)'<+2(L+"*[3QPAB4(J*2H@%>25-8RTE=7TU>05="QT
M]0^9FIN;*QTX8FN)MC$R,S?]N0@,OG.GB+"(S.[=,J:J"JJF_[%!KP%"$#B
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M:JELK1(/-]OI/KYZ=-"U\+O&Q@:37C3"[2H(R!=#H D!@66#Q5>&$$C1<(4
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M;\1>[CG#_?S,'4FT4\4PGDQ2J#NJ^CAPB<:M@+M\>QU_14(?_@%02P,$%
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M(O1E!'QY'<#=ZG!O&R*EP$2&%.3#?,6<A=Q? :$%X@0#.0 R%,]2&TC0.Q[
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M+UO8CT8M; *HY6!E2THMJ6P)+ULR'XU:,@F@EH.5+2FUI+(EO&S)?C1JR2:
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M=D/&!VA_O*T9')C#WY+( +7!^U;N5^B80(@W[C$@L"ET:33@(^BD+<V'%2&
M>3[-+9.G2WW_.=ZL!7A: 8(GK-<_]Q:WC[6NR-ZK9[]LZ?%%\3,,F:=S9"'C
ME[\4UL'?7FDOI8&E'GU((@O0-F%]^=T06?S^^MI$%LD9AD5D[/I$]CEJM[/B
M3P>A_/(?SPKUFZ.OE6I_J3L:=@?P2Z-)--*@X@ ^&2X6ZO><:.R@/T"9K._R
M;X_CM7.'XL6Q?T**^]"N!'4Y>C G-3E1J,EE;BSJG&3G)EOT.FW?YFGEH3^0
MV3U7C,[ )5#_E5-1)G@3XOUFKP>@,8Z$OWR>S-+PW_SJA+]D9OJO@ZOMN^?0
M>9K,,?'D^K/>:FQC9."\XX8^!"H4%V,5#(&LB2^@)D-K!EPKFE8'>J/?X=Y\
MU<(T+]_>2M)S[2&[FT3=^6IL>P6$@I: 3#!G#80$P?<:7-;UZ$M=Y61-PB/D
M"$'L]X&*9J+$7L/V:645\CJ;$K7:U""H_YV<+B2/,]!J69T=NHB6B R7O:)S
M"PT9A$Z:S%";",//RW@[Z^+M%M Y409"E5-ER#::"P]6-J13RY,?Y5P,?3&^
M?WVMWEP76V+RBGK<#"]XLSH/,>M[!?&NWL2(V#^ 2BF6S-!%LLA$UF3O<[I;
MVTN7H-UB2(K.DE0^LF9<2Z5-;FF.>%?LS&P%W1(M[OJ>W^IMO?!3_MMJ;M)0
M/+[Z'LTG??S]"YK%_=N17<%D219:N\6\7Y0]E3";;5/T]@J3(5EH M*9R&H'
MEXH6=HV&<AY!X\B70J]>SE8$NIY+8&GR0BDA/GU(ENB)OR?EJIV--R*8]@Z-
M=9\BBRJF_44_XG'P;%BPSU#)$',2XYJ'>L%IHG9\9.;R:D#6<?2(A RC&RI.
M)U'&0,4?FC)]H$!:0/S! U5&,[:(3ZB+$D&O'.RYQU6BB0AX0K!^? 1>X \W
MX*LAW^_03YN<XIK8'/T$ML.#N W \1''HU@K)T\0A9NMP72%T(< D;LU"95W
M3T+MS^:=:[-YYV?SRUXRJSKSC6B84SJ^(EC; "N";P0^VH)?+QUE;<^!G@V&
MWF*V=;@IK'Z\M72\O9^Z<DE.Z]$L^V^0;+6OR/P;0  NY-IH_49T)F,(8$F%
M2I[_1M2AZC=17U<00C.>.=7V7>B;H+>S_E-^YL7\]^UG>@?LY=B[]9 ?W%PV
MWL$4[MAG-B94 K^KB>&SV<XXM:<QT^M)7<?AS [WFYB9,!"CU\G)&V]>Z-(T
MVYV^_)4&SR5A^-SA-QAO'L0EASKH' ON4 .=XD@,RA09<]0Y3=%=U]!S7LM7
MF<*OOQ77F5Q"'$ ']"H>>CX#G39!__7T]Y=1ERFF'#GH<8T_#PC1S$9;YT\"
M;CS,T=6=H0H <0._&6I$%9*^<&@#K(-FL:\9Y@E)*/XCB>,;C1[<!LE&ICG2
M_5! I2/;EM# KQ0X43W)_SR#]B1FO #9 !K.O+C](72G<O57+W?#*YW.)KV'
M0QQ5N&?LAAVJ;8$9X.0E:#ZLC4]O%!JUU#1/"VCX?UV)8K %%>+TZU!&[H:L
M%,Y0ZU0*;SDJ]\*3$ZWIC;ZUMUVQWA7$[DBS&.:M)#>O5&;PIQ#E).IP C.P
M%%G3D0&L^K/-.SJ#]NQ,W$R7+4;63OB@\P)"\^M:+0XB:_/K+C6^4A5-:ZI*
M'V48=G"/7\2T2-MQ_* [K6OJW90'X]Y+3+,XUVH=N9JS\7HL:_:@26@I5[MV
M+6Z>SJ1M?S=@[-P.&?O @RG)BH_$=$#ND;_N8CXK!"</K$'/FJ=;;^V%JZIM
MJ?)'>TJ ]/4(VAG@1'5N1'J2-B!9T*Q.GVL!#:#H2$D6*M!FDY0Q"M9:&$8E
M -BL?F0KW>EC^WYZT5>-/M@D\7_[$6^"P>M0<<R A'I(T_<T4LKQ+I>@+W:7
MDX%LQFQ2=9.$FKGU44>;J#-_VPIQ- .]=2:6 CIO/SRE#S0-%P9> G.NA<-/
M?\;WM]6+VI]F,R99&YZU9E 2?;"O*6U.JSPOTF+G(E1-&2*!,)E<% I;D3$.
M0^>AQ(EG)IM;*[6!)$$ZO0(RU/D2FK0JC$191(8**LWT54_]YZ%^6?CQ\K/9
M3TC%B+4*DAB8ZS!G 7M60H Y6^8@G93E10FA]C+V2%$V0Q:8;.I9QKYIT0D;
M"FJV0F2EA>N%J6;>AE,#C,1-O8,CS;HI<V9!JU[GY1[<-'^QMU("W*;5DLGQ
MI=#"WB\9^^QB]((FH":J "5.+K?:R$PESEI;M85X"=BH+)LGL]G8Y4P:-4LL
M-/[JP-V=VB%*1(9E2):B;$!\.PEM%S@3V;RNP[T!K?H&E27D$E'FU$E-!R.M
MKLB(H%4%ZU9[.BP>=HA5"E(E2*48C^7N=%RYG!;*6DGC8RI0C%BE(-P09CJV
MU6H%4N_HD.75BH/.&$EBISJ*H:,NVDVW.X+M3KR>\ZG03E5<8J$)G.P]4W&0
M-A6O#69Y>9X#HL?R[56.'H@_)2$!:LGKU&"M4W-IG21M0+*@\2>'HL?B,863
M*]8VR[+Z\>>U.^7K+R]Z1GG4E,SNXVTA! 2=/Z.RB"[LE=BQMG>MI#R;%G]0
MC2)S;-K\*:*=B2QRELD723:WFS9/Q3 JQ/%QD.B8^3A&9E3K7#&CH40G0)F$
M[<NRJ&?>(;T&;N7.?)-4N,2T6=%[%O'+F]2S2"PT_FK!/<^V#G3O*8JI"LPP
M5_:AU1_3;>5YDSY_4:F \%0!U^(Y,XEK)U9QO!NE.Q/)J"MMABR$2-!=(G\3
MB['HY2)-4G2.+#*K VRI$'R/0M"=TA*FNW1)UU6Q9^!"_8[2Y%2X09[H"\O\
M;;%<:\),DE <X1-]66ROGL3=2A8T_K13"$D[EXH*MTLN&RIJ3S_IH*;UII I
MR4+':6'? KS$:9K8A[2"OQ4>#4U'*9=(_)4:Y5H+0!"G0+@;*W*;DT!#O1:?
M#=3' 5[N;O+?G:IW!>W/K<;6,\5DQWZJ;_R0DP? U<"?@*IAUMI?'B 9CQ#H
MZLSVCCV%!%'2SJR6(ILV#UZGEJC )+F6:--!L\F5_\F"QE\;E;WSJ.;%QTP[
M3%\>,MFG^L],HQCEN)>(XWCE!2L%R1C<FQ J 5$1]L#F4?3I75F:';AQ.W4A
MLV2^L+IJ)<$B.8%[M4_G=8=AO;!5+ZES&[M*R'4!#^T^971Z^H E,Q!*<"-1
M9U #C35M]*W)F7W7F$'7&$W4*YE'Q5^B9,![N].Z7 *:]$/I15I?&+'JL)=*
M<.9:"1DO%O7V")CSZIJ!2D*XX:)Q'8A@+ON@#4I?"5:Z;G6^1D$1$>NDY3-7
M,[YSX;<V==.-#;NQFRJP@&UEH*%!9T@JE[R\[M2#V8>ZHAUUA8(=3:!B6EG0
M0OFWY\[X8OQ8DT%RM1!.MH:NBJESDJ%68C2*L>19LFMQ: I?J[AIRQ?J+#I]
M\<X\F(TV:ROIO_.M"C6&)%G-G]\O=(<[S&+Y.(ML.J\BAGD5V71>13H#(J89
M$&5.&Q*7DO*:SH#8'M)T!D029D!<=&F:Z4YO+U^*8^I-^EUGMYX!X7#)0<^
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M7E=Y'XH(C<I8=WMA:&;X(>'%P"'A%]WI+6BIO]7BZTW;21Z*<DBXU]+[$*/
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M>JI$L87<R?GI;'4!$G!O]F$Z&O#@"3%%[?Y3&+*K1@.VS32@B\D5='@YJ (
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M)*ZQUQ<1QQMV7Y 8:O?3@L1U$LBC#D=$79"X.>NG!8G>3<]%'Z?85T'B3N0
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M]=)[?BE\&9QZ*('O[XCH7(!__@LG''[8 /[RGVSGIG9^>/<L>R>C$_%UKT:
M@L(J.A0\DP&@XWOY<;7WY[;5S5_?7UX>Y?J0!/?%C^-.<);^O<)-9/OD _<
MV/T#5^!*7Z>%EG%2^Q1S\USIV._Q/[5_@;/M[CP<54ZOKB^N3\Z.[KFSJ\K^
M/_^M_>N[WI,O'NZO4*BGI==N\2Z7GV?Q4:[S2C.)L;MC:EQ%4R6B&B#!P9\H
M.Q&Q^?>QK(H@>H,P<&_"![9=9(;UI^'P[Q1%:'[63PPA*>L_UG36T?RAI1/"
M @@,[DC%_NXA/:UG6CE0C9]UX:;Q^'IS4DK,R7\#:?$1Y"I8*#U9X_M,BQ.J
M/>TV<YJYT1J'%\E9W*,J6A(N;K95 8G\W1$/?AL_WVYD*2FK&A N!A<T3SF
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M!F0)4\,>!+0!*%]*%8HECJ+!TX&P\27V ^L'DD-YG6X8'N%UZ#B\",ET"OZ
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M2UD@NND[<E&IO-YC+?5D[-(<QP[DIO;S^4F[?2T=DKE$B$1H)!&';^6JO99
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M!7XAE G 2:,47A<-D[[862;%!#M%[(5.&0H @-%3/S9&CME'6>&J>/<.P<J
M:G4 J@!'J\VT9EOK]N!IMD!U_L"V5W3W &2[.XRG&9K*5&NW+3CR#Y?IZ)1B
M[W//+4(WU6QI!ADYE*.:P[L5K/CK?B 1MM$,HFQG@.E2.T#8=:'&'OCBHR4C
M:F&QDHS-4*@508,3())LWT@\F1JNK@O<EUXK:F+0E'VD",AYF/4!SRIL/'8H
M;$#Z,AP)5HOG""!2@.?:38IQ]1_V!F!'>G?Q1-KG[MC%#]SSE-V>O0F:(5[[
M_M-/V9"B,A][O^\NV^00Z!^^FSMFD^>0MAD,?A1E,K;Y-'!B;?&5>&*)CUCB
MN$>?]98(,T'V[#1?_H;/V7?K_JABWZOONSL=2S<LN,ZXU_?V6'SFF_@]A?^I
MXW^RB'<^]TWZS@6XBT),V+<]6Q7\P>VE]S/(.&"J-O.S%^6;GSLWEX1GT$_[
M;XI6C ;%FTH&_MGZ?^%,F^ZFI@-FJ1 $.-,)'"35RE'BD54\#Z!F0#<I?02H
MV'?4JXEM8P47/H # *P'!(/0CCVPV7!.:!@;2J<I(]*)0ZU5C2)(1X+ [B;^
MVAA)ZE,^FI-"8971'#_)\5$+>R#G$MIT$@=R[@,L&FF7LUC-QXI@( .)NWV9
MD2&&7P@'L=-LQ E0:8IJ@_3?%!2QB<Y*AL/YX$IA*3@\WG=%Q(:?JF3ALA29
M[AU@$G>-;L<0$KH_%IO4]?E,'&Q*6*M:E-NL"[G79@GF8'4H<?0.R[Z/N+DP
M0PL>KB-&1%75+':VQ-MAUM=<)^^R02DG%;_=1N>C>+Q[K S#^$O M0)'Y*#7
MI6\V$<,V)0$FL_)2YYH(ST"U2,>D@&7<EAAU7>XXI+Q/WAP\>V:)]X0 ^WO#
M$3_'X B>HH*UPW[%3@<PZXI)H<J;2>HM*AXY?"3L(: 9'0UE$8/H[W+=?M*1
M?QR"DF)$R)&@45+&YT!8#5("ER?2L>#%AEP#)F=VV>_]S@@D43^X;_)WI'<6
M$V;@?F#K.W0<4/KG3<H5[+'WM;NP;@I>('^G#B8=2&2+"DDPZX;,+)V:J^M2
M2@H/PWA(F( ($_0TH!44O\=S8YHWS%U$^>G-DG5TE6A ,CI4_0TR'/I.>%*B
M%?#=<V8B"6,V@"BJ%N!_ARC8]CM=2<"5 (XJ3)A2#/*!;[8U"A\J/#$2K1T#
MMH#=G;I=OX=)_*)/[*.M'6K(E)C?1[50;:<BB4T9!_4>>H!^'BP&)+10KAM@
M-NS&U#SI: 3M7WERL294[]H"?E3WVZ<:KGVJ#XKTK_1L ]&9G(1^)-T#'LC_
MH,"Q)\4Z"'T2E0@H\A_W[T'0*)=OM@!(R#+.5+R^H%"^N59,IEJBNJ30#KNH
M7W[(*$T"F:'J#]!%1?$D>$H;7/- NXW"7PL@X%IOZ).. 27PA&-MJ8L=H.C*
M[@YU,F_1D9!EE UJKO*,'(,HP2-EQAO'4C5@&K*,_D_@R-V/?)JCCWE2HQ]0
M%/N;\L7=@_WQ[@X:(3GXA'OP"T!G:GT_!+2P-RA'$2E^4"T[F""S#2:((Y@@
MLZG!!(F^(/_4_KU^1^V!?$3MAUW!SG63<(=,=K]$D^*B6DA8V/L'RP9">KV[
M(V-\&8B5HD]]809^U588;5,(6FSI%SII$=6@BEL'U#P175&:U_2NC@*FK:DR
MWQ;3,$50O#5F]3W4K297EMJR"AJ[;GNAOMELY/BP[%@DN;I"J)B*/_I'_O>4
MB I(J&>J8_Z[ ?8FVLHM=;76:?*"\Y'GT<JC.91SAC@]NRG[!H$UH4G,=-<
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MU/'(^@*S6*0<>[EL#ML2>!EL7X$9.GTC!>V[(:_G F]O,6MT6S;9LC\T79%
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M(*I)^$@ JL98\^!)P(+5("'N3!/,#6/8M*DS#<PEJ-^F91-O-3";2Q="0<;
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M?AGU#Y^PHB&XCGKFR'S15-DF/ I-C-=!Q\M[L6H?G 8*))TDIW!5 ]=S:"1
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M8]!@A54)(.7*,$["*T88I@0>*2KU2TH];@5(BMF\U3W$&9"$A0.*AI;9@TL
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M/R'DX:/I$EO1.Q['-0+/%7KG7KC<BU(QZB*TK,T516FEAI-?J=%DOY>5'U&
M)L&^ZE!+1Q9O\,7B2DF:)*Z4'F[DII3\WPL?"21HIQS%%YGY.40BPJ)?([I.
M/Y(26L2@;@_OY:)V-$-#G*O6BW6\-9^/%*4?<Q&5,J4?/?]L+M*R_9CYBX7B
ML@,/RXJW!M<XW;3M.&]B*9_[T4*<S_YL)<Y&NV<_9O[Y\K)M6!(\34:S&J.)
MY5%\"IE/5G;#R^^H.G7B;)*2(_EG'TG)D9P<R3_IV$E&LTI'\HP783QQJZ$3
M=Y56+QE-7$83SP!W%0I$H!\+8<G\6)^Z^<\ 1^/O=>2*Y1\]_^BLX8^9OIA?
MMM.YK MTW71D_9M<G1,CEABQ'SS]Y1NQ!59JQ7][II[!]Y3.9/K)])=MGY;E
M9)T31SA=#E1@K&S\(P=+*I?YV6 GZE>*A1^] MG2S_8MLZ5Y&J]YM=-):(&C
M"6<-:G !F^73PSI [;2%+'; ^Z]!3_&)]'=]V1:RI;^%C5]<ZG\+T#P$>%3;
M,J/N]E\@.U%T>-MH[H%R=B0SC2!8VS&5)\YHBVRQALTX4>'%OW*(JQ0VQ,S?
M_GLYF;<_D_?X^*24P*EV@<9O?8VW.)CJNW3PMP1?K+.>*M#JD/$'ZI'9]K?G
MY#$#:G0Y9 '*%Z7,OT#\>EBI7 I-S9 -(*45.D2V78O@!\1_>:<5_D.@3O=8
MO1E;N$4Z9H\M"3""PS!LUH=F:'>Z%@'^=,;N;;I SFN@CL-S@&Z6_I?QB)M-
MP?1Y*4?>KIK J6LZ0EON,9I>.F/94I$)F'[(@(%0-X.NQ\UV;5N F6W3E?5[
M+;@V]G,(3PABQP90K./FD)ZLN] 9![KG>/3#0T/"#=4<-G'>'4*CVZL@?\6D
MU4\AQ:[_%+K,L"R<"UWSXM>RHE@$?C\-[VXLZ"ZC;5E"]_@3R=N^%:M?0O>8
M"$:D8"1TCPG=8T+WF- ]?L,G?3G=8V3XCX7T\MLY'W:\PRY" 0AJ++ZW#-['
M"?CA.#$-3H  QVD*$U"\<9K".!!WN72/'XK,E\>C\F50X-JD<(5F*+JKLC:W
M]OL5S![V*P5]&X<K_7G+QG<(,&(9"Y4R/SH6_,-A)E+A9Z<"\M*WK7R>9"XG
M^#MHXL*F=#=D2F.:[,QG?W;]5:[TLQ.=N9]-:R$NG45WNO*K299J=8L<DM'$
M931S3]-/EP.3DCZ_$Q/ZX<QSD+=\*^_L9?YY2U._R?UT^7.X!V*P#[/-/">_
MOJ:ZA%[I-+H@="K0'2_XV#271;P6FDU(Y<H\S8M-N.%""(^"=L9X\[2(SF9!
M7U$YO:X+M4.>LO5_Y2?UKT'0;>&"=\&>:^_49;=)E9(VJ8MHDRHE;5+CA6<8
M>A*^2B6*R4 =_S#H"32G_^N_'NG>^MIAR Q51ECWN I^#ZQ',.4W+.^(B048
MD,9:O]BR3JTY#]?!SZE1!CR/9ZL[ 8RG2RS;- RBI]X\=M;7S"YB=H0>/:58
M%]7HI]#1]0@;+_VC2@2[;?;96%,"=+;W^F:/'F)T[[NP_81^H*DI)"7T2<.F
M?G,XT+B^QF8-C_>69F0=Z&%HNJVVH,H#JH!;]#]A%%2L3I+8RN\>8OOH<4[W
MF4$34^$]%]JR.J.;8?K\=#PZ;0_! 07N.-CT6/# D-2Q0.C?^AJT@9\A\$T?
M35X@9 ZOFPQ#&W:GR@SBR%&-8WA%.L#U-1A.*N1LJ19]JP%?EPW_<1BEYPI,
M/RP/+'IJ^T.+5.FNK.$*A-2P(VLP71ZPI^XE_ 55GQZQFJS;ZVOH=05+-^)S
MP3#@QZA53,5A4:ENVL2!(0^]60:!>R* Y;,)N)Y"4[,Z0N@5="$ZQ )8I/;*
MS$I7EPTZC$E.[9XF-XA#WU$S=9?G,=B(<$G9COFCPM_0B=*'#>@  .W(/FD:
M'A9R"@E87QM:9WQ;6S9:#)QH$3H"A6Y5 \2);IP,8%Q=-_OV/]]%<[\%RG"Z
M6%%PS+XA$?\DP*,$D99 %1/!2*"*"53QAT 5OPJ<5I@>G%9[XT8[(;Z37PA"
M;?3C/G/\G!%JGQK]V]BH"5,0<W-NY_OU4RAD/S6#+X9X#0EX/2ILLO#.*I%"
MNZRTUFHU>9E],,M#OPQ)TBV/FK'<"KU==WC:A2AM@[ZL-5CTVJU4>YR5:@OU
MU5+U>:-DV$UB"3*](#LIH<EB2CX2]-DU'29<7]( +1*BMZRMC#QJEC682'A3
M+*S5V4C8<()OMZB%$R-1OTLS#RMU'F^(4PYG.2V]AL3H<B1,OG"YB434+0\0
M]&X#Y64-[2,+M2*FZ5130)98"H58'>T+6GRNDE2MEFW<F/+T7P%C5&O+%FF;
M.I!G0-K+->AK,?V\\ -DI<S2:KG>'W#85L00'9@6H9^!I#0F(W^4G[W"9]L'
MUFF95821LL4J7R;E/T=O=MX;8X7^_]FU']$.V(^9_L9G^)/GX4M,<0Q$.Q%N
MPP$>\X7',3(?"!XL\)B.;L&[-!/_U=>71=CX287A<=9K*?>S"W:G<(M^S%K,
M3Q:^RM*_K[/UL.W_PDV92[EQTD;^1\]_?FWD$W+A%:K#N62\+^MK$<0OTU;?
MK/924)\;>' =C9'8TG\'R/()G#=!W4D(ZR[_%FQB]30%$/*6V=-45B2@T!=:
MLN*8ECU2!8,W[\;O .;O/9;AXR->SQ#NWM?]44PLXN%/AO?^*DCA6H4KD96'
MCM0#0*$/+QK@M3]8G@ELOE&KX1"Y,U2.\2M;&'^+.-<"G$@A253\4RKN$SY1
MR<,$[/=0[?&9C57.V:QNV<\_LV!83[--:^"7SBG4'90U8X@:"^BMX8=$30FR
MJVH.?CHE./*+]SQJ5/@/+:)8+KWC66P4*7KJM<+L6F\6?WM%>"U+-KBJ#@UD
M6]CW"Y= AU4-JGFP$):..43P[EA:PW5X6=*(MN,(QE[%BV^"$ILH>C"5A$NB
MLNB6!Q3F[Q3NK*\%E3O>@X21I6:O 4[Y#EUP**%R":R"OZJALJ09RH5"94VR
ML;X6+L4*;4]D1=2VL!<0V8=KW28\)+"RT]0,K;HI_$AAD/3^M(;*T\/%U)FQ
M4NK,>^7J< T+>:'\T9Z!&?%1_=\N@+BBE V6;W(\:0%;5P%Z?!L+,H49_FFX
M]#OTBW0,%CWM@>)?UI'B'W3)3G%>0:S)9%S_GM4$T*&G$K*A=:CLMPG];IL:
M)&I/J28/KT2XS#X1J[B(U;Z_Z;/)%3LL45;HWO(>#G[I*EASV^UV3<N)J!G%
MM!1I:<P:U^A#Y"[PI_!JS=D&<F-H8(EKT#'#3B0R_A)9=>S9)("Z%ET3W)6.
MUN+Y3BI^OEC]"W*5R$7LY0)NR3J9W5+!^66QLGC3*XOGW7V@:KAK$>I9(DF
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MBLZN>-25>,+)=CO%R#]1IQ5+ZX*)XE2A>,K0)T&I.0' CH<NLA=?K;W:$K%
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M4FD(- F,*"8)S>:7F$5E$]C5 V\_D82T8P8NL$A(#JN.VZ%$@5=D&O2<\@F
M1T4MQ8]3OZYVY .1YZ@71V;G:8H7/.KR$#EQZ )KTF.3'G*)0"R'\!7*D62[
MO;YV #4G\:Q"BEGIR701W;]P7P2^+0D6_',7DF_4>R^A4$T$(U(PQLE4OZB
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MQQK/>8@(QPWH%J&!*, 5RDU##(NP#X3C(</G4X'<UBG]6;6?@X*L$YI%*'0
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M90>U4_,V@Y>K4F6U/Y-G*,A$8:LFLF_A7O&IA<F&UJL<B(RGGDBDTLN4PYS
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M="TR,#(R,#,S,5]C86PN>&UL4$L! A0#%     @ .V^P5&,-:STX#@  [+(
M !4              ( !P1T  &%L<G0M,C R,C S,S%?9&5F+GAM;%!+ 0(4
M Q0    ( #MOL%3 PU-EBCH  &PO P 5              "  2PL  !A;')T
M+3(P,C(P,S,Q7VQA8BYX;6Q02P$"% ,4    "  [;[!4 AZAU0 G   Q80(
M%0              @ 'I9@  86QR="TR,#(R,#,S,5]P<F4N>&UL4$L! A0#
M%     @ .V^P5+JSN *\#   T0T   T              ( !'(X  &EM86=E
M7S P,2YJ<&=02P$"% ,4    "  [;[!4 .13KB < 0!?Q P $P
M    @ $#FP  <V9S86QR,3!Q,#4Q,C(R+FAT;5!+ 0(4 Q0    ( #MOL%2Z
MX#[<)P<  +LU   9              "  52W 0!S9G-A;'(Q,'$P-3$R,C)E
M>#,Q7S$N:'1M4$L! A0#%     @ .V^P5' N^DJ6!   /!<  !D
M     ( !LKX! '-F<V%L<C$P<3 U,3(R,F5X,S)?,2YH=&U02P4&      D
,"0!5 @  ?\,!

end
</TEXT>
</DOCUMENT>
</SUBMISSION>
